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CHAPTER 1 
INTRODUCTION 
HAEMOPOIESIS 
Haemopoiesis is the process by which very large numbers of a wide 
· variety of mature blood cells are generated. Haemopoietic cells can be found 
in many tissues of the body. In the adult animal, the bone marrow, one of 
the largest organs in the body, is the primary site of haemopoiesis (Metcalf 
and Moore, 1971). The bone marrow is a complex tissue composed of cells 
belonging to multiple haemopoietic differentiation lineages of 'various stages of 
differentiation, although most bone marrow cells are mature cells. In the 
bone marrow cavities all morphologically recognizable blood cells are pro-
duced, i.e., erythrocytes, megakaryocytes/platelets, monocytes/macrophages, 
neutrophilic-, eosinophilic- and basophilic-granulocytes, 8-lymphocytes and 
T-lymphocytes. Once released into the circulation the mature cells exhibit 
highly specialized functions and fulfil the vital roles of oxygen and carbon 
dioxide transport (erythrocytes), blood clotting (platelets), antibody produc-
tion ( 8-lymphocytes), cell mediated immunity (T -lymphocytes), and response 
to invading organisms and their by-products (granulocytes and macro-
phages). 
Most of the mature blood cell types in the circulating blood have only a 
short life span, varying from several hours (monocytes, granulocytes; 
Springer et al., 1979; Whetton and Dexter, 1986) to several weeks ·(erythro-
cytes; Metcalf, 1984). This "programmed" cell death necessitates the constant 
production of very large numbers of new blood cells throughout life, even in 
unstressed (steady state) situations. The continuous replacement of termi-
nally differentiated cells is regulated with great precision and the levels of 
circulating cells are maintained within narrow limits of variation (Metcalf, 
1985b). Yet, under conditions of haemopoietic stress, like bleeding or infec-
tion, the haemopoietic system is capable to respond rapidly to the altered 
demands by transiently altering the output of cells of the appropriate 
type(s) (Metcalf, 1985b; Whetton and Dexter, 1986; Clark and Kamen, 1987). 
Derangements of the complex process of blood cell formation do occur and 
result in a range of diseases from anaemia to leukaemia (Metcalf, 1985b; 
Quesenberry and Levitt, 1979). 
Clinical and experimental data suggest that all the mature haemopoietic 
cell types are derived from the same ancestral cell, i.e., the pluripotent 
haemopoietic stem cell (PHSC) (McCulloch, 1983; Metcalf, 1984). PHSC are 
believed to mediate long-term haemopoietic reconstitution after bone marrow 
transplantation (Van 8ekkum et al., 1981) and are characterized by exten-
sive proliferative capacity, the ability to generate progeny committed to one 
or more of any of the myeloid and lymphoid differentiation lineages and the 
ability for self-renewal. The ability for self-renewal does not decline during 
the natural life span (Schofield, 1978) and makes the PHSC essentially 
immort<JI. However, it is still not known if the self-renewal of PHSC under 
normal physiological conditions leads to the production of daughter cells that 
are exactly identical to the parental cell. 
The existence of PHSC is recognized for many years and was first 
predicted from studies assessing the reconstitutive capacity of transplanted 
bone marrow cells following total body irradiation of mice (Jacobson et al., 
1949; Lorenzetal., 1951; Vosetal., 1956; Fordetal., 1956; Nowelletal., 
1 956). Convincing evidence for the existence of cells which can give descen-
dants in all haemopoietic differentiation lineages was obtained using radiation 
induced chromosomal translocations as lineages markers (Wu et al., 1968; 
Abramson et al., 1 977) and, more recently, retroviral integration sites (Dick 
et al., 1985; Lemischka et al., 1986; Keller et al., 1985; Williams et al., 
1984). 
Based on the results obtained with both in vivo and in vitro clonal 
assays which will be discussed in the next sections, many investigators 
divide the haemopoietic system into three compartments of increasing maturity 
and size (Watt et al., in press; Till, 1976; Ogawa et al., 1983; Till and 
McCulloch, 1980). These three compartments comprise: 1) the PHSC, which 
are not usually undergoing mitotic divisions during normal haemopoiesis but 
have an extensive capacity to generate; 2) committed progenitor cells, which 
form a transient population and are predominantly dividing and proliferating, 
but have lost the capacity of self-renewal. They are "programmed" to differ-
entiate in only one or two lineages. These committed progenitor cells 
generate and are thought to be primarily responsible for maintaining the 
level of 3) mature, morphologically recognizable haemopoietic cells. This 
subdivision represents an abstraction, since development is I ikely to be a 
process of continuous change rather than a series of discrete steps, except 
perhaps at the level of the genome. Thus, each cellular subclass is likely to 
be heterogeneous in composition (Till, 1976; Botnick et al., 1979). The three 
compartments are depicted conventionally as "J.ineage-diagrams", an example 
of such a diagram is shown in Fig. 1.1. It is assumed that the transition 
between compartments are unidirectoral, always leading towards increasing 
specialization and an associated loss of proliferative potential. 
Regulation of haemopoiesis appears to depend on interactions among 
haemopoietic cells, stromal elements and a variety of growth factors 
(McCulloch, 1983; Dexter, 1982; Metcalf, 1984). Despite of the fact that a 
number of models has been proposed concerning the regulation of self-
renewal and commitment of PHSC (reviewed by Metcalf, 1984) it is still not 
known whether the above mentioned interactions direct commitment to parti-
cular lineages or whether the commitment process occurs at random or is 
programmed and microenvironmental factors merely influence the probability 
of self-renewal or differentiation commitment. However, it is obv(ous that a 
balance must be maintained between the three cellular compartments. If too 
many cells were to differentiate the haemopoietic system would soon undergo 
exhaustion; if too few were to differentiate there would not be sufficient 
input into the progenitor cell compartment to meet the demands (Chervenick 
and Boggs. 1 971). 
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A schematic representation of haemopoietic stem cell differentiation. The 
capacity of pluripotent and multipotent stem cells for self-renewal is indi-
cated by dashed lines (low capacity) and solid lines (high capacity). The 
morphologically recognizable but immature cells in each differentiation lineage 
are not shown. For details, see text. 
IN VIVO ASSAYABLE HAEMOPOIETIC STEM CELLS 
Much of the knowledge and understanding of the complex process of 
haemopoiesis has been, and still is, derived from the development and appli-
cation of a series of both in vivo and in vitro clonal assays for haemopoietic 
cells (reviewed by Metcalf;-1984). In ,-961~11 and McCulloch described the 
first clonal assay, i.e., the spleen colony forming assay. These authors 
discovered that when haemopoietic cells are transplanted into lethally irra-
3 
diated mice, nine days post transplantation discrete macroscopic colonies 
could be detected on the spleens of the recipients. The number of spleen 
colonies appeared to be linearly related to the number of transplanted cells 
(Till and McCulloch, 1961). Later it was shown by injection of bone marrow 
cells with unique radiation induced chromosome markers, that cells present in 
an individual spleen colony carried the same unique marker (Becker et al., 
1963, Wu et al., 1 967). This suggested that spleen colonies were derived 
from a single cell, thus were of clonal origin. 
Analysis of the cellular content of spleen colonies has shown that 
erythroid-, granulocytic-, megakaryocytic-, and monocytic cells were con-
sistently present, either as pure populations or in varying mixtures (Fowler 
et al., 1967; Lewis and Trobaugh, 1 964; Curry and Trentin, 1 967). This 
multiplicity of cell lineages present in spleen colonies indicated that spleen 
colonies were derived from a pluripotent cell operationally called colony 
forming cell-spleen ( CFC-S). In contrast with cells of the different myeloid 
lineages, cells of the T-lymphocytic lineage have never been demonstrated in 
spleen colonies (Metcalf, 1984), whereas the presence of B-lymphoid cells is 
still a controversial issue (Paige et al., 1979; La Ia and Johnson, 1978). 
It was shown in serial retransplantation experiments of individual spleen 
colonies that a proportion of these spleen colonies contained cells that could 
form new spleen colonies (Siminovitch et al., 1963; Lewis and Trobaugh, 
1964). These observations led to the conclusion that some of the original 
CFC-S had the capacity to renew themselves. In addition, it has been 
demonstrated that cells from a single spleen colony could reconstitute the 
complete haemopoietic system (both myeloid and lymphoid) of lethally irra-
diated animals (Trentin and Fahlberg, 1963; Till and McCulloch, 1980; Wu 
and Liu, 1984). In many respects, therefore, the CFC-S possess the charac-
teristics of pluripotent haemopoietic stem cells ( PHSC). 
It was recognized that following bone marrow transplantation only a 
fraction (3-25%) of the total number of CFC-S reaches the spleen and forms 
a colony, the remainder entering other tissues such as the bone marrow, 
liver and lungs (Quesenberry and Levitt, 1979; Lahiri and Van Putten, 1969; 
1972; Lahiri et al., 1 970; Till and McCulloch, 1972; Schooley, 1966; 
Siminovitch et al., 1963). The fraction that settles in the spleen and forms a 
colony is called the spleen seeding efficiency (f-factor) and can be deter-
mined by secondary transplantation of the spleen shortly (2-48 hours) after 
marrow injection. Since only a fraction of the CFC-S reaches the spleen and 
gives rise to a colony, the number of spleen colonies is called the number of 
colony forming unit-spleen (CFU-S) and the colony forming assay is called 
the CFU-S assay. The development of the CFU-S assay made it for the first 
time possible to quantitate the frequency of PHSC in various haemopoietic 
populations and has been proven invaluable for characterizing the PHSC in 
terms of their biological and physical properties and cell surface character-
istics (see later section). However, the pluripotency of CFU-S and hence the 
usefulness of the CFU-S assay as the endpoint for PHSC has been, and still 
is, a matter of debate. For instance, it has been observed after injection of 
bone marrow cells with an unique chromosomal marker (Wu et al., 1968; 
Lemischka et al., 1986) that cells repopulating the thymus, lymph nodes and 
spleen of lethally irradiated recipients carried the same unique marker a·s 
cells present in spleen colonies. Together with the absence of at least one 
class of lymphoid cells in spleen colonies, this led some investigators to 
conclude that CFU-S are not the ultimate PHSC (Metcalf and Moore, 1971; 
Schofield, 1978; Ogawa et al., 1983; Curry and Trentin, 1967; Trentin et 
al., 1967; Curry et al., 1967). In this view, CFU-S and lymphoid cells are 
both derived from a more primitive stem cell, the true PHSC (Fig. 1.1). The 
CFU-S are regarded as multipotent haemopoietic stem cells (MHSC) with the 
capacity to generate cells of all myeloid lineages and the capacity for 
self-renewal. It should be realized, however, that the absence of lymphoid 
cells in spleen cell colonies could also be the result of the lack of the 
appropriate microenvironment for lymphoid development (Wolf and Trentin, 
1968; Metcalf, 1984). 
More data suggesting that CFU-S were not the ultimate PHSC have been 
obtained. It has been reported that a loss of the repopulating ability of a 
graft could occur with (initially) little change in the number of CFU-S 
(Ogden and Micklem, 1976; Ross et al.. 1982). In addition, it was shown by 
Boggs et al. (1982) that to cure genetically anaemic W/Wv mice, less bone 
marrow cells were needed than was expected on the basis of the number of 
CFU-S in the inoculum. Analysis of bone marrow regeneration following 
treatment of mice with 5-fluorouracil suggested the existence of a more 
primitive stem cell, i.e., the pre-CFU-S and that the CFU-S assay does not 
adequately predict haemopoietic reconstitution (Hodgson and Bradley, 1979; 
1984; Hodgson et al. , 1982; Van Zant, 1984). 
A part of the observations described above suggesting that CFU-S are 
not the ultimate PHSC can be explained by the finding that, in contrast with 
what was initially assumed, the CFU-S form a heterogeneous population in 
which a hierarchy consists of cells with differing self-renewal capacities and 
with differing abilities to allow prolonged survival of irradiated mice 
(Rosendaal et al., 1976; 1979; Hodgson and Bradley. 1979; Hellman et al.. 
1978). The quality of the CFU-S appears to depend on the day the CFU-S 
are examined (Magli et al., 1982; Wolf and Priestley, 1986). It is now 
generally accepted that spleen colonies visible 7 to 8 days post trans-
plantation (day-7-8 CFU-S) are derived from different cells than the spleen 
colonies visible after 12 to 14 days (day-12-14 CFU-S) (Magli et al., 1982). 
This is consistent with the early observations of Siminovitch et al. (1963) 
who showed that day-8-10 CFU-S did not contain new CFU-S upon retrans-
plantation, whereas most day-14 CFU-S did. In other words, day-8 CFC-S 
have no self-renewal ability, while day-12-14 CFC-S do have the ability to 
renew themselves and therefore must represent more primitive stem cells. 
Besides the difference in self-renewal capacity both types of CFC-S appear 
to differ in a number of physical properties (Worton et al .• 1969b; Haskill et 
al., 1970; Metcalf et al., 1971), differentiating potentials (Mulder et al., 
1985; Mulder, 1986). sensitivity to a number of cytostatic drugs (Schofield 
and Lajtha, 1973; Botnick et al., 1979; Hodgson and Bradley, 1979; 1984; 
Johnson and Nicola, 1984; Ross et al.. 1982). cell cycle status (Baines and 
Visser, 1983) and cell surface properties (Harris et al., 1984a; Berman and 
Basch, 1985; Mulder et al., 1985; Mulder, 1986). Based on these differences 
it was suggested that day-8 CFC-S are the progeny of day-12 CFC-S. 
At present, the relation between CFU-S and PHSC is still not clear 
although it seems that at least a proportion of the CFU-S (day-12-14 CFU-S) 
is closely related to, and might even be identical with the PHSC. 
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IN VITRO ASSAYABLE HAEMOPOIETIC STEM CELLS 
Following the description of the CFU-S assay, a series of semi-solid 
culture techniques in which the progeny of the individual stem cells can be 
recognized as clones or colonies and thus can be enumerated and analyzed 
has been developed (Piuznik and Sachs, 1965; Bradley and Metcalf, 1966; 
reviewed by Metcalf, 1984). These in vitro clonal assays revealed the 
existence of different types of haemopoietic stem cells each with unique 
properties. 
The first haemopoietic stem cells that became assayable in vitro were 
the committed progenitor or the precursor cells. Assays for thistype of stem 
cells depend on the identification of colonies consisting of mature cells 
formed from a single progenitor cell and the time in culture at which these 
appear. The progenitor cells that give rise to a colony in methylcellulose or 
soft-agar are referred to as colony forming units - culture (CFU-C). CFU-C 
are restricted in their differential capacity to only one or two lineages (in 
case of granulocytes and macrophages; see Fig. 1.1) and produce colonies 
consisting only of one (or two) mature cell type(s). From this it is generally 
concluded that CFU-C have no or very limited self-renewal capacity (Suther-
land et al., 1970; Metcalf and Moore, 1971; Metcalf et al., 1979; Suda et al., 
1983; Whetton and Dexter, 1986) and act merely as an amplification compart-
ment for the production of the mature cells. Even under steady state condi-
tions most CFU-C, in contrast with CFU-S, are actively dividing and prolif-
erating ( Lajtha et al.. 1969; Rickard et al., 1970). Thus, committed pro-
genitor cells are capable of extensive clonal expansion to supply the need of 
the haemopoietic system, but they need to be replenished from the self-
renewing stem cell pool. 
CFU-C most likely represent the precursors for the immature blood cell 
types and form the earliest committed progenitor cells in each lineage 
(Metcalf, 1984). Lineage restricted progenitors are identified by the type of 
progeny they produce in the presence of specific growth stimulating prepa-
rations. The eight groups of mature haemopoietic cells (Fig. 1.1) are 
thought to originate from lineage restricted progenitors and CFU-C of all 
myeloid I ineages have now been identified. Progenitors for T- and 8-lympho-
cytes cannot be identified in these clonal assays (Watt et al., in press). The 
generation of T- and 8-lymphocyte colonies has been reported (Metcalf et 
al., 1975; Rosenszajn et al., 1975), but the cells that produced these 
colonies showed functional and morphological properties of relatively mature 
cells. 
The survival, proliferation and differentiation of the committed pro-
genitor cells appears to be absolutely dependent on the presence of a group 
of well defined lineage specific growth factors (Dexter and Spooncer, 1987; 
Whetton and Dexter, 1986; Metcalf, 1985b; Nicola, 1987a). Haemopoietic 
growth factors or colony stimulating factors (CSFs) are soluble glycop.roteins 
which exert their stimulating activity at very low concentrations ( 1 o- 1-1 o-13 
M) (Metcalf, 1985c; 1986b). Some of the CFSs will be discussed in more 
detail in Chapter 6. 
CFU-C, like CFU-S, are a heterogeneous population which is reflected 
by the amount of progeny they produce (50-10,000 cells/colony) and the 
concentration and the type of growth factor(s) needed to stimulate colony 
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formation (Bol et al., 1979; Bol and Williams, 1980; Gregory, 1976; 
Wagemaker, 1980). 
In the late 1970s an in vitro assay was described that allowed the 
detection- of colonies in which commitment to one (or two) differentiation 
lineage(s) had not -yet occurred (Johnson and Metcalf, 1977; Hara and 
Ogawa, 1978). These colonies appeared to contain cells of the .9.ranulocytic 
(neurophils, eosinophils and basophils/mast cells), erythroid, megakaryocytic 
and _!!!acrophage lineages (Metcalf et al., 1979;- Johnson et al., 1980; 
Schrader et al., 1981). Hence, the stem cell that generated these colonies 
was called CFU-GEMM (Fauser and Messner, 1979). Some controversial data 
indicate that the human CFU-GEMM may also have the potential to develop 
into T-lymphocytes (Messner et al., 1981). CFU-GEMM derived colonies have 
been obtained from a variety of mammalian species including mouse, rat, cat, 
dog, sheep, cow and man (Dexter and Spooncer, 1987). Colony formation by 
CFU-GEMM is stimulated by (a source of) interleukin-3 ( IL-3). 
Further analysis of the cells present in CFU-GEMM derived colonies 
showed that besides a variety of mature cells and committed progenitor cells 
these colonies may also contain CFU-GEMM, indicating that CFU-GEMM have 
self-renewal ability (Humphries et al., 1981; Metcalf et al., 1979; Johnson, 
1980). Together with the variety of cell types present in CFU-GEMM derived 
colonies this indicated that the CFU-GEMM are multipotent haemopoietic stem 
cells (MHSC). The self renewing capacity of CFU-GEMM appeared to be rela-
tively low and not all CFU-GEMM derived colonies gave rise to new colonies 
upon replating (Humphries et al., 1981; Metcalf et al., 1979). It has also 
been shown, by transplanting CFU-GEMM derived colonies into lethally 
irradiated mice, that some CFU-GEMM colonies contain a low frequency of 
CFU-S (Humphries et al., 1979; Johnson, 1980; Metcalf et al., 1979; Johnson 
and Nicola, 1984). 
The exact relationship between CFU-S and CFU-GEMM is not (yet) clear 
but these cells clearly represent overlapping populations (Ogawa et al., 
1983; Nakahata and Ogawa, 1982a; Dexter et al., 1984a). It has even been 
suggested, on the basis of similarities in frequency. sedimentation velocity 
and proliferative state, that CFU-GEMM and day-8 CFU-S might be the same 
(Hara and Ogawa, 1978; Johnson, 1980; Till and McCulloch, 1980; Metcalf, 
1984). 
In 1982 another in vitro detectable MHSC type was discovered (Nakahata 
and Ogawa, 1982b; Ke~and Phillips, 1982). This MHSC gives rise to 
colonies in methylcellulose cultures stimulated with (a source of) IL-3. 
Colonies appear after 6-18 days (Sud a et al., 1983). The formed colonies are 
small and the cells within such colonies show no sign of terminal differentia-
tion but all have the morphology of blast cells. Hence, the colonies are 
called blast cell colonies. The cell that gives rise to these blast cell colonies 
is called S-cell or CFU-"stem" (Nakahata and Ogawab, 1982; Ogawa et al., 
1983). S-cells are not actively cycling and are thus relatively resistant to 
treatment with 5-fluorouracil (Sud a et al. , 1983; Nakahata and Ogawa, 
1982b). 
Replating of these blast cell colonies resulted in a high frequency of 
secondary blast cell colonies, indicating a high self-renewal capacity of 
S-cells (Nakahata et al., 1982). In addition, analysis of individual blast cell 
colonies showed that these colonies also contain high numbers of CFU-GEMM 
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and day-8-9 CFU-S (Nakahata and Ogawa, 1982b; Keller and Phillips, 1982) 
and a variety of more restricted progenitor cell types (Suda et al., 1983; 
1985). No evidence is yet available regarding the potential of lymphoid dif-
ferentiation by 5-cells (Williams et al., 1987b). Together with the observa-
tion that replating of CFU-GEMM derived colonies resulted in only a few 
secondary CFU-GEMM derived colonies but not in the formation of blast cell 
colonies (Ogawa et al., 1983) this indicated that S-cells must be more primi-
tive multi potent stem cells than CFU-GEMM. It has been suggested that 
5-cells might be the precursors of the more numerous CFU-GEMM (Nakahata 
et al., 1982; Nakahata and Ogawa, 1982b; Ogawa et al., 1983; Keller and 
Phillips, 1982; Metcalf, 1984). Since CFU-GEMM and day-8 CFU-5 appeared 
to be very similar cell types (see above) this indicates that S-cells must also 
be more primitive than day-8 CFU-S (Nakahata and Ogawa, 1982b; Ogawa et 
al., 1983). It has also been shown by Keller et al. (1984) that the spleen 
colony forming cells present in blast cell colonies could not give rise to 
day-12 CFU-S. This makes the relation between S-cells and day-12 CFU-5 
unclear, although it is evident that both cells must be closely related in the 
hierarchy of haemopoietic stem cells. 
Another type of primitive haemopoietic stem cells has been described in 
studies on the regenerative capacity of bone marrow cells from mice treated 
with 5-fluorouracil and has been identified by its requirements for two or 
more growth stimuli in order to generate colonies in agar cultures (Bradley 
and Hodgson, 1979; Bradley et al. , 1980; Bertoncello et al. , 1985; 1986; 
1987; 1988; McNiece et al., 1986; 1987). One of these stimuli must be a 
source of macrophage-colony stimulating factor (M-CSF), whereas the other 
must be an enhancing- or synergistic-factor. Growth factors and growth 
enhancing factors will be discussed in more detail in Chapter 6. These stem 
cells produce very large colonies consisting of thousands of macrophages 
which demonstrates the extensive proliferative capacity of these stem cells. 
The stem cells giving rise to these huge colonies are therefore called high 
proliferative potential-colony forming cells (HPP-CFC). Initially, it was 
believed that HPP-CFC were primitive macrophage progenitors but a recent 
report by McNiece et al. (1987) suggests that HPP-CFC derived colonies can 
be replated and in addition to macrophages also may contain cells of the 
granulocytic- and megakaryocytic-lineage but no erythroid cells. Thus, 
HPP-CFC may represent another MHSC type. This was also suggested by 
earlier data. It appeared that HPP-CFC are not actively cycling (Baines and 
Visser, 1983; Hodgson and Bradley, 1979; 1984). In addition, it has been 
proposed that HPP-CFC are more primitive cells than day-8-10 CFU-S on 
basis of their relatively resistance to 5-fluorouracil (Bradley et al., 1980) 
and are closely related to day-13 CFU-S because in experiments to purify 
these cells both were enriched to the same degree (Baines et al., 1984). 
Furthermore, a strong correlation between the HPP-CFC content and the 
capacity of a bone marrow graft to repopulate the marrow of lethally irra-
diated mice has been found (Hodgson et al., 1982; Berton cello et al., 1985). 
Cells with marrow repopulating ability (MRA) are regarded to be more primi-
tive than day-12-13 CFU-S (Hodgson and Bradley, 1979; 1984; Hodgson et 
al., 1982; Bertoncello et al., 1985; VanZant, 1984). Thus, the exact 
relationship between HPP-CFC and the other multipotent haemopoietic stem 
cells and the pluripotent haemopoietic stem cell is as yet unclear. 
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From the above described studies it is clear that there exist several 
different haemopoietic stem cells capable of self-renewal albeit to a different 
extent. The observation that of the different MHSC types not all cells ·have 
the same self-renewal capacity, reflects the heterogeneity and also the com-
plexity of the haemopoietic stem cell compartment. The process of differentia-
tion commitment is still poorly understood, but an attractive theory on basis 
of data derived from both in vivo and in vitro clonal assays holds that hae-
mopoietic stem cell commitme~is a random process (Till et al., 1964; 
Nakahata et al., 1982; Ogawa et al., 1983) and that stem cells are arranged 
such that more primitive cells have a higher self-renewal capacity than do 
more differentiated cells (Hellman et al., 1978; Rosendaal et al., 1979; Ogawa 
et al., 1983). 
ENRICHMENT AND PURIFICATION OF HAEMOPOIETIC STEM CELLS 
Traditionally, haemopoietic stem cells have been identified by morpholo-
gical criteria (Van den Engh, 1976). The different mature haemopoietic cell 
types all have their characteristic morphology (Bess is, 1977). This approach 
has been of limited value when applied to haemopoietic stem cells. PHSC and 
the various types of MHSC and committed progenitor cells cannot be distin-
guished from each other on basis of morphological criteria (Van den Engh et 
al., 1981; Spivak et al., 1985; Williams et al., 1987b; Till and McCulloch, 
1980). · It has been postulated that both CFU-S and committed progenitors 
may resemble traditional lymphocytes (Yoffey, 1973), while others have sug-
gested that they may be blast cells in appearance (Van Bekkum et al., 1971; 
1979). The lack of a definitive description of the morphology of the various 
haemopoietic stem cells is mainly due to the very low frequency of these cells 
in the bone marrow ( Fitch~n et al., 1981; Metcalf and Moore, 1971; Boggs et 
al., 1982; Lord and Spooncer, 1986; Van Bekkum, 1977; Van Bekkum et al., 
1979; Dicke et al., 1985), and the very heterogeneous cellular composition of 
this tissue (see Fig. 1.1). The frequency of haemopoietic stem cells is too 
low to make any direct measurements. of their properties (Visser and Bol, 
1981; Lord and Spooncer, 1986). In fact, the quantities and qualities of the 
haemopoietic stem cells can still be determined only retrospectively from their 
abilities to reconstitute the haemopoietic system of lethally irradiated 
recipients or from their abilities to form colonies in vivo and in vitro. 
Colony forming assays have the disadvantage that they take at least 
seven days and that not the stem cells themselves but their (mature) 
progeny is analyzed. In addition, there are often a number of cellular stages 
between the measured progeny and the ancestral stem cells (McCulloch, 
1983). Thus, the critical events during the initial stages of differentiation 
cannot be studied or manipulated using colony forming assays. Highly puri-
fied stem cell suspensions would allow direct analysis of the early molecular, 
biological and biochemical events taking place in haemopoiesis and further 
definition of the properties of the various stem cells. These suspensions will 
also be helpful in investigations and possible manipulations of the conditions 
which lead to self-renewal, commitment or differentiation of the various stem 
cell types and in exploring the relationship between PHSC, MHSC and CFU-C 
(Harris et al., 1984a; Bertoncello et al., 1985). In addition, studies on the 
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mode of action of various haemopoietic growth factors and the role of acces-
sory cell populations can be studied with purified stem cells (Williams et a_l., 
1987b; Strife et al., 1987; Civin et al., 1987; Hoang et al., 1983). 
A major drawback in the development of procedures that would allow the 
resolution and purification of the various haemopoietic stem cells has been, 
and still is, the paucity of these cells in haemopoietic tissues and the lack of 
specific distinguishing probes (Hoang et al., 1983; Mouchiroud et al., 1985; 
Van den Engh et al., 1981). Past attempts to obtain various haemopoietic 
stem cell types in pure populations have relied on differences in physical 
. characteristics between cells of different maturation stages ( Shortman, 1972; 
Moore et al., 1972). Differences in sedimentation velocity at unit gravity 
(Worton et al., 1969a; Miller and Phillips, 1969; Miller, 1973). buoyant 
density (Turner et al., 1967; Shortman, 1968; Bol et al., 1977). adherence 
to glass beads (Metcalf et al., 1971) and cell electrophoresis ( Bol, 1980; Bol 
et al., 1981) have been used, but none of these rather nonspecific techni-
ques resulted in such a resolution and concentration sufficient for useful 
practical application (Van den Engh, 1981; Fitchen et al., 1981; Lord and 
Spooncer, 1986). Equilibrium density gradient centrifugation, however, is a 
frequently employed separation technique in combination with others. Another 
currently used technique for the separation of cells is counterflow centri-
fugal elutriation (Pretlow and Pretlow, 1979; Inoue et al., 1981). Using this 
technique the cells are separated on basis of cell size. To provide a more 
homogeneous starting population and to improve the separation, counterflow 
centrifugal elutriation has been mostly used to separate and purify stem cells 
from mice treated with cytostatic drugs (Nijhof and Wierenga, 1984; Williams 
et al., 1987) or endotoxin (Pioemacher et al., 1987; Ploemacher and Brons, 
1988a; 1988b). 
More specific and better separation and purification can be obtained 
with immunological procedures such as immune adherence (panning) (Hoang 
et al., 1983; Mouchiroud et al., 1985), immune- rosetting (Harris et al., 
1983; 1984a; Koizumi et al., 1985; Miller et al., 1985b). complement mediated 
cytotoxicity (Boswell et al., 1984), affinity chromatography (Mattson et al., 
1987) and, more recently, immunomagnetic depletion ( Kanourakis and Bol, 
1987). All these techniques allow for the rapid and bulk separation of cells 
and are based on the binding of a (monoclonal) antibody to the wanted 
(positive selection) or unwanted cells (negative selection). The purity of the 
resulting cell suspensions using these procedures is still relatively low. 
A very powerful tool for the identification, isolation, and purification of 
haemopoietic stem cell subpopulations is flow cytometry and electronic cell 
sorting using a fluorescence activated cell sorter ( FACS). Unlike the other 
cell separation procedures described above flow cytometry allows to make 
rapid quantitative multiparameter measurements of individual cells in large 
numbers (Shapiro, 1985; Van den Engh et al., 1980; Van den Engh and 
Visser, 1984; Parks et al., 1986). For instance, flow cytometry makes it 
possible to analyze the size, shape and structure (light scatter intensities) 
and viability of individual cells and to combine these measurements with 
those quantifying the cell surface-, cytoplasmic-, or nuclear-fluorescence 
intensities. This makes it possible to evaluate discrete populations of rare 
cells. like haernopoietic stem cells in such a heterogeneous tissue like bone 
marrow (Van den Engh et al., 1979; 1980; Visser et al., 1978; Van den 
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Engh and Visser, 1984; Herzenberg et al., 1976; Loken et al., 1987a, 1987b; 
Parks et al., 1986; Herzenberg and Herzenberg, 1978). 
An important feature of cell sorting by flow cytometry is that the cells 
are inspected individually before they are sorted, which means that high 
purities of the wanted cells can be obtained. In addition, the sorting criteria 
can be based on any combination of measured parameters. Furthermore, it is 
possible to isolate defined populations of viable cells for functional analysis 
like colony formation and repopulation of lethally irradiated animals. Flow 
cytometry and cell sorting either alone or in combination with any of the 
bulk separation procedures described above have been successfully used to 
highly enrich and separate murine and rat haemopoietic stem cell subpopu-
lations on the basis of their light scatter properties, lectin-binding, nucleic 
acid content, metabolic state, and most widely by their affinity for various 
(combinations of) (monoclonal) antibodies directed against cell surface 
structures (Harris et al., 1984a; 1985; Muller-Sieburg et al., 1986; Visser et 
al., 1984; Bauman et al., 1986; Bauman and Chen, 1987; Watt et al., 1983; 
in press; Palavicini et al., 1985a; 1985b; 1987; Lord and Spooncer, 1986; 
McCarthy et al., 1987; Castagnola et al., 1981; Goldschneider et al., 1980; 
Bertoncello et al., 1985; 1986; 1987; Visser and de Vries, in press; and 
many others). In Chapters 5 and 6 of this thesis the use of flow cytometry 
and cell sorting for purification and enrichment of murine haemopoietic stem 
cells will be discussed extensively. 
CELL MEMBRANE STRUCTURES ON HAEMOPOIETIC STEM CELLS 
The regulation of self-renewal, commitment and differentiation of haemo-
poietic stem cells is still poorly understood but appears to depend on inter-
actions among haemopoietic stem cells, stromal elements and a variety of 
growth factors (Metcalf, 1984; Dexter, 1982; McCulloch, 1983). It is obvious 
that determinants expressed on the cell membrane must play an important 
role in the control of these complex processes (Watt et al., in press; 
Berridge, 1982; Fitch en et al., 1981). Thus, knowledge of the composition of 
the cell surface membrane of haemopoietic stem cells might result in a better 
understanding of the events taking place during the early steps of haemo-
poiesis. It can be assumed that the presence of certain cell surface deter-
minants is more related to the functional capacities of a cell than features 
like cell size and density (Van den Engh et al., 1980). Evidence for this was 
obtained in studies on the cell surface characteristics of lymphocytes. Now 
more than 50 antigenic determinants have been described on murine lympho-
cytes (Morse Ill et al., 1987). Although many of "these antigenic determi-
nants are not specific for lymphocytes and are also expressed on other cell 
types, the identification of some of these structures have led to the 
description of discrete functional subsets of cells (Hibbs et al.. 1984; Habu 
and Okumura, 1984; Ceredig et al., 1985; Cantor and Boyse, 1975; Cantor 
et al. , 1976). 
The success in the segregation of functional lymphocyte subsets on the 
basis of recognition of distinct cell surface determinants suggested that a 
similar approach could be used to segregate and purify various morpholo-
gically indistinguishable stem cell subsets. In earlier studies polyclonal 
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antisera and complement mediated cell lysis were used to determine the 
expression of certain antigenic determinants on CFC-S and different types of 
committed progenitor cells. It was found that CFU-S express antigenic deter-
minants associated with mouse brain (Golub, 1972), sperm and testis 
(Berridge and Okech, 1980), lymph nodes, thymocytes, peritoneal macro-
phages and platelets (Berridge and Okech, 1979}, embryo (Price et al., 
1979}, endogenous xenotropic C- type virus (Staber et al., 1978), Abelson 
murine leukaemia virus (Risser, 1979) and class II and various class I H-2 
antigens (Russel and Van den Engh, 1979; Kincade et al., 1980; Fitch en and 
Ferrone, 1981). Some of these antisera have been used in attempts to enrich 
for mouse CFU-S, but none of these attempts were very successful (Monette, 
1979; Price et al., 1979; Van Bekkum et al., 1979) and it is not clear to 
what extent any of these detectable surface antigens may be uniquely 
expressed on CFU-S and not also on other haemopoietic (stem) cell types 
(Till and McCulloch, 1980). 
A diffference was observed between CFU-S and CFU-C with regard to 
the expression of brain associated determinants (Van den Engh and Golub, 
1974). CFU-S were killed by treatment with anti-brain serum and comple-
ment, whereas CFU-C were not. Therefore, it was believed that CFU-S and 
CFU-C could be distinguished on basis of reactivity with anti-brain serum. 
Later, using flow cytometry, however, it was found that anti-mouse brain 
serum did not react with CFU-S (Van den Engh et al., 1980). 
On basis of various patterns of reactivities two hypotheses with regard 
to cell surface marker expression on haemopoietic stem cells have been 
proposed. The first hypothesis proposed by Davis (1975) is that none of the 
cell surface markers of mature cells is expressed on the PHSC. The second 
model proposed by Till ( 1976) predicts that PHSC, because of their pluri-
potentiality, co-express antigenic determinants of all haemopoietic lineages at 
low and perhaps nonfunctional levels. In Fig. 1.2 a schematic representation 
of the two hypotheses is shown. According to the hypothesis of Till differ-
entiation of stem cells could involve a progressive restriction in the expres-
sion of cell surface markers, with a specialization in the expression of the 
particular markers characteristic of a single pathway of differentiation and a 
concomitant disappearance of irrelevant markers. The validity of this hypo-
thesis is supported by the description of multiple lineage marked leukaemic 
cells, but has never been verified in normal haemopoiesis (Ferrero et al., 
1985). A major obstacle to testing both hypotheses is that low level expres-
sion of antigenic determinants or other structures on rare cells I ike haemo-
poietic stem cells is difficult to establish (Watt et al., in press). 
Progress in the understanding of the surface characteristics of haemo-
poietic cells has been advanced by the introduction of the technology for 
monoclonal antibody (MCA) production (Kohler and Milstein, 1975} and flow 
cytometry. MCAs have several advantages over conventional polyclonal anti-
sera ( Galfre and Milstein, 1979). Their homogeneity, high specificity and 
unlimited availability are the most pronounced advantages. The MCA techno-
logy especially in conjunction with flow cytometry has led to the description 
of numerous antigenic determinants expressed on haemopoietic cells of dif-
ferent maturation stages and differentiation lineages (Ledbetter and Herzen-
berg, 1979; Springer et al., 1978a; b; Trowbridge, 1978; Austyn and 
Gordon, 1981; Watt et al., 1983; 1984; and many others). 
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A diagrammatic illustration of the two hypotheses proposed regarding the 
expression of cell surface markers on haemopoietic stem cells. Lower case 
letters represent markers present at low levels or of limited functional 
capacity, upper case letters represent the converse. For simplicity two of 
the possible pathways of differentiation (G: granulocytes, E: erythrocytes) 
from the pluripotent haemopoietic stem cell are shown. (Partly adapted from 
Till, 1976). 
To date a great number of MCAs directed against the various mature 
haemopoietic cell types has been described. Very few MCAs appear to be 
specifically directed against cells of a certain lineage or a particular stage 
within that lineage (Harris et al., 1985). Despite many efforts and in con-
trast with what was proposed by Till (1976) (see Fig. 1.2), MCAs specifi-
cally directed against a subpopulation of murine haemopoietic stem cells have 
not yet been described (Bertoncello et al., 1987; Watt et al., in press). 
From these studies it appeared that some antigenic determinants 
expressed at early stages of differentiation are lost during the course of 
differentiation, whereas other antigenic determinants become increasingly 
expressed ( Bertoncello et al.. 1987; Williams et al., 1985). In addition, some 
antigenic determinants are only transiently expressed during differentiation 
within a certain lineage, whereas others are expressed in the same densities 
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throughout differentiation (Van den Engh et al.. 1983). Antigenic determi-
nants that appeared to be specific for a particular cell lineage and that 
remain conserved on all cell types of that lineage throughout differentiation 
(cell lineage antigens) have also been described (Berridge, 1979). 
The knowledge of the cell surface structure of haemopoietic cells has 
proven to be a very powerful tool for the identification, segregation and 
purification of subsets of haemopoietic stem cells. Subsets of stem cells could 
be identified. isolated and significantly purified on basis of quantitative 
differences in the expression of antigenic structures and carbohydrate 
moieties (identified by lectins) using a cell sorter and combinations of 
fluorescent probes (Nicola et al., 1980; 1981; Visser and Bol, 1981; Visser 
et al., 1984; Bauman et al., 1986; Bauman and Chen, 1987; Hoang et al., 
1983; Watt et aJ,., 1983; 1984; in press; Bertoncello et al., 1986; 1987; 
Muller-Sieburg et al., 1986; and many others). 
OBJECTIVES AND OUTLINE OF THIS THESIS 
The work described in this thesis deals with the production and appli-
cation of monoclonal antibodies to characterize murine haemopoietic stem cells. 
Monoclonal antibodies directed against determinants uniquely expressed on 
various classes of haemopoietic stem cells should provide valuable tools for 
analyzing the early differentiation steps in the stem cell compartment at the 
molecular level, for elucidating the relationhip between the various stem cell 
classes and for purifying the various stem cell types. In the following 
chapter the experimental approaches used are described. Chapter 3 deals 
with attempts to produce stem cell specific monoclonal antibodies. The 
characterization of the monoclonal antibodies and their possible usefulness in 
haemopoietic studies are described in chapter 4. Using one of the produced 
monoclonal antibodies a widely applicable multiparameter flow cytometric 
procedure for the identification and purification of murine haemopoietic stem 
cells is described in chapter 5. In chapter 6 various purification procedures 
for haemopoietic stem cells are compared. It appeared that the highly puri-
fied day-12 CFU-S suspensions are heterogeneous, therefore the usefulness 
of the CFU-S assay as endpoint-assay for pluripotent haemopoietic stem cells 
is discussed. In the final chapter, the results will be considered in a 
broader perspective and possible approaches for further study will be out-
lined. 
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CHAPTER 2 
MATERIALS AND METHODS 
ANIMALS 
The mice and rats that were used in this study were bred at the Radio-
biological Institute TNO. They were maintained under specific pathogen free 
conditions until the initiation of the experiments. Thereafter, the animals 
were housed in conventional animal quarters, except for mice used in the 
30-day survival studies (Table 6.2). In these experiments the mice were 
housed in a sterile hood. 
In Table 2.1 the mouse strains used in this thesis are listed. In most 
experiments, BC3 mice were used, unless stated otherwise. Mice, 7-9 weeks 
old, were used as bone marrow or other organ and tissue donors throughout 
this study. Mice, 11-16 weeks of age, were used as recipients in the CFU-S 
assay and 30-day survival experiments. Both male and female mice were used 
but within single experiments, there was a restriction to one sex. 
Table 2.1 
MOUSE STRAINS USED IN THIS STUDY 
mouse strain 
(C57BI/Rij x C3H/Law)F1 
(C57BI/Rij x CBA/Rij)F1 
C5781/Rij 
C3H/Law 
abbreviation 
BC3 
BCBA 
C57BL 
C3H 
H-2 haplotype 
b/k 
b/q 
b 
k 
Rats were used for immunization purposes (Chapter 3). Only female 
rats, varying in age between ~ and 16 weeks at the time of the first immuni-
zation, were used in the present study. In Table 3.1 , the used rat strains 
are listed. In most cases, BN rats were used. 
PREPARATION OF CELL SUSPENSIONS 
Single cell suspensions were prepared in Hanks' Balanced Salt solution 
(HBSS) (Laboratoires Eurobio, Paris, France) buffered at pH 6.9 with 10 mM 
HEPES buffer (Merck). This solution is abbreviated as HH (HBSS + HEPES) 
and had an osmolarity of 300-305 mOsm/ kg. Organs and tissues were removed 
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after asphyxiation of the animals with C02. Bone marrow cells were obtained 
by flushing the femurs or tibias with 1 ml of ice-cold HH using a 25 gauge 
needle adapted to a syringe. A single cell suspension was obtained by 
pipetting and subsequent filtration through a six-layer nylon sieve. 
Fetal liver cells were obtained from 17 days old C57BI fetuses by gently 
pressing the liver through a nylon sieve with a spatula after premoistering 
the sieve. Single cell suspensions of thymus and spleen were prepared in the 
same way as fetal liver cell suspensions. Peripheral blood leukocytes (PBL) 
were prepared from whole blood obtained by orbital puncture of anesthesized 
(aether) animals. Clotting of the blot was prevented by adding tromboliquine 
(2% v/v, Organon Technika, Oss, The Netherlands) to the collection tube. 
After dilution of the blood with an equal volume of HH erythrocytes were 
lysed using a 150 mM NH 4CL solution buffered at pH 7.0. Peritoneal exudate 
cells (PEC) were isolated by injection of 5 ml ice-cold sucrose solution (0.34 
M) into the peritoneal cavity. After gentle massage of the abdomen for 3-4 
min, the cells were isolated by withdrawing the fluid into the syringe. 
All cell suspensions were washed with HH containing either 5% fetal calf 
serum (FCS, Seralab) or newborn calf serum (NCS; Seralab) and 0.02% 
(v/v) sodium azide (Merck) at 300 g for 7 min at 4°C. This medium is 
abbreviated HSA (HH + serum+ azide). Cells were resuspended in HSA prior 
to counting. Nucleated cell counts were performed in a Burker haemocyto:-
meter using Turk's staining solution. All cell suspensions were kept on 
melting ice until use. For all experiments at least two mice were used to 
minimize variation due to individual differences. 
IRRADIATION OF MICE 
For CFU-S assays and 30-day survival experiments mice were subjected 
to lethal total body irradiation. Irradiations were performed with a l37cs 
gamma-cell-20-small-animal irradiator (Atomic Energy of Canada). A maximum 
of 25 mice was irradiated at a time in an animal container flushed with air. 
The gamma-dose rate at the position of the mice was 0. 83 Gy /min. BC3 and 
C3H mice received a total dose of 9. 25 Gy, BCBA mice received a total dose 
of 9.0 Gy. Bone marrow cell transplantations were given 2 to 8 hours after 
irradiation. Without bone marrow transplantation the lethally irradiated 
recipients died around the 15th day post-irradiation. 
THE SPLEEN COLONY ASSAY 
The number of spleen colony forming cells in various bone marrow sus-
pensions was determined according to the assay system described by Till and 
McCulloch (1961). Appropriate numbers of cells, estimated so as to give 
approximately 10 colonies per spleen, were suspended in HH and injected in 
0.5 ml volumes into the lateral tail vein of lethally irradiated syngeneic 
recipients. Irradiated mice which had not been transplanted with haemopoietic 
cells served as controls for endogenous colony formation. Seven to ten mice 
were used per experimental group. After eight (or seven, Table 6.6) to 
twelve days the mice were killed, their spleens removed and fixed in 
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Tellyesniczky1s solution. Macroscopically visible nodules were scored as 
spleen colony forming units (CFU-S). Spleen colonies counted at different 
days are referred to as day-8 CFU-S, day-10 CFU-S and day-12 CFU-S. 
30-DAY SURVIVAL ASSAY 
Unseparated or sorted bone marrow cells were transplanted at several 
dilutions in groups of ten lethally irradiated syngeneic recipient mice. A 
dilution of the same suspensions was used for determination of the day-12 
CFU-S content of the graft (Table 6.2). The proportion of mice surviving 30 
days after irradiation and transplantation was determined for each dilution. 
The number of bone marrow cells and the number of day-12 CFU-S needed 
for survival of 50% of the animals was calculated from these data by probit 
analysis. 
CLONAL ASSAYS IN VITRO 
A. Agar cultures 
A detailed description of the in vitro assay for colony forming cells is 
given by Bol and Williams (1980)-:-Bone marrow cells were suspended in 
supplemented Dulbecco•s modified eagle medium (Gibco M07-2501) (Bol et al., 
1979) containing 0. 3% agar ( Bacto agar, Difco Laboratories) and 20% of a 
mixture of 2 volumes of horse serum (HS, non-commercial batch or obtained 
from Sera lab l and 1 volume of FCS (Sera lab). Immediately before use 1. 5 mM 
L-glutamine was added to the medium. Aliquots of 1 ml containing 5 x 1 o4 
unseparated bone marrow cells, or the indicated number of sorted cells were 
plated into 35 mm Petri dishes (Falcon, 1 008). Prior to plating, solutions of 
one or more types of growth stimulating factor preparations were added to 
the dishes. The total volume of these preparations never exceeded 50 ).LI. 
Each experimental group was tested in triplicate. 
To stimulate colony formation by primitive macrophage progenitors, i.e .• 
CFU-C2 ( Bol and Williams, 1980; Bol et al •• 1979). 25 )11 of a crude pregnant 
mouse uterus extract preparation (PMUE) was added to the cultures (Bradley 
et al., 1971; Stanley et al., 1972). The cultures were incubated for 7 days 
at 37°C in a fully humidified atmosphere of 10% C02 in air. In the experi-
ments depicted in Table 6.4 cultures were stimulated with 10 units (U) 
recombinant murine IL-3 (7.5 )11 per culture dish). One unit of IL-3 is 
defined as the quantity needed for 50% proliferation of the I L-3 dependent 
cell line DA-1 (see Table 4.4). IL-3 was a gift from Dr. L. Dorssers. 
Recombinant human IL-1a (Genzyme Corporation, Boston, MA, U.S.A.) was 
used at a concentration of 10 U/ml (10 ).til culture dish). In these experiments 
(Table 6.4) colonies were scored after 14 days. 
Colonies (more than 50 cells) were counted using an inverted microscope 
at a 30-fold magnification. 
B. Methylcellulose cultures 
The method employed for serum-free methylcellulose cultures of haemo-
poietic progenitors was described in detai I before ( Merchav and Wagemaker. 
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1984; Merchav, 1986). The serum-free medium consisted of Dulbecco's medium 
( Dulbecco's MEM, Gibco 430-1600) supplemented with amino acids, vitamin 
812, biotin, Na-pyruvate, glucose, NaHC03 and antibiotics (a:-medium, 300 
mOsm/kg). This a:-medium was supplemented with 1% (w/v) delipidated, 
deionized (Worton et al., 1969a) bovine serum albumin (BSA; Fraction V, 
Sigma), 4 x 10-6 M iron-saturated human transferrin (Boehring-Mannheim), 
10-7 M Na2seo3.5H 20 (Merck), 10-4 M B-mercaptoethanol (Merck), 1.5 x 
10-5 M linoleic acid (Merck) and cholesterol (Sigma), nucleosides (10 JJg/ml 
each), and 0.8% (w/v) methylcellulose (Methocel A4M Premium grade, Dow 
Chemical). 
One ml aliquots of this medium supplemented with the appropriate 
amount of bone marrow cells and the appropriate (combinations of) growth 
factors were plated in 35 mm Petri dishes (Falcon 1 008). Each experimental 
group was tested in duplicate. Cultures were incubated at 37°C in a fully 
humidified atmosphere of 7.5% C02 in air. Colonies were scored after 7-14 
days, except BFU-E which were scored after 10-14 days. Colony formation 
by granulocyte-macrophage progenitor cells (CFU-GM) was stimulated with 
recombinant murine GM-CSF at a predetermined optimal concentration. In 
addition, the culture medium was supplemented with 1 o-6 M hydrocortisone 
sodium succinate (Sigma). Colony formation by macrophage progenitor cells 
(CFU-M) was stimulated with a partly purified preparation of CSF-1. CSF-1 
was purified from PMUE as described by Merchav and Wagemaker ( 1984) 
using affinity chromatography (Concanavalin-A (ConA) - Sepharose) and ion 
exchange chromatography (DEAE-Sepharose, pH 8.0). The formation of 
colonies by BFU-E (burst forming unit-erythrocyte) was stimulated with a 
combination of 20% of a crude preparation of ConA stimulated mouse spleen 
cell conditioned medium (MSCM) (Wagemaker and Visser, 1980) and a partly 
purified preparation of erythropoietin (Epa). Epa was purified as described 
by Merchav ( 1986). B FU-E were assayed in medium supplemented with 0. 2 M 
hemin ( Photoporphirin I X, Sigma). 
In the experiment shown in Table 6. 5 cultures were stimulated with 10 
U IL-3, 10 U IL-1 and the same concentration of CSF-1 and Epa + hemin as 
used to assay CFU-M and BFU-E, respectively. 
SUSPENSION CULTURES 
Suspension cultures of sorted bone marrow cell fractions (see Table 6. 6 
and 6. 7) were performed in serum-free medium as described by Merchav 
(1986). The indicated number of cells were cultured in plastic round 
bottom tubes (Falcon, 2057) containing 1 ml of the above described modified 
Dulbecco's medium, supplemented with 1 o-6 M hydrocortisone sodium 
succinate (Sigma) and 10-6 M isoproterenol (Sigma). The cultures were 
stimulated with a saturating dose of IL-3 (10 U/ml), IL-l (10 U/ml) or CSF-1 
(the same batch and concentration as used for methylcellulose cultures). 
Loosely capped tubes were incubated at 37°C, 7. 5% C02 in a fully humidified 
atmosphere for a period of four days. Then, the cultures were terminated by 
adding 5 ml ice-cold HH to the tubes. The diluted suspensions were either 
injected intravenously ( i. v.) in 0. 5 ml volumes into lethally irradiated 
syngeneic recipients for enumeration of the CFU-S content (Table 6. 6) or 
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were washed and suspended in modified Dulbecco's medium and cultured in 
methylcellulose medium to determine the CFU-M, CFU-GM and BFU-E content 
of the cultures (Tables 6. 7). 
The standard deviations of the in this study presented CFU-S and in 
vitro clonogenic progenitor cell counts were calculated on basis of the 
assumption that colony counts are Poisson distributed (see Van den Engh, 
1976; Bol, 1980). 
EQUILIBRIUM DENSITY CENTRIFUGATION 
As the first step in stem cell purification procedures and in the 
preparation of immunization suspensions, bone marrow cells were separated 
using a discontinuous metrizamide (Nyegaard, Oslo, Norway) density 
gradient as described earlier (Visser et al., 1984). In brief, discontinuous 
gradients were prepared by first pipetting 1 ml of a high density 
metrizamide (MA) solution (1.100 ~/cm 3 , dissolved in HH + 1% BSA, pH 6. 7, 
300 mOsm/kg) containing 5-6 x 10 bone marrow cells in a round bottom tube 
(Falcon, 2057). On top of this solution, 3 ml of a MA solution with 
intermediate density (1. 078 g/cm 3 ) was layered. Finally, 1 ml of the low 
density solution (1.055 g/cm 3 ) was put on top of the intermediate solution. 
The cells were centrifuged for 10 min, 4°C, at 1000 g. The cells in the low 
density fraction and from the interface between the top and intermediate 
layer (low density cells) were collected, washed, centrifuged and counted. 
The yield of low density cells in the present study was 10 ± 5% of all 
nucleated cells. 
IN VIVO TREATMENT OF MICE WITH 5-FLUOROURACIL 
Seven to eight weeks old mice were injected i. v. with 150 mg 
5-fluorouracil (FU, Sigma) per kg body weight. FU was dissolved in HH at a 
concentration of 7.5 mg/ml. Mice were injected with a volume determined by 
their weight (in grams) x 0.02 mi. After 7 days the mice were sacrificed and 
bone marrow was isolated. Low density FU treated bone marrow cell fractions 
were used for immunizations of rats (Tables 3. 4 and 3. 5). 
JNTRASPLENIC IMMUNIZATION OF RATS 
For intrasplenic (i. s.) immunization of rats, the animals were anaesthe-
tized by intraperitoneal ( i. p.) injection of avertine (Janssen Pharmaceutics, 
Beerse, Belgium). Immediately before use, the stock solution of avertine (1 
g/ml) was 40-fold diluted in prewarmed (37°C) HH. Rats received 0.1 ml 
of this avertine solution per 100 g body weight. The fur from the left side 
was shaved and the abdomen swabbed with 70% ethanol. First, a 10-15 mm 
long skin incision was made followed by incision of the muscle layers and 
peritoneum. The spleen was exposed by gently lifting its lower pole with the 
aid of. forceps. A thin needle (0.35 mm diameter) was inserted deeply into 
the spleen and the cells were injected (100-150 ]11) as the needle was pulled 
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out, in order to ensure that the antigen was distributed through most of the 
spleen (Spitz et al., 1984). After injection, the spleen was carefully pushed 
back into the peritoneal cavity. Subsequently, the peritoneal and muscular 
walls were sutured with thread and the skin was closed with 2-4 wire 
stitches. One to three months later the rats were boosted in the same way. 
Four days after the final immunization, the animals were killed and the 
spleen removed. The spleen was used in fusion experiments. The intrasplenic 
(i.s.) immunization was performed in a laminar airflow to prevent infection of 
the animal. 
1 n the experiments shown in Figures 3. 2 and 3. 3 some rats were 
immunized by i. p. or i. v. administration of murine bone marrow cells. For 
i. p. and i. v. immunization the appropriate number of cells was injected in a 
volume of 0.5-1 ml HH. 
FUSION PROTOCOL 
Fusion was performed 4 days after the final immunization according to 
standard procedures (Goding, 1980). The spleen of the immunized rat was 
asceptically removed and a single spleen cell suspension was prepared in 
HEPES buffered RPMI-1640 (RPMI, Gibco) by pressing the spleen (using a 
spatula) through a steel sieve. The suspension was transferred to a conical 
50 ml plastic tube (Falcon, 2070), dispersed by repeated pipetting and 
allowed to settle for 5 minutes. The supernate was then removed and 
transferred to another tube and RPM 1 was added to a final volume of 50 mi. 
The cells were spun down at 300 g for 10 min at room temperature, resus-
pended in 50 ml RPMI and spun again. Finally, the cells were resuspended 
in 20 ml RPMI and counted. Prior to fusion, myeloma cells (see Table 3.2) 
were grown in RPM I supplemented with 10% FCS (Seralab), 3 mM L-glutamine 
(Gibco), 1 mM MEM-sodium pyruvate (Gibco), 0.05 mM S-mercaptoethanol 
(Merck) and 100 IU/ml penicillin and 100 Jlg/ml streptomycin (Gibco). This 
medium is designated as RPM 1-total. Two weeks before a fusion experiment 
the myeloma cells were expanded (150 cm 2 flasks, Falcon) in RPMI-total and 
kept at low density (half confluency) to be sure that on the day of fusion 
they were in the logarithmic growth fase. Myeloma cells were collected and 
washed twice with RPM I. The cells were then resuspended in 20 ml RPM I and 
counted. 
In most cases the number of myeloma cells determined the "size" of the 
fusion. In a typical experiment 1. 5 x 1 o8 spleen cells were fused with 
5-7.5 x 107 myeloma cells in the following way: The appropriate number of 
spleen cells was added to the myeloma cells and the cells were centrifuged. 
After removing the supernate, 1 ml of a prewarmed solution of 40% (w/v) 
PEG 4000 (Merck) was added slowly over one minute with constant agitation 
and careful stirring. Another ml of 40% PEG 4000 was then added slowly over 
the next minute. Subsequently, 1 ml of RPM I was added over the next 
minute followed by another 8 ml of RPMI over the next three minutes. The 
fused cells were incubated for 5 minutes at 37°C before they were cel1tri-
fuged at 300 g for 5 min. The fused cells were resuspended at a density of 
1-2.5 x 106 spleen cells per ml selective medium. The cells were then plated 
into the wells (100 )ll/well) of 96-wells microtiter plates (Mikrotest III, 
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Falcon) and were cultured at 37°C, 5% C02 and 100% humidity. Selective 
medium consisted of RPMI-total supplemented with 10% HECS (human endo-
thelial cell culture supernatant, Astaldi et al., 1980; Costar), 5% HS (either 
a noncommercial batch or obtained from Seralab) and HAT; a combination of 
Hypoxantine (0.1 mM, Merck 4517), Aminopterine (0.4- J.lM, Sigma A-2255) 
and (desoxy) Thymidine (0.016 mM). HAT was used as selective medium in 
the fusion experiments shown in Table 3.3. In the fusion experiments listed 
in Table 3.5, a combination of azaserine (1 J,lg/ml; Sigma) and hypoxanthine 
was used as selective agents. After 3-4 days, 1 00 J.ll of fresh selective 
medium was added to the wells. After another 3-4 days half the medium was 
removed and an equal volume (100 J,ll) of fresh selective medium was added, 
etc. After 2-4 weeks when growing hybridoma clones became visible, either 
aminopterine or azaserine was ommitted from the selective media. 
Antibody producing hybridoma clones were subcloned by limiting 
dilution at average densities of 0. 5 cells/well and 2 cells/well in RPM I total 
supplemented with 1 O% HECS, 5% HS and either HT (in case of HAT selec-
tion) or H (in case of selection with azaserine). Antibody producing 
subclones were expanded in RPMI-total, frozen and stored in liquid nitrogen. 
LABELLING OF BONE MARROW CELLS WITH MONOCLONAL ANTIBODIES 
For flow cytometric analysis (screening), 1 o6 bone marrow cells were 
washed with HSA and centrifuged once at 300 g for 7 min at 4°C. The cells 
were then resuspended in SO J.ll of spent hybridoma culture supernatant and 
incubated on melting ice for 45 min. Subsequently, the cells were washed 
and centrifuged twice with ice-cold HSA. The cells were subsequently resus-
pended in SO ]..II of a 50-fold dilution (in HSA) of goat-anti-rat/lgG (H+L)/ 
FITC (GARA/FITC, affinity purified, TAGO Inc., Burlingame, CA, U.S.A.) 
and incubated for 30 min on melting ice. The labelled cells were washed with 
HH and centrifuged once. Finally, the cells were resuspended in HH. 
Labelling of cells was done either in plastic tubes (Falcon 2058 l or in wells 
of 96-wells round-bottom microtiter plates (Greiner). When the labelling was 
done in tubes, cells were washed with a volume of 1 ml HSA or HH. When 
this was performed in microtiter plates, the cells were washed with 200 ]..II of 
HSA or HH. After the last wash, the cells were resuspended in 100 ]..II HH 
and transferred to a plastic tube containing 900 ]..II of HH. 
For CFU-S purification purposes cells were labelled with SO J.ll of the 
appropriate diluti.on (1 : 20 in HSA) of biotinylated anti-H-2Kk antibody 
(a-H-2Kk-biotin) (Becton Dickinson Monoclonal Center Inc., Mountain View, 
CA, U.S.A.) and either 50 J.ll of the appropriate dilution (100x) of fluores-
cein-isothiocyanate labelled avidin (Av/FITC, Sigma, Deisenhofen, West-
Germany) or SO J.ll of avidin conjugated with phycoerythrin (1 :SO in HSA) 
(Av/PE, Becton Dickinson, lmmunocytometry Systems, Mountain View, CA, 
USA). Anti-H-2Kk was biotinylated as described by Bauman et al. (1985). 
Bone marrow cells were also labelled with 50 J.ll of a hundred-fold 
diluted mouse MCA directed against Thy-1 (a-Thy-1 .1, New England 
Nuclear, NEI 014) and goat-anti-mouse/lg/FITC (GAM/FITC, Nordic Immuno-
logical Laboratories, Tilburg, The Netherlands) diluted 50-fold in HSA (see 
Fig. 5. 4). Besides this indirect labelling of bone marrow cells, cells were 
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also stained directly with FITC conjugated MCAs. MCA 15-1.1 (this thesis) 
and anti-GM1.2 (New England Nuclear, NEI 031) were conjugated to FITC as 
described below. Labelling of bone marrow cells with directly conjugated 
antibodies involved a 45 min incubation on melting ice, followed by two wash 
steps with HH. Anti-GM1.2/FITC was diluted 5 times and 15-1.1/FITC 10 
times in HSA. 
In chapter 3 (Figures 3. 2 and 3. 3) bone marrow cells were incubated 
with 50 J.il of diluted heat inactivated rat serum instead of hybridoma culture 
supernatant. Serum incubated cells were subsequently stained with 
GARA/FITC as described for cell suspensions incubated with hybridoma 
supernatant. 
CONJUGATION OF MCAs WITH FITC 
Equal volumes of saturated ammonium sulphate and supernatant 
containing the MCA of interest were mixed. After 1-2 hours at room tempe-
rature (with occasional shaking), the suspension was centrifuged at 12,000 g 
for 30 min and the supernate removed. The pellet was dissolved in 40% 
ammonium sulphate and centrifuged again. The pellet was then resuspended 
in 1/5- 1/10 of the original (supernatant) volume of distilled water and 
dialyzed against distilled water for 48 hours at 4°C. The content of the 
dialysis bag was centrifuged at 1200 g for 10 minutes and the supernate was 
collected and lyophilized. A solution was made containing 5 mg lyophilized 
protein per ml Phosphate Buffered Saline (PBS, pH 7.2). Per ml protein 
solution 0.1 ml of a 0.5 M NaHC03 solution, pH 9.5 was added, the pH 
checked and, if necessary, adjusted to pH 9.0 by adding NaHC03• 
Under continuous stirring, 10 ).ll of a stock solution of FITC isomer-1 (1 
mg/ml DMSO, Nordic Immunological Laboratories, Tilburg; The Netherlands) 
was slowly added per mg protein. The mixture was incubated (continuous 
stirring) for 3 hours in the dark at rqom temperature. During this period 
the pH was repeatedly checked and, if necesary, adjusted to pH 9.0. The 
mixture was then loaded on a PD-10 Sephadex column (Pharmacia 17-08500) 
and eluted with PBS. 
FLOW CYTOMETRIC ANALYSIS OF CELLS 
Cell suspensions were analyzed using a modified fluorescence activated 
cell sorter (FACS-11, Becton Dickinson, Sunnyvale, CA, U.S.A.). The 
machine was adapted to measure two light signals perpendicular (70-11 0 
degrees) to the laser beam by introducing an achromatic beam splitter and a 
second photomultiplier. Forward light scatter (FLS) was collected over the 
angles 0.5-13 degrees with respect to the axis of the laser beam. Perpen-
dicular light scatter (PLS) intensity was measured by an S-11 type photo-
multiplier. FITC (green) fluorescence intensity was measured through a 
combination of a broad band multicavity interference filter ( 520-550 . nm 
transmission; Pomfrett Research Optics Inc., Stamford, CT, U.S.A.) and a 
520 nm cut-off filter (Ditric Research Optics Inc., Hudson, MA, U.S.A.) by 
a S-20 type photomultiplier. The laser was tuned at 488 nm with an output 
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of 0.5 W. FLS and PLS signals were linearly amplified. The amplification of 
the FLS was adjusted such that the peak of the lymphocytes in the pulse 
height-analyzer histogram was at channel 100. PLS amplification was adjusted 
so that the peak of the lymphocyte cluster (Figure 4.1) was at channel 25. 
FITC-fluorescence was logarithmically amplified (T. Nozaki, Stanford, CA, 
U.S.A.). The sheat fluid consisted of 0.9% (w/v) saline. 
For screening of hybridoma culture supernatants electronic windows 
were set to select each of the four major cell dusters distinguishable on 
basis of FLS and PLS intensities (Fig. 4.1). The fluorescence distribution of 
5 x 1 o3 events falling within each cluster were stored in a histogram and 
compared with the fluorescence distribution of the negative control 
(incubated with GARA/FITC only) by means of the ANNA software package 
developed in the Radiobiological Institute TNO. 
To determine the reactivity of MCAs with CFU-S or in vitro clonogenic 
progenitor cells of various differentiation lineages first electronic windows 
were set to select the blast cells or the blast cells + granulocytes (Fig. 4.1, 
Van den Engh et al., 1979). Then, depending on the fluorescence distribu-
tion, two or more fractions differing in fluorescence intensities were selected 
by setting electronic windows (see Figs. 4.5 and 4.6) and the subpopulations 
sorted. For sorting experiments, the sheat fluid consisted of HH (without 
phenol red). Cells were sorted into 15 ml glass tubes, containing 0.5 ml HH 
+ 10% FCS. The walls of the tubes were rinsed prior to and after the sort 
with HH + 10% FCS. During the sorts the collection tubes and the tube con-
taining the unsorted cells were cooled (4°C). The sorted cells were assayed 
for their CFU-S or in vitro clonogenic progenitor cell content as described 
above. 
PURIFICATION OF CFU-S USING A FACS-11 
In this study CFU-S were purified using three different procedures 
(Fig. 6.1). The first step in all three procedures consisted of the separation 
of low density cells using a discontinuous density metrizamide gradient as 
described above with one modification. During the centrifugation the cells 
were labelled with the FITC-Iabelled lectin wheat germ agglutinin 
(WGA/FITC; Polysciences Inc., Warrington, PA, -U.S.A.). For this purpose, 
3 ]11 of a WGA/FITC stock solution (1 mg/ml) was added to 14 ml of the 
intermediate density solution. (In CFU-S purification experiments normally 4 
gradients were processed simultaneously.) During the centrifigation only low 
density cells travel through the WGA/FITC containing layer to the top layer, 
as a consequence of which they are labelled. ·The low density cells were 
subsequently analyzed on the FACS and the WGA/FITC positive cells with 
medium to high FLS and low PLS intensities (blast cell cluster) were sorted 
as described earlier (Visser and Bol, 1981). The in this way selected cells 
comprised between 4-8% of all low density cells. 
CFU-S were further purified according to the procedure described by 
Visser et al. (1984). First, WGA/FITC was removed from the cells by incu-
bation (15 min, 37°C) in 10 ml of an isotonic solution of 0.2 M N-acetyi-D-
glucosamine (Polysciences Inc., Warrington, PA, U.S.A.). Subsequently, the 
cells were centrifuged at 300 g for 7 min, resuspended in 1 ml H H trans-
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fer red to a ~lastic tube and centrifuged again. The cells were then labelled 
with a-H-2K -biotin and Av/FITC and sorted again. In this second sort 
20-30% of the most brightly fluorescent cells with the same FLS and PLS 
intensities as during the first sort were selected. In chapter 5 (Table 5.2} 
Av/PE was used to detect bound a-H-2Kk-biotin instead of Av/FITC. This 
procedure yielded typically about 1 x 105 cells. 
Another way to purify CFU-S employed here, was by means of two 
subsequent WGA/ Fl TC sorts as described by Lord and Spooncer ( 1986}. 
After the first WGA/ FITC sort the cells were transferred to a plastic tube 
(Falcon 2058} and immediately sorted again using the same FLS, PLS and 
FITC-fluorescence window settings as in the first sort. In this second sort, 
60 - 80% of the cells were sorted. Selection of CFU-S in this way yielded 
typically 2 x 1 o5 cells. 
The third procedure to select CFU-S was developed in the present 
study (chapters 5 and 6} and involved selection on basis of MCA 15-1.1 
fluorescence intensity in a second sort. First WGA/FITC conjugates were 
removed from the cells which were then labelled with 15-1.1/ FITC. In the 
second sort the 15-1.1 negative cells with the same FLS and PLS intensities 
as in the first sort were selected. In this second sort between 40 and 50% of 
the cells were isolated resulting in the ultimate selection of 1-2 x 1 o5 cells. 
STAINING OF CELL SUSPENSIONS WITH RHODAMINE 123 (Rh123} 
Cells were labelled with Rh123 as described by Bertoncello et al. 
(1985}. Rh123 (Eastman Kodak, Rochester, New York, U.S.A.) was dissolved 
in distilled water (1 mg/ml). Bone marrow cell suspensions sorted on basis of 
a-H-2Kk or 15-1.1 fluorescence were incubated in 10 ml HH + 5% FCS and 
0.1 ].lg/ml Rh123 for 15-20 min at 37°C in the dark. The cells were washed 
once with HH + 5% FCS and resuspended in HH at a concentration of 1-3 x 
106 cells per mi. Cells isolated on basis of two sequential WGA/ FITC sorts 
were stained with Rh123 while at the same time WGA/FITC was removed. To 
the sorted cells 10 ml of a solution containing 0. 2 M N-acetyi-D-glucosamine 
+ 5% FCS and 0.1 ].lg/ml Rh123 was added. After 15-20 min at 37°C in the 
dark, the cells were washed as described above. Rh123 stained samples were 
sorted on the FACS-11 using the same FLS and PLS windows as in the 
previous sorts and the same optical filters as used for FITC fluorescence 
measurements. Rh123 stained samples were processed in subdued light. 
PURIFICATION OF CFU-S USING A ONE SORT PROCEDURE 
Purification of CFU-S in a one sort procedure, employing two different 
fluorochromes was done using the Rijswijk Experimental Light Activated Cell 
Sorter ( RELACS, Stokdijk et al., 1985}. The RELACS is a two laser flow 
cytometer and allows for 8 parameter measurements (for details about the 
RELACS, see Herweijer, 1988}. 
Low density bone marrow cells were separated and at the same time 
labelled with either WGA/FITC or with WGA conjugated to the red fluorescent 
dye Texas Red (Titus et al., 1982; WGA/TxR, Molecular Probes, Eugene, 
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OR, U.S.A.) as described before. WGA/TxR ~as used at a 2000-fold dilution 
in HSA (final concentration 0.5 ).lg/ml). Subsequently, the WGA stained cells 
were labelled with a:-H-2Kk-biotin and Av/PE. When cells were labelled with 
WGA/FITC only one laser of the RELACS was used (Coherent CR6, 
Coherent, Palo Alto, CA. U.S.A.). The laser was operated at 488 nm and 
0. 4 W. FLS and PLS intensities were measured through 488 nm band pass 
(BP) filters (Melles Griot, Irvine, CA, U.S.A.) and were linearly amplified. 
Green FITC fluorescence (WGA) and orange PE fluorescence (a:-H-2Kk) 
signals were separated with a 570 nm dichroic mirror (Zeiss, West Germany) 
and measured through a 530 nm and 577 nm BP filter, respectively (Cor ion, 
Hollistone, MA, U.S.A.). Fluorescence signals were measured using 
logarithmic amplifiers. Spill over of green fluorescence into the detector used 
for the orange fluorescence was corrected as described in chapter 5. 
When cells were labelled with WGA/TxR both lasers were used. The 
second laser of the RELACS (Spectra Physics 2020-05, Mountain View, CA, 
U.S.A.) was used to pump a tunable dye laser (Spectra Physics 375) circu-
lating rhodamine 6G. The dye laser emitted 590 nm light (0.3 W) and was 
used to excite TxR. TxR fluorescence was measured using two RG630 nm 
long pass (LP) filters (Schott Optical Glass Inc., Duryea, PA, U.S.A.) and 
was logarithmically amplified. 
Selection of the cell population that is enriched for CFU-S is described 
in detail in chapter 5. Briefly, after exclusion of aggregates consisting of 
two or more cells, the blast cells were selected by means. of electronic 
window settings including cells with low to intermediate FLS and low PLS 
intensities. Then, a window was set to select the WGA positive blast cells. 
This was done in the same way for samples labelled with WGA/FITC or 
WGA/TxR. Finally, a window was set to select the 20-30% most strongly 
a:-H-2Kk positive cells. In this way about 0.1-0.4% of all nucleated bone 
marrow cells were selected. The selected cells were sorted and assayed for 
their CFU-S content (Table 5.1). 
THREE COLOUR IMMUNOFLUORESCENCE FLOW CYTOMETRJC SCREENING OF 
MCAs FOR REACTIVITY WITH CFU-S 
The above described procedure was modified to allow in vitro screening 
of MCAs for reactivity with CFU-S. Unseparated or low density bone marrow 
cells were stained in the following way: First, 1 o6 bone marrow cells were 
resuspended in 50 ).ll of spent hybridoma culture supernatant to which the 
appropriate dilution of a:-H-2Kk-biotin was added (see above). After incu-
bation on ice the cells were washed twice with HSA. The pelleted cells were 
then resuspended in 50 ).ll of the appropriate dilution of GARA/ FJTC (to 
detect MCA) and Av/PE. After incubation and washing of the cells they were 
resuspended in 1 ml HH supplemented with WGA/TxR (1: 2000) or WGA con-
jugated to the blue fluorescent dye 1-pyrenebutyryl (WGA/PYR, Molecular 
Probes, Junction City, OR, U.S.A.). WGA/PYR was diluted 2500-fold (final 
concentration 0.4 ).lg/ml HSA). After 10-15 min incubation at room tempera-
tur,e the cells were analyzed on the RELACS. The first laser was tuned as 
described above. In case, WGA/PYR was used, the second laser of the 
RELACS was tuned to emit UV light with lines at 351 nm and 364 nm. In 
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case WGA/TxR was used the machine was tuned as described above. A total 
of 1 o5 nucleated cells was analyzed (erythrocytes were excluded from the 
analysis by setting a threshold after the FLS amplifier). Of each cell six 
parameters were measured and stored simultaneously in a list mode file in the 
memory of an HP9000-220 microcomputer. The recorded parameters were time 
of flight (TOF), FLS, PLS, FITC fluorescence (MCA) and PE fluorescence 
(a.-H-2Kk) generated by the first laser and TxR fluorescence (WGA) or PYR 
fluorescence (WGA) generated by the second laser (see chapter 5). The data 
were analyzed using the ELDAS software package written in the Radiobio-
logical Institute TNO. Analysis was done as described in detail in chapter 5. 
In brief, first CFC-S were selected as described above, then the FJTC 
fluorescence (MCA) of the selected cell population was analyzed and 
compared with a sample treated in the same way except that MCA was 
ommitted (see Figs. 5.4 and 5.5). 
DETERMINATION OF THE IMMUNOGLOBULIN (SUB)CLASS OF MCAs 
The immunoglobulin (Jg) (sub)class of the produced MCAs was 
determined by an Ouchterlony immunodiffusion reaction in 1% (w/v) agarose, 
dissolved in verona! buffer, pH 8.4 (12 g/liter 5.5 diethylbarbituric acid -
sodium salt and 4. 4 g/Jiter 5. 5 diethylbarbituric acid). The central well was 
filled with ten-fold concentrated culture supernatant (1 0 J,JI/well), the 
surrounding wells were topped with undiluted rabbit- or goat-anti-rat lg 
(sub )class specific antisera (Nordic, Til burg, The Netherlands): 
RARA/lgG1, lgG2a, lgG2b, lgA (Fc-part), JgE (Fc-part) and GARA!IgG2c 
and lgM ( Fc-part). After diffusion for 24 hours at 4°C, the slides were 
placed in distilled water during 2x one hour. Subsequently, the slides were 
stored in PBS for 24 hours after which they were air-dried and stained with 
Coommassie Brilliant Blue Staining solution. 
GOLD LINKED IMMUNOSORBENT ASSAY (GLISA) 
Terasaki flat-bottom tissue culture plates (Greiner 726180, Nuertingen, 
FRG or Nunc, Roskilde, Denmark) were pretreated with poly-L-Iysine 
(Sigma, P2636) suspended in PBS (0.01 mg/ml) as described by Lansdorp et 
al. (1980). Then, un:;eparated bone marrow cells were added to the wells or 
WGA positive low density blast cells were sorted into the wells (1 000/well) 
using a modified automated microscope stage positioner as described by 
Visser et al. ( 1984). The cells were spun to the bottom of the wells at 100 g 
for 1 minute and fixed (10 minutes, room temperature) with 0.025% (v/v) 
glutaraldehyde (in PBS, Merck, 4239). Plates were then washed 3 times with 
PBS and could be stored for several weeks at 4°C by adding PBS supple-
mented with 200 ].lg/ml gelatin (Merck 4072) and 0.1% NaN3 (see Lansdorp et 
al., 1980). 
Screening was done by adding 10 ].11 of spent hybridoma culture super-
natant to the wells after the plates had been washed 3x with PBS and 1 x 
with PBS supplemented with 0. 2% (v /v) Tween-20 (PBS-T). The plates were 
incubated for one hour at room temperature and were then washed 4 times 
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with PBS and once with PBS-T. Subsequently, 10 J.!l of a 1:20 dilution (in 
HSA) of a goat-anti-rat lg serum conjugated with 5 nm colloidal cold 
particles (GARA/gold, Janssen Pharmaceutics) was added to the wells and 
the plates were incubated for another 30 min at room temperature. The 
plates were washed 3 times with PBS. once with PBS-T and finally with PBS 
and fixed again with 2% glutaraldehyde for 15 min at room temperature (10 
J.!l/well). After the plates had been washed twice with 0.2 M citrate buffer, 
pH 3.85, ten J.!l/well of a silver enhancing solution (77 mM hydroquinone, 5.5 
mM silver lactate in 0.2 M citrate buffer, Janssen Pharmaceutics) was added. 
After 4-6 minutes at room temperature the reaction was stopped by adding 10 
J.JIIwell fixing solution (Janssen Pharmaceutics). The fluid was removed and 
the wells examined for silver precipitates on the surface of the cells using 
an inverted microscope. 
ANTIBODY DEPENDENT AND COMPLEMENT MEDIATED CYTOTOXICITY 
ASSAY 
In the antibody dependent cytotoxicity assay. 1 o6 bone marrow cells 
were incubated with hybridoma culture supernatant as described before. 
Subsequently, equivalents of 5 x 1 o4 cells were injected into lethally irra-
diated recipients for determination of the CFU-S content. Injected unlabeled 
bone marrow cells served as control (100% recovery). 
· In the complement mediated cytotoxicity assay, 1 o6 unseparated bone 
marrow cells were incubated with hybridoma culture supernatant followed by 
incubation (30 min, 37°C) with an appropriate dilution of a noncommercial 
batch of guinea pig complement (1:10 dilution in HH, D.5 ml/106 cells). 
The cells were washed once with HH. The pelleted cells were then 
resuspended at a concentration equivalent to 1 x 1 o5 cells/ml HH. Subse-
quently, lethally irradiated recipients were injected with 5 x 1 o4 cells for 
determination of the CFU-S content. Bone marrow cells incubated with HSA, 
instead of MCA, and complement were injected and served as reference (1 00% 
recovery) for the determination of the expression of the antigenic deter-
minant recognized by the MCAs on CFU-S. Mice were killed after 8, 10 and 
12 days for spleen colony counts (Table 4.3). 
MORPHOLOGICAL DIFFERENTIATION 
Cell suspensions from bone marrow (subpopulations) and other organs 
and tissues were deposited (750 rpm, 5 min, Shandon Cytospin-2) onto glass 
slides (1 04 cells/ slide in 50 J.d HSA), previously coated by centrifugation of 
50 ].II HSA. The microscope slides were air-dried and subsequently stained 
with May/Grunwald Giemsa staining solution according to standard 
procedures. Stained slides were examined using an inverted microscope. Of 
each slide 100 cells were counted. 
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CHAPTER 3 
SETTING UP THE FUSION SYSTEM 
INTRODUCTION 
Kohler and Milstein (1975) first reported the derivation of immortalized 
cell lines (hybridomas) capable of unlimited production of monoclonal anti-
bodies (MCAs) of desired, predefined specificity. Since that time many 
people have adapted the hybridoma technology and the technique has moved 
into almost every area of biomedical research (Goding, 1980; Galfre and 
Milstein, 1982). 
The great advantage of the hybridoma technology is that unlimited 
quantities of homogeneous, exquisitely specific antibodies can be produced, 
even if the immunizing antigen is not pure, or is present in only low 
amounts, for instance, on minor cell populations (Goding, 1980; Kohler, 
1986; Galfre et al., 1977; Springer et al., 1978a; Springer et al., 1979). 
The technique is based on the fusion between cells from an in vitro 
adapted, enzyme deficient myeloma cell line, and spleen cells from------ari 
immunized animal. Fusion is reached by incubation of the myeloma-spleen cell 
mixture for a short time in the presence of a fusing agent like polyethylene 
glycol (PEG, Pontecorvo, 1976). Hybrids between myeloma and spleen cells 
can be selected from the two parental components as the only cells that 
actively multiply in selective medium (for details, see later section). Once 
the hybrids are growing well, the cultures are tested for the production of 
the desired antibody. Individual clones, that secrete the desired antibody, 
can be selected and isolated from the positive cultures by replating and can 
be expanded either in vivo or in vitro. All antibodies produced by an 
isolated clone have the same unique specificity and are thus of monoclonal 
origin. A general scheme for the production of MCAs is shown in Figure 3.1. 
The advent of hybridoma technology has proven to be very important 
and successful in defining cell surface antigens on cells belonging to the 
immunohaemopoietic system of mice and man (Goding, 1980; Galfre and Mil-
stein, 1982; Ledbetter and Herzenberg, 1979; Griffin et al., 1981!; Hogarth 
et al., 1980; Lachmann et al., 1980). In the mouse, more than fifty different 
antigenic complexes on haemopoietic cells have been described by means of 
MCAs raised by allogeneic (mouse) or xenogeneic (rat) immunization (Shen, 
1981; Hogarth and McKenzie, 1981; Morse Ill et al., 1987}. Many of the 
antigens recognized by these MCAs are differentiation antigens (DAG). DAG 
are cell surface antigens of which the expression can be turned on and off 
during cellular differentiation with regard to the specific physiological 
functions at that differentiation stage. DAG are either specific for individual 
cell types, at a particular differentiation stage, or common to sets or subsets 
of cells belonging to a certain cell lineage (Wang and Kruger, 1985; Swirsky 
et al., 1983; Williams et al., 1979). MCAs against DAG have contributed to 
the identification and phenotyping of leukaemias, and are used as probes in 
the study of normal haemopoiesis ( Chatenoud, 1986; Cote et al., 1983; 
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Figure 3.1: 
Schematic representation of the general procedures for monoclonal antibody 
production. Adapted from Campbell ( 1984). 
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Hokland et al .• 1986; Janossy et al.. 1978; Takei, 1984; Griffin et al., 
1984). From these studies it was clear that most antigenic surface markers 
are not specific for one single type of leukaemia, or one individual subset of 
normal haemopoietic cells. In the mouse and human haemopoietic system, 
MCAs have been described that react with antigenic determinants present on 
pluripotent haemopoietic. stem cells (PHSC) and early committed progenitor-
cells, but none of these MCAs react exclusively with these cell types. All 
MCAs reactive with stem cells or progenitor cells are also reactive with 
other, more mature cells. Many of these recognized antigens are DAG 
(Griffin et al., 1984; Springer et al., 1978a; 1978b; 1979; Hogarth et al., 
1980; Shen, 1981; Davignon, 1981; Kurzinger et al.. 1981; Trowbridge, 
1978; Gaul ton et al.. 1985; Chan and Takei, 1986; and many others). 
In this chapter, aspects concerning the production of MCAs which 
would be exclusively specific for antigenic determinants on murine PHSC or 
early committed progenitor cells will be discussed. First, factors determining 
the choice of the animals to be immunized and the myeloma fusion partners 
will be discussed. Furthermore, attention will be payed to the importance of 
the purity (content of stem cells) of the immunization suspensions and the 
route and dose of immunization with regard to the frequency of stable 
antibody producing hybridomas. Finally, some of the results will be 
discussed. 
ANIMALS USED FOR IMMUNIZATION 
The first developed and still most commonly used system for the 
production of MCAs employs spleen cells of (hyper) immunized mice that are 
fused with mouse myeloma cells (Kohler and Milstein, 1975; Ware et al., 
1984). The choice of mice. was mainly based on the availability of a number 
of good mouse myeloma cell lines. This will be discussed in a later section. 
Many cell surface antigens of the mouse have been discovered by 
immunization of mice with cells from mice belonging to other strains (allo-
geneic immunization). A disadvantage of allogeneic immunization is that 
strong immune responses can be elicited only against polymorphic antigenic 
systems like for instance antigens of the major histocompatibility complex 
(MHC) and that only a minority of cell surface antigenic determinants are 
subject to polymorphic variation (Springer, 1980; Springer et al., 1978b). 
Against monomorphic antigenic molecules, only weak immune responses or no 
responses at all are elicited by means of allogeneic immunization (Kohler and 
Shulman, 1978; Springer et al., 1978b). 
Xenogeneic immunization has the advantage over allogeneic immunization 
that responses can be elicited against both polymorphic and monomorphic 
determinants (Omary et al.. 1980). In xenogeneic immunizations most 
molecules are potentially antigenic, because many commonly occurring homo-
logous proteins have diverged significantly during the course of evolution. 
The difference between homologous proteins from different species will be 
greater than between the polymorphic variants in one species. Therefore, 
the xenogeneic antibody response will be stronger (expressed as the anti-
body concentration in serum) and directed against a much wider range of 
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antigenic determinants than the allogeneic immune response (Springer et al., 
1978a; 1978b; Springer, 1980). For this reason, in this study rats were used 
for xenogeneic immunization. In addition, it has been reported that in many 
cases immunized rats showed stronger immune responses than mice (Wester-
woudt, 1985). 
Significant differences in the strength of the immune response between 
animals of different inbred strains have been reported upon challenging with 
the same immunogen (Spitz et al. , 1984). Springer et al. ( 1978b) found a 
six-fold difference between the strength of the immune response of rats from 
the DA and AO strain after immunization with the same antigen. In order to 
establish which rat strain gave the strongest immune response, rats of three 
different strains (Table 3.1) were intravenously (i.v.) immunized (lateral tail 
vein) with 107 nucleated bone marrow cells of BC3 mice. At the peak of anti-
body production, i.e., ten days after immunization, the rats were bled 
(orbital puncture), and, subsequently, serum was isolated and inactivated 
(56°C, 30 min). Appropriate dilutions of the sera were incubated with BC3 
bone marrow cells, stained and analyzed on a FACS-11 (Chapter 2). The 
percentage of fluorescent cells was determined and regarded as a measure of 
the strength of the immune response. Results are shown in Figure 3. 2. A 
clear difference in the percentage of antibody binding cells is observed 
between the sera of BN rats and those of SD or WAG rats. BN rats showed 
a stronger immune response than SD and WAG rats. 
rat strain 
BN/BiRij 
SD/Rij 
WAG/Rij 
Table 3.1 
RAT STRAINS USED IN THIS STUDY 
abbreviation 
BN 
SD 
WAG 
histocompatibility antigen haplotype 
Rt-1 (Ag-8) Rt-2 (Ag-C) Rt-3 (Ag-D) 
n 
u 
u 
a 
b 
b 
b 
b 
b 
Only female rats, 8-16 weeks of age were used. 
Because the strength of the antibody response appears to be the 
critical factor in the production of specific antibody producing hybridomas 
(Springer et al., 1978b; Galfre and Milstein, 1982; Kilmartin et al., 1982; 
Lane, 1985), it was decided to use BN rats for immunization. 
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Comparison of the immune response of three different rat strains. Female 
BN, SD and WAG rats were injected (i.v.) with 107 nucleated murine (BC3) 
bone marrow cells. After 10 days sera were collected (orbital puncture) and 
tested for reactivity with BC3 bone marrow cells on a FACS as described in 
Chapter 2. 
MYELOMA CELL Ll NES 
The success of a fusion, reflected in the number of growing hybridomas 
producing the specific MCA, is not only dependent on the immune state of 
the animal from which the spleen is taken but also on the myeloma cell line 
used for fusion (Reading, 1982; Kearny et al., 1979). Myeloma cells can be· 
cultured indefinitely because a myeloma is a transformed immortalized tumour 
of the immune system (Milstein, 1986). 
There are three major considerations in choosing a specific myeloma cell 
line as fusion partner. First, the expression of a drug resistance gene for 
selection of unfused myeloma cells. Second, the presence or lack of produc-
tion of heavy and light chains of immunoglobulin (lg) molecules by the 
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myeloma cells. Third, the number and stability of the hybridomas formed by 
fusion with the myeloma cells. 
The myeloma lines used in this study (Table 3. 2) were all selected for 
resistance to the purine analogue 8-azaguanine. The resistant cells lack 
functiona I activity of the enzyme hypoxanthine-guanine-phosphoribosyltrans-
ferase (HGPRT). required in the salvage pathways of nucleotide biosynthesis 
(Littlefield, 1964). The HGPRT deficient cells can still synthesize the 
necessary bases for RNA and DNA synthesis via de novo pathway. In 1962, 
Szybalski et al. described the selective HAT -medium containing hypoxan-
thine, aminopterin and thymidine. Aminopterin (an analogue of fOlic acid) 
blocks de novo synthesis of purines and pyrimidines. To survive in the 
presence of aminopterin, cells must be able to synthesize these nucleotides 
by utilizing an exogeneous source of hypoxanthine and thymidine (provided 
in HAT-medium) via the salvage pathways. Myeloma cells die in HAT-medium, 
since they lack HGPRT activity and cannot use the salvage pathways. Normal 
spleen cells have functional HGPRT activity and therefore can survive in 
HAT-medium. However, the normal parental spleen cell is terminally differ-
entiated and has a finite short life span. In HAT -medium unfused myeloma 
and spleen cells and hybrids between two or more myeloma cells and between 
two or more spleen cells will die within a few days. Only hybrids between 
myeloma cells (providing tumour cell growth properties) and spleen cells 
(providing HGPRT activity and the genetic information for the required 
antibody) are able to grow in HAT -medium (Littlefield, 1964). 
myeloma line 
SP2/0 Ag14 
VB Ag1-2.3 
VB 2/0 
Table 3.2 
MYELOMA CELL LINES USED IN THIS STUDY 
abbreviation 
SP2 
Y3 
YO 
origin 
species/strain 
mouse/BALB/c 
rat! Lou/ M /Wsi 
rat/ Lou/ M /Wsi 
lg-chain expression 
none 
kappa 
none 
Nowadays, HAT -medium is the most commonly used selective medium in 
hybridoma technology. Another selective medium consisting of hypoxanthine 
·and azaserine has been described. The selective mechanism exploits 
deficiency of the enzyme adenine-phosphoribosyltransferase ( APRT) in 
myeloma cells. Azaserine blocks the pathway of de novo synthesis of purine 
nucleotides of 8-azaguanine resistant cells, but not of pyrimidine nucleotides 
and consequently thymidine need not be included in the medium ( Foung et 
al., 1982). Selection with azaserine is reported to result in higher 
frequencies of stable antibody producing hybridomas than selection with 
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aminopterin which is photosensitive and highly toxic (Campbell et al.. 1986; 
Horenstein et a I. , 1987; Westerwoudt, 1985). Both selection media were used 
in the present studies. 
Hybridomas codominantly express the lg-molecule chains of both 
parental cells. If the myeloma line used expresses both heavy and light 
chains of an Jg-molecule, the hybrids will express four chains, two of each 
parent. In this case, sixteen combinations of the four different lg-chains are 
possible, resulting in ten different lg-molecules. Just one out of the sixteen 
combinations will be made up of the desired heavy and light chains of the 
parental spleen cell (Shulman et al., 1978). The affinity and frequency of 
MCAs with the desired specificity obtained in fusions between lg-molecule 
producing myeloma cells and spleen cells will be lower than in fusions in 
which mutant myeloma cells are used which only express lg-light chains. The 
amount of irrelevant antibodies in the latter kind of fusions will be lower 
than in the former case. At least twenty five percent of the produced anti-
bodies wilt be made up of the desired heavy and light chains of the parental 
spleen cells ( Galfre and Milstein, 1982). Mutant myeloma cell lines that do 
not express any lg-chain, will give rise to hybridomas which only express 
the antibody of the parental spleen cell. The use of such (non-producer) 
myeloma lines is recommended by many investigators, because they are 
obviously the most suited lines for the production of stable hybridomas, 
secreting (only) the desired, specific MCAs (Galfre and Milstein, 1982; 
Hudson and Hay, 1981; Lemke et al., 1979; Milstein, 1986; Ozata and Sachs, 
1981; Reading, 1982; Stahli et al., 1980). 
The first established myeloma lines suited for fusion were of mouse 
origin. Most, if not all, murine myeloma Jines known today, are derived from 
the MOPC BALB/c plasmacytoma (Potter, 1972; Clark et al.. 1983; Kohler 
and Milstein, 1976). In the present study, the widely used non-producer line 
SP2 was employed (Shulman et al., 1978). It has been shown that this line is 
well suited for fusions with spleen cells of mice, rats, humans, frogs and 
birds, but stable hybrids are only rarely obtained in other than rodent-
rodent fusions ( Galfre and Milstein, 1982; Hudson and Hay, 1981; Lemke et 
al., 1979; Kohler and Shulman, 1978; Misra et al., 1981; Ozata and Sachs, 
1981; Reading, 1982; Stahli et al., 1980). 
In contrast with mouse myeloma cell lines, rat myeloma cell lines are 
comparatively rare. Only three rat myeloma cell lines suited for fusions with 
both rat and mouse spleen cells have been described (Kilmartin et al., 1982; 
Galfre et al., 1979; Bazin, 1982). Two of the three rat myeloma lines were 
used in the present studies. The kappa-light chain producing line Y3 was 
the first line used for fusions ( Galfre et al., 1979) and is still commonly 
used. From this line a non-producer mutant .Jine called YO was derived 
(Kilmartin, 1982). All rat myeloma cell lines are derived from spontaneously 
occurring ileocecal immunoplasmacytomas in rats of the Lou strain (Bazin et 
al., 1973). 
There is no consensus of opinion in the literature about the best choice 
of a myeloma line for the production of stable rat-anti mouse antibody 
producing hybridomas, except that, if possible, non-producer myeloma lines 
should be used. 
In general, the use of myeloma cells of the same species and, when 
possible, of the same strain as the immunized animal is recommended, 
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because in xenogeneic fusions the hybridomas tend to lose chromosomes more 
rapidly and more frequently than in intraspecies fusions, resulting in lower 
frequencies of stable antibody producing hybridomas ( Bazin, 1982; Clark et 
al., 1983; Galfre and Milstein, 1982; Galfre et al., 1979; Goding, 1980; 
Hokland et al., 1986; Kohler and Shulman, 1978; Milstein, 1986; Nowinski et 
al., 1980; Weiss and Green, 1967). On the other hand, many investigators 
successfully used interspecies fusions between rat spleen cells and mouse 
myeloma cells, for the production of stable antibody producing hybridomas 
(Misra et al., 1981; Ledbetter and Herzenberg, 1979; Lemke et al., 1979; 
Springer et al., 1978b; Takei, 1984; Shen, 1981; Stern et al., 1978; 
Koeslter et al., 1984; Trowbridge, 1978; Gaulton et al., 1985; Kearny et al., 
1979; Hemmi et al., 1985; and many others). 
FUSION EXPERIMENTS WITH DIFFERENT MYELOMA CELL LINES 
To find out which of the available myeloma cell lines resulted in the 
highest percentage of growing and stable antibody producing hybridomas, 
fusion experiments were performed to compare the quality of the three 
myeloma cell lines. 
A total of eight fusion experiments were performed between spleen cells 
of the same rat and cells of the three myeloma cell lines. In five of the 
experiments no growing hybrid clones could be detected with any of the 
myeloma cell lines. The results of the experiments in which growth was 
detectable are shown in Table 3. 3. The fusion frequency (percentage of 
growing hybridomas) with both allogeneic (Y3 and YO) and xenogeneic (SP2) 
myeloma lines was very low. In fusions in which Y3 was used no growing 
hybridoma clone was observed in any of the 1020 seeded wells. Only in one 
fusion experiment in which YO was used as fusion partner, growing hybri-
domas were observed in a low frequency. The highest fusion frequency was 
obtained in xenogeneic fusions with SP2 cells. In all three fusion experiments 
with this cell line, growth was observed. The fusion frequency showed a 
great variability, as was also reported by others (Lemke et al., 1979; 
Abrams et al., 1983; Kilmartin et al., 1982), and was rather low. 
The frequency of initially antibody producing hybridomas in the fusion 
with YO was 100%, while the mean frequency of initially antibody producing 
hybridomas in the fusions with SP2 was 43%. These percentages are in 
agreement with those observed by Clark et al. (1983). They reported that 
the proportion of hybridomas expressing antibodies was greater than 90% in 
rat x rat fusions, 60% in mouse x mouse fusions (using a variety of myeloma 
lines) and somewhat lower than 60% in rat spleen x mouse myeloma fusions. 
In both intra- and interspecies fusions the initially producing hybri-
domas were very unstable. In the fusion with YO only 5% (one clone) could 
be rescued by subcloning. Ninety five % of the initially positive clones either 
stopped growing (they probably lost the chromosome containing the HGPRT 
enzyme gene), or ceased antibody production, upon further growth and sub-
cloning. In just one of the three fusion experiments with SP2, a low 
percentage (6%, 2 clones) of the initially antibody producing hybridomas 
appeared to be stable clones. All the other initially positive hybridomas (in 
all three experiments) were lost due to either cell death or loss of antibody 
production. 
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Table 3.3 
FUSIONS IN WHICH DIFFERENT MYELOMA CELL LINES WERE USED 
antibody 
wells containing initial positive stable positive 
hybrids/ hybrids/ hybrids/ 
total wells seeded* total hybrids total positive hybrids 
fusion no. % no. % no. % 
BN X SP2 6/960 5/6 83 0/5 0 
X YO 20/480 4 20/20 100 1/20 5 
X Y3 0/660 0 
BN X SP2 83/360 23 15/83 18 0/15 0 
X YO 0/360 0 
x Y3 0/360 0 
BN X SP2 113/1260 9 32/113 28 2/32 6 
X YO 0/720 0 
*1-2. 5 x 105 spleen cells per well. Spleen cell : myeloma cell ratio: 2:1. 
Immune spleen cells were fused with the myeloma cell lines as described in 
Chapter 2. Initial positive hybrids represents the number of wells in 
which the hybridoma(s) produced antibody as determined in the initial 
screening round using the FACS (Chapter 2). 
Stable positive hybrids: hybridomas of which the supernatant contained 
antibody in 4-5 independent sequential screening assays. 
In this study, no difference in the frequency of stable antibody pro-
ducing hybridomas was found between xenogeneic (SP2) and allogeneic (YO) 
fusions. This is in agreement with data in the literature indicating that 
fusions between rat spleen cells and mouse myeloma cells cab be equally suc-
cessful as rat x rat fusions (Kohler and Shulman, 1978; Ledbetter and 
Herzenberg, 1979; Misra et al., 1981; Hemmi et al., 1985; Bazin, 1982; 
Westerwoudt, 1985). 
Because of the slightly higher fusion frequency, the similar frequency 
of stable antibody producing hybridomas, and the fact that the nonadherent 
SP2 cells are easier to handle than the adherent YO cells, it was decided to 
use SP2 myeloma cells in further fusion experiments. Results of these fusions 
are discussed in a later section. 
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ANTIGENICITY AND PURITY OF THE IMMUNOGEN 
Besides the choice of the animal used for immunization and the myeloma 
cell line used as fusion partner, another major factor that influences the 
success of a fusion is the immunogen itself and the schedule and dose of 
immunization (Dresser, 1986; Spitz et al., 1984). 
It is reported that, )n general, cell surface antigens are highly immuno-
genic when presented on intact cells (Goding, 1980; Taggart and Samloff, 
1982; Westerwoudt, 1985). Cell surfaces are complex mosaics of many 
different immunogenic glycoproteins and glycolipids. Some of these 
determinants are immunodoiT}inant and give strong immune responses even 
when present in only trace amounts, while others are minor antigens and 
hardly elicit an immune response (Galfre and Milstein, 1982). Therefore, it is 
rather difficult (especially in xenogeneic immunizations) to obtain highly 
specific MCAs which recognize individual poorly represented cell surface 
molecules (Springer et al., 1978a; 19?8b; Stern et al., 1978). 
One of the great advantages of the hybridoma technology is that each 
hybrid produces a single MCA specific for a single antigenic determinant, 
regardless the complexity and the impurity of the antigen or the overall 
immune response of the spleen cell donor. The idea exists that all specifi-
cities can be rescued by cell fusion methods if an immune response can be 
elicited (Goding, 1980; Kohler, 1986; Stern et al., 1978; Lachmann et al., 
1980). An example of the irrelevance of the purity of the immunogen and the 
usefulness of the hybridoma technique for the identification of antigens 
present in low amounts on minor subpopulations of cells is reported by 
Springer et al. (1979). They obtained a MCA (M1/70) specific for an anti-
genic determinant (MAC-1) only present on macrophages, whereas macro-
phages comprised only 3% of the cells present in the immunization 
suspension. 
Although purity of the immunogen per se is not necessary, it is obvious 
that the purer the immunogen, the higher the chance of obtaining immunogen 
specific MCAs will be. The incidence of CFU-S in normal murine bone marrow 
is very low (less than 1 %; Lahiri et al., 1970; Lord and Spooncer, 1986; Van 
Bekkum et al., 1979) and therefore (some) purification of CFU-S in the 
immunization suspensions to be used, seemed necessary to enhance the 
likelihood to obtain haemopoietic stem cell-antigen specific MCAs. 
PURIFICATION OF CFU-S 
Visser et al. (1984) described a method to highly purify murine haemo-
poietic stem cells: Normal bone marrow cells are separated by means of dis-
continuous density gradient centrifugation. The low density cells are stained 
with the lectin WGA conjugated to the fluorochrome FITC, and the brightly 
fluorescent cells with medium forward light scatter and low perpendicular 
light scatter intensities are sorted of a FACS-11. After removal of the bound 
WGA-FITC conjugates, the cells are labelled with a-H-2Kk antibodies 
visualized with a fluorescent conjugate, and, the most brightly fluorescent 
cells are sorted (for details, see Chapter 2). With this method approximately 
105 cells of a suspension that is 135-fold enriched for day-12 CFU-S and 
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53-fold enriched for day-8 CFU-S, can be isolated in one day from normal 
bone marrow. 
A less complicated way to enrich for CFU-S is treatment of mice with 
5-Fiuorouracil (FU). VanZant (1984) showed that treatment with FU resulted 
in an enrichment of late appearing CFU-S, reaching its maximum (four-fold) 
seven days after treatment (day-7-FU). In addition, the presence of a very 
primitive cell type, i.e., pre-CFU-S in FU treated bone marrow was 
suggested by Hodgson and Bradley (1979). Thus, day-7-FU bone marrow 
seemed a suitable suspension for immunization, especially when the low 
density cell fraction was used (see later section). The advantage of the use 
of the low density cell fraction in day-7-FU bone marrow for immunization 
over the suspension purified with the method described by Visser et al. 
(1984), is that the former can be obtained more easily: Approximately 1 o7 
day-7-FU low density cells can be isolated in about half a day. 
CELL SUSPENSIONS USED FOR IMMUNIZATION 
In the initial fusions (Table 3.3) rats were immunized with the low 
density bone marrow cell fraction of mice that were treated seven days 
before with FU (Chapter 2). These suspensions will be further indicated as 
day-7-FU-MA. It was expected that in this suspension relatively high 
amounts of late appearing CFU-S would be present, due to FU treatment, 
and because in the low density cell fraction of untreated normal bone marrow 
(NBM), day-8 and day-12 CFU-S are five-fold enr.iched (Visser et al., 
1984). There are no indications that the density of CFU-S from FU-treated 
bone marrow is different from the density of CFU-S in normal marrow. 
However, it appeared that the day-7-FU-MA suspension contained an 
unexpected low frequency of stem cells (Table 3.4). Day-8 CFU-S were only 
two-fold enriched which was not unexpected since it is known that FU 
preferentially kills early appearing CFU-S, but the poor (four-fold) 
enrichment of day-12 CFU-S could not be explained. 
The antibodies produced by the hybridomas obtained from the fusions in 
which day-7-FU-MA was used as immunogen all reacted with most of the 
nucleated bone marrow cells, which might be explained by the low enrichment 
factor of CFU-S in this suspension. Based on these results it was decided to 
use immunization suspensions that were more enriched for CFU-S. 
Selection of the cells present in day-7-FU-MA that bound the highest 
amounts of WGA (day-7-FU-MA-WGA+) resulted in a ten-fold enrichment of 
day-12 CFU-S and a four-fold enrichment of day-8 CFU-S (Table 3. 4). 
Although the frequency of CFU-S in this fraction was 2-3 times higher than 
in the day-7-FU-MA fraction, the enrichments were still unsatisfactory low. 
Because of the low enrichment factors obtained with FU treated bone marrow, 
and because in the method to highly purify CFU-S, untreated NBM is used, 
it was decided to use only untreated NBM derived suspensions for immuniza-
tions. 
Selection of the cells in the low density cell fraction which bound the 
highest amounts of WGA (NBM-MA-WGA+) resulted in a six-fold enrichment of 
day-8 CFU-S and an eighteen-fold enrichment of day-12 CFU-S (Table 3.4). 
Although the enrichment factors were higher than in the comparable fraction 
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Table 3.4 
BONE MARROW SUSPENSIONS USED FOR IMMUNIZATION OF RATS 
suspension 
day-7 FU-MA 
day-7 FU-MA-WGA+ 2 
NBM-MA-WGA+ 3 
NBM-MA-WGA+/a.-H-2Kk+ 4 
enrichment factor 
day-8 CFU-S day-12 CFU-S 
2 4 
4 10 
(3-5) (9.8-10.2) 
6 18 
35 71 
(11-108) (39-157) 
Figures represent the mean enrichment factor (and the range of enrichment) 
of CFU-S with regard to the number of CFU-S in unseparated normal bone 
marrow suspensions. The average number of day-8 CFU-S and day-12 CFU-S 
in unseparated normal bone marrow was 28 ± 3, respectively 31 ± 4. 
1 day-7 FU-MA: low density cell fraction after density gradient centrifugation 
(MA) from bone marrow of mice treated 7 days before with 5-fluorouracil 
(day-7 FU). 
2day-7 FU-MA-WGA +: WGA positive blast cell fraction of day-7 FU-MA bone 
marrow sorted on a FACS-11 as described in Chapter 2. 
3NBM-MA-WGA+: WGA positive low density blast cell fraction from normal 
bone marrow (NBM). 
4NBM-MA-WGA+/a-H-2Kk+: a.-H-2Kk positive, WGA positive low density blast 
cell fraction from N BM. 
of FU treated bone marrow, the enrichment factors were still not as high as 
those reported (Visser and Bol, 1981; Visser et al., 1984). Therefore, 
further purification of the N BM-MA-WGA + suspensions was performed. 
Selection of the cells that bound the highest amounts of a-H-2Kk antibodies 
(NBM-MA-WGA+/a-H-2Kk+) resulted in a mean enrichment factor of 71 for 
day-12 CFU-S and 35 for day-8 CFU-S with regard to NBM (Table 3.4). 
Based on the assumption that the seeding efficiency of CFU-S in this 
purified suspension was 10% for day-12 CFU-S and 5% for day-8 CFU-S 
(Visser et al., 1984), it was calculated that 35% of the injected cells were 
day-12 CFU-S and 47% were day-8 CFU-S. Data by Wolf and Priestly (1984) 
and Magli et al. (1982) indicate that at least half of the number of CFU-S 
present at twelve days after transplantation are already present at eight 
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days after transplantation. Thus, the mean frequency of CFU-S in the 
immunization suspension was about 50 percent. In some experiments the 
frequency was higher, in other experiments lower, due to the variability in 
the enrichment factors of CFU-S between different experiments as was also 
found by Visser et al. (1984). 
IMMUNIZATION REGIMENS 
There exists no standard immunization protocol for rats or mice. A 
typical immunization regimen for rats consists of an intraperitoneal (i. p.) 
priming dose of 1-5 x 107 cells, followed by an i. v. boost with the same or 
somewhat higher cell dose (Goding. 1980; Spitz et al., 1984). 
According to this immunization regimen. highly purified bone marrow 
suspensions could not be used for immunization, because not enough stem 
cells can be purified for conventional i.p. or i.v. immunization of rats (see 
previous section). In the comparative fusions (Table 3. 3) rats were primed 
(i. p.) and boosted (i. v.) with approximately 107 day-7-FU-MA cells. Because 
of the importance to use highly purified immunization suspensions, alter-
native ways for immunization had to be found, which allow to use less cells. 
In vitro immunization had been reported to be very successful for 
soluble antigens (Raymond and Suh, 1986; Van Ness et al., 1984; Reading, 
1982). An advantage of in vitro over in vivo immunization is that it is 
possible to produce MCAs-against highly-conserved or weakly immunogenic 
determinants and comparatively little antigen is required. A disadvantage, 
however, is that complex culture conditions are needed and that it is 
difficult to introduce insoluble antigens (like cell surfaces) into the in vitro 
stimulation reaction. For our purpose in vitro immunization has no advantage 
because the same number of cells, i.e.- ~cells are needed as for in vivo 
immunization. This high amount of cells excludes the possibility of in vitro 
immunization with highly purified stem cell suspensions. - --
Another way of immunization is immunization into the mesenterial lymph 
nodes (Raymond and Suh, 1986; Rits et al., 1986). This method was 
reported to be successful for the production of MCAs against soluble 
antigens available in only limited amounts. 
A third method of immunization suitable for the production of MCAs 
against limited amounts of both soluble and particulate immunogens is direct 
intra splenic (i. s.) injection (Nilson et al., 1983, 1987; Spitz et al., 1984; 
Svalander et al., 1987) .. For i. s. immunization of mice and rats about 2. 5 x 
105 cells are sufficient to evoke a strong immune response. Thus, by means 
of i.s. immunization, it might be possible to immunize rats with highly 
enriched bone marrow suspensions. 
It was first tested in BN rats if i.s. immunization indeed resulted in a 
stronger immune response in comparison with conventional i. p. and i. v. 
injection. Rats were immunized with 1 o5 unseparated normal bone marrow 
cells of BC3 mice. Ten days after immunization sera were collected and 
analyzed in the same way as described earlier. It can be seen in Fig. 3.3 
that i. s. immunization indeed resulted in a stronger immune response than 
i. p. or i. v. immunization. Therefore, it was decided to use i. s. immunization 
in further experiments. 
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Figure 3.3: 
Comparison of the strength of the immune response of BN rats after injection 
of 1 o5 BC3 bone marrow cells via different routes. Rats were immunized by 
i.s., i.p. and i.v. injection. After 10 days the sera were collected (orbital 
puncture) ar:~d assayed on a FACS as described in Chapter 2. 
FUSIONS IN WHICH THE ANIMALS WERE IMMUNIZED AND BOOSTED BY 
JNTRASPLENJC INJECTION 
Since it was shown that for i. s. immunization approximately 1 o5 cells 
are sufficient to evoke a strong immune response (Figs. 3.3 and 3.4), it was 
decided to immunize rats via this route with as many cells of as highly as 
possible enriched bone marrow suspensions (Table 3, 4). It was not alwa~s 
possible to immunize rats with the highly purified NBM-MA-WGA + /a:-H-2K + 
cells (Table 3. 4). In each step of the purification method described by 
Visser et al. ( 1984) cells are lost. When the yield of WGA positive cells was 
high enough, the suspension was further purified with a:-H-2Kk antibodies. 
If the amount of WGA positive cells was not high enough, this cell 
suspension was used as such for immunization. 
After i .s. immunization and boosting, growing hybridomas were obtained 
in a relative high frequency (Table 3. 5). The mean fusion frequency was at 
least 60%, which is in agreement with frequencies in rat x mouse fusions 
obtained by others (Lachmann et al., 1980; Misra et al., 1985). This high 
fusion frequency indicated the suitability of the employed immunization 
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Immune response of a BN rat after i.s. immunization with 50,000 NBM-MA-
WGA+/a-H-2Kk+ cells. After 4 days the spleen was removed and used in a 
fusion experiment. At the same time serum was collected and assayed for 
reactivity with BC3 N BM cells on a FACS. The fluorescence distribution of 
bone marrow samples treated with serum dilutions (dotted line, Ox; thick 
line, 20x; broken line, BOx) was compared with that of bone marrow cells 
incubated with GARA/ FITC. only (thin line). 
The frequency of initially antibody producing hybridomas was rather 
low (one exception) and the frequency of stable antibody producing hybri-
domas showed a large variability. In two of the four fusions listed in Table 
3.5 the frequency of stable producing clones was relatively high, while in 
the two other experiments it was about ten times lower. As stated earlier, 
the immune state of the animals can make all the difference between success 
and failure of a fusion. In this study, i.s. immunization resulted in a mean 
higher frequency of stable antibody producing hybridomas than i. p. or i. v. 
immunization (compare Table 3.3 and Table 3.5). 
Although every fusion in Table 3.5 resulted in stable antibody pro-
ducing hybridoma clones, many initially producing clones were lost upon 
further growth. The mean frequency of stable antibody producing hybri-
domas in these four experiments was 25% of the number of initially producing 
hybridomas. This percentage is in agreement with that found by others (Van 
Snick et al., 1985; Clark et al., 1983; Springer et al., 197Bb). According to 
Goding ( 1980) it is realistic to expect 50-70% of all initially producing 
hybridomas will be lost. 
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Table 3.5 
RESULTS OF FUSIONS IN WHICH THE RATS WERE I.S. IMMUNIZED AND BOOSTED 
rat immunization/boost wells containing hybrids/ 
strain suspension and total wells seeded 
cell number number % 
--- --
SD i. day-7 FU-MA-WGA+ 648/1080 60 
2.5 X 105 
b. day-7 FU-MA-WGA+ 
7 .5x105 
BN i. day-7 FU-MA 1350/1800 75 
4.5x106 
b. day-7 FU-MA-WGA+ 
9.6x105 
BN i. day-7 FU-MA-WGA+ 356/1380b 26 
6x105 
b. NBM-MA-WGA+ 
2. 5x1 o5 
BN i. NBM-MA-WGA+/a-H2Kk+ a 864/1080 80 
5x1o4 
a in this fusion the rat was only primed and not boosted. 
bonly the fastest growing hybrids were tested. 
initial positive hybrids/ stable positive hybrids/ 
total hybrids total positive hybrids 
number % number % 
--- - --- -
45/648 7 1/45 2 
288/288c 100 5/lod 50 
29/356 8 2/29 7 
27/864 3 12/27 44 
c288/1350 growing hybrids were tested. 
d1 0/288 initially positive hybrids were further grown, 5/10 appeared to be stable antibody producing 
hybridomas. 
See for number of spleen and myeloma cells seeded per well legend Table 3.3. Spleen cells of immune SD or 
BN rats were fused with SP2 myeloma cells as described in Chapter 2. Rats were immunized (i) or boosted 
(b) with the indicated cell suspensions and numbers. 
DISCUSSION 
Pluripotent haemopoietic stem cells can either renew themselves 
(proliferate) or give rise to all mature blood cell types (differentiate) under 
the influence of specific growth factors and according to the haemopoietic 
situation. PHSC specific antigens are most likely involved in the control of 
these two important processes. It has been reported that only a minority of 
cell surface antigenic determinants are subject to polymorphic variation 
(Springer, 1980; Springer et al., 1978b). Therefore, it seems reasonable to 
assume that these processes in different mouse strains are regulated by 
monomorphic, or a combination of both monomorphic and polymorphic anti-
genic molecules, rather than by just polymorphic molecules. Therefore, rats 
were used for immunization, because xenogeneic immunization leads to strong 
immune. responses against both polymorphic and monomorphic antigens. 
Of the available and tested inbred rat strains (Table 3.1), BN rats 
.gave the strongest immune response upon challenging with 107 normal murine 
bone marrow cells (Fig. 3.2). It was also planned to use rats belonging to 
the Lou strain, because the two available rat myeloma cell lines (Table 3.2) 
were derived from this rat strain, and fusion between spleen and myeloma 
cells of the same strain would favour the number and stability of antibody 
producing hybridomas (Galfre and Milstein, 1982; Hokland et al., 1986). 
However, Lou rats were not sufficiently available throughout this study. The 
lack of Lou rats seemed not insurmountable, because successful fusion 
between myeloma cells of Lou origin and spleen cells of other rat strains has 
been reported by a number of investigators (Leong et al., 1986; Chan and 
Takei, 1986; Campbell et al., 1986; Misra et al., 1981; Hemmi et al., 1985). 
Although many investigators obtained very good results with xenogeneic 
fusions between rat spleen cells and mouse myeloma cells, it was surprising 
that fusions with Y3 and YQ were less successful than with SP2 (Table 3. 3). 
It has been reported that Y3 and YO myeloma cells are very suitable for the 
production of rat x rat hybridomas (Clark et al., 1983; Kilmartin et al., 
1982) and that rat x rat hybridomas are characterized by a great stability 
early after fusion, whereas loss of antibody expression is hardly observed 
(Hemmi et al., 1985; Lachmann et al., 1980; Hale et al., 1985; Galfre and 
Milstein, 1982; Pierres et al., 1982). It was expected that fusion with YO 
would result in a somewhat higher percentage of stable antibody producing 
hybridomas than fusion with Y3, because the former is a non-producer 
myeloma line, while Y3 produces kappa-light chains. In fusions with Y3 also 
irrelevant antibodies will be produced, while in fusions with YO the hybrids 
will only make antibodies encoded by the parental spleen cell. 
lntrasplenic (i.s.) immunization resulted in stronger immune responses 
than i.p. or i.v. immunization (Fig. 3.3). This might be explained by the 
fact that upon i. s. immunization a maximalization of the number of specific B 
cell blasts is achieved by a prolonged presence of relatively high concen-
trations of antigen. Uptake and elimination of antigen in other parts of the 
body as is the case with other routes of injection, is minimized by this 
procedure (Nilson et al., 1987; Spitz et al., 1984). Direct i.s. immunization 
therefore is likely to enhance the antibody response. Furthermore, i.s. 
immunization made it possible to immunize rats with only 1 o5 cells of highly 
purified bone marrow suspensions (Table 3.4), that otherwise would not be 
45 
sufficient and thus enhanced the likelihood to obtain CFU-5 specific MCAs. 
Theoretically, all immunization suspensions listed in Table 3.4 could 
have resulted in CFU-5 specific MCAs, because the purity of the immunogen 
per se is irrelevant in hybridoma technology. However, immunization with 
rather impure day-7-FU-MA bone marrow suspensions resulted in unsatis-
factory reactivity of the obtained MCAs. A stem cell line as described by 
Dexter et al. (1980) would probably have been the best immunogen because 
of the unlimited amount of cells available and because of its reproducible 
purity. A number of laboratories have established immortalized cell lines 
derived from murine haemopoietic cells, by means of infection with a 
recombinant retrovirus (Dexter et al., 1980; Greenberger et al., 1983). All 
these lines are characterized by absolute dependency on exogenous colony 
stimulating factor (C5F), usually multi-CSF. A stem cell line was not 
available in this study. 
In Table 3.5 only one fusion is shown in which the rat was immunized 
with the highly purified NBM-MA-WGA + /o:-H-2Kk+ bone marrow suspension. 
However, more rats were immunized and boosted with this type of bone 
marrow suspension. A number of fusions between spleen cells of these rats 
and myeloma cells was lost at a stage before growth of hybridoma clones 
could be observed. The fusion cultures were lost due to contamination, 
which was probably introduced during the booster operation four days before 
fusion. Consequently, in later experiments the immunization and booster 
operation was performed with sterilized instruments, in a sterile 
environment. Under these conditions infections did no longer occur and a 
number of stable antibody producing hybridomas was obtained (Table 3.5). 
According to (Dresser, 1986) the nature of the antigen introduced into 
an animal is important, but the amount of antigen is of even greater signifi-
cance. Too little or too much antigen can be counter productive due to 
tolerization of the animal. The. low frequency of initially antibody producing 
hybrids in the fusion experiments listed in Table 3. 5 might have been due to 
the induction of tolerance (Thalhamer and Freund, 1985). However, this 
seems not very likely. It can be seen in Fig. 3.4, that i.s. injection of 5 x 
1 o4 cells resulted in a good immune response which suggests that no toleri-
zation occurred. The low frequency of antibody producing hybrids might also 
been due to the close relationship between rats and mice. According to 
B ruggemann et a I. ( 1986) rats and mice are closely related to each other and 
diverged some 1 o7 years ago. This could explain the success of fusions 
between rat spleen cells and mouse myeloma cells. On the other hand, this 
close relationship might also be the cause of the low frequency of antibody 
producing hybrids (Table 3.5), as the xenogeneic immune response will be 
weaker the smaller the evolutionary distance between immunogen and host. 
Rabbits and hamsters might have been more suited for immunization than 
rats, but it has been reported that the spleen cells of the former two 
species do not produce stable hybridomas upon fusion with a murine myeloma 
line (NS-1) (Ralph et al., 1982). 
The instability of the initially positive hybrids is most likely caused by 
loss of chromosomes. Hybridomas have a tendency to lose variable numbers 
of chromosomes of both fusion partners, especially during the early stages of 
proliferation after fusion. This loss of chromosomes may lead to the loss of 
their antibody secretion capacity, or may cause cell death when the 
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chromosome containing the HGPRT gene is lost (Oi and Herzenberg, 1979; 
Goding, 1980; Galfre and Milstein, 1982; Clark et al., 1983; Abrams et al., 
1983; Yelton et al., 1978; and many others). It has been described that 
during selection in HAT medium segregation of the X-chromosome on which 
the gene for HGPRT is .located causes the loss of a large number of hybri-
domas, whereas this occurs less frequently during selection in azaserine 
(Taggart amd Samloff, 1982). Another cause of the loss of antibody 
producing hybridomas is overgrowth by a non-antibody secreting clone 
present in the same culture well. Non-antibody secreting clones have a 
competitive growth advantage and will overgrow the slower proliferating 
antibody producing clones. To diminish the chance of overgrowth by non-
antibody producers, antibody secreting clones should be subcloned as early 
as possible (Galfre et al., 1977; Springer et al., 1978a; Goding, 1980; Galfre 
and Mi.lstein, 1982; Clark et al., 1983; Hokland et al., 1986; and many 
others). 
To enhance the probability to obtain at least one stable antibody 
producing hybridoma, in this study, numerous wells were seeded and 
positive hybridomas were cloned as soon as possible. This approach has led 
to the production of a number of stable antibody producing hybridomas. 
Characteristics of the produced MCAs will be discussed in Chapter 4. 
47 
118 
CHAPTER 4 
CHARACTERIZATION OF THE MONOCLONAL ANTIBODIES 
INTRODUCTION 
The availability of a number of screening assays is crucial for the 
production of MCAs. Some MCAs have been reported to behave unpredictably 
in different screening assays, i.e., the same MCAs have been shown to react 
in one assay, but not in another (Dang I and Herzenberg, 1982; Drover and 
Marchal!, 1986; Fitchen et al., 1981; Haaijman et al., 1984; Hessian et al., 
1986; Hough et al., 1986; Ledbetter and Herzenberg, 1979; Liebert et al., 
1987; Milstein, 1986; Sieff et al., 1982; Swirsky et al., 1983). To reduce 
erroneous interpretations, MCAs should be screened in different ways in 
different assays (Swirsky et al., 1983). Furthermore, the selection of the 
desired MCAs is dependent on the efficiency of the screening procedures, 
which need to be rapid, sensitive and specific and capable of handling many 
samples at a time (Dang! and Herzenberg, 1982; Liebert et al., 1987; 
Milstein, 1986). 
Often, hundreds of growing hybridomas appear at the same time after 
fusion. The initial screening must be done as soon as possible after these 
growing hybridomas appear and the results must be known soon to reduce 
the chance of loosing clones of interest (Chapter 3) and to avoid the 
unnecessary expension of uninteresting (nonproducing) clones. Production of 
MCAs directed against cell surface antigens on rare cells like PHSC in 
particular, requires highly sensitive screening assays. 
Several screening procedures for MCAs against cell surface antigens 
have been developed. The enzyme linked immunosorbent assay (ELISA), 
complement mediated cell lysis and immunofluorescence assays by means of a 
fluorescence activated cell sorter (FACS) are commonly used ones (Dang! and 
Herzenberg, 1982; Drover and Marchal!, 1986; Falkenburg et al., 1984; 
Fitchen et al., 1981; Herzenberg and Herzenberg, 1978; Parks et al., 1986). 
FACS analysis can be used for rapid screening of large numbers of 
hybridoma supernatants (Dang I and Herzenberg, 1982; Hale et al., 1985; 
Ledbetter and Herzenberg, 1979; Perrot et al., 1'986; Springer, 1980). By 
combination of light scatter properties and cell surface immunofluorescence it 
can simultaneously be determined if antibody is present and, with what 
subpopulation ( s) of cells in murine bone marrow· it is reactive ( Civin et al., 
1987; Parks et al., 1986). Another assay used in this study for the initial 
screening of hybridoma cultures was an immunoasorbent assay (I SA) on 
NBM-MA-WGA+ cells (Chapter 3). The ISA in contrast with FACS analysis, 
provides no indication of selective cell binding, but only gives information 
about the presence of antibody (Hough et al., 1986). 
Once clones were established they were analyzed for reactivity with 
CFU-S and/or in vitro clonogenic progenitor cells (CFU-C) of various differ-
entiation lineages~ this study, reactivity of MCAs with CFU-S was 
determined by means of a CFU-S assay after bone marrow cells were 
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incubated with the MCAs of interest with or without guinea pig complement. 
A reduction in the number of recovered CFU-S with respect to control 
samples, is an indication for the presence of the determinant recognized by 
the MCAs on CFU-S (Basch et al., 1977; Berman and Basch, 1985; Berridge, 
1979; 1983; Boswell et al., 1984; Fitchen et al., 1982; Fitchen and Ferrone, 
1981; Van den Engh et al., 1981). Reactivity with CFU-S or CFU-C was also 
determined by separating cells with increasing fluorescence intensity, i.e., 
antibody binding capacity (Springer, 1980) by means of a FACS, followed by 
a CFU-S or CFU-C assay to determine in which fraction(s) these cells were 
recovered (Bertoncello et al., 1986; Harris et al., 1985; Russell and Van den 
Engh, 1979; Van den Engh et al., 1983). 
To further characterize the produced MCAs, they were screened against 
a panel of tumour cell lines and cell suspensions prepared from different 
organs and tissues. Screening against a panel of tumour cell lines and 
organs could give more information about presumptive stage specificity and 
differentiation lineage restriction of the MCAs ( Civin et al., 1984; 1987; 
Schmidt et al., 1986; Springer, 1980; Springer et al., 1979; Strauss et al., 
1986a; 198Gb). In addition, tumour cells are often characterized by 
over-expression of markers that are expressed at an early stage during 
normal development and therefore could be very useful in the screening of 
MCAs putatively directed against CFU-S or CFU-C. 
In this chapter, the strategies and tactics followed to screen and 
characterize the MCAs that were produced in this study are discussed. 
INITIAL SCREENING OF HYBRIDOMA CULTURE SUPERNATANTS BY MEANS 
OF A FLUORESCENCE ACTIVATED CELL SORTER 
It has been described by Visser et al. (1978) and Van den Engh et al. 
(1979) and many others that the different cell populations (based on morpho-
logical criteria) present in murine bone marrow can be recognized and 
distinguished from each other on the basis of light scatter characteristics 
using a FACS. Based on forward light scatter (FLS) and perpendicular light 
scatter (PLS), erythrocytes, lymphocytes, granulocytes and blast cells can 
be distinguished as major clusters. In figure 4.1 the FLS and PLS character-
istics of the different cell populations present in murine bone marrow are 
shown. 
With the FACS it is possible to analyze and separate (sort) cell 
populations of interest (Herzenberg and Herzenberg, 1978; Dang! and 
Herzenberg, 1982; Nicola, 1982). This can be achieved by gating (window 
setting l on either FLS, PLS or fluorescence, or a combination of these 
parameters. In this way, only the cells of interest are analyzed or sorted, 
while all other cells are excluded from the analysis or sort procedure (Dang! 
and Herzenberg, 1982; Janossy et al., 1978; Swirsky et al., 1983). Cells are 
sorted in a viable state which allows for subsequent functional assays. In 
this way, it was determined that most of the CFU-S are recovered from the 
blast cell population (Van den Engh et .al., 1979), while the CFU-C from 
different lineages are characterized by the same (intermediate) FLS but 
mostly a somewhat higher PLS (Figure 4.1). CFU-C are recovered from the 
cells falling within the blast and granulocyte (blagra) population. 
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marrow cells. Each dot represents one cell. E = erythrocytes; L = lympho-
cytes; 8 = blast cells; G = granulocytes. 
The initial screening of the supernatants of the hybridoma cultures was 
performed with normal mouse bone marrow cells. The supernatants were 
added to the cells followed by GARA/ FITC and the fluorescence intensity and 
distribution was determined by means of FACS analysis (for details, see 
Chapter 2). The presence of antibody in the hybridoma culture supernatants 
was reflected by a higher fluorescence intensity with regard to the control 
sample that was incubated with GARA/ FITC only. 
During the initial screening procedure, windows were set around the 
blast cell population and the blagra population, but also around the 
erythrocyte, lymphocyte and granulocyte population. Antibodies that react 
only with cells belonging to the latter populations are obviously not CFU-S 
or CFU-C specific, but might be used to deplete bone marrow of mature cells 
and thus, for the negative selection and purification of CFU-S and CFU-C 
(Andrews et al., 1986; Edelman et al. , 1986; Fitchen et al., 1981; Hoang et 
al., 1983; Mouchiroud et al., 1985; Muller-Sieburg et al., 1986). Screening 
in this way allows for simultaneous determination of the presence of antibody 
and its reactivity with subpopulations of bone marrow cells. The range of 
staining intensities and the percentage of positive (fluorescent) cells can also 
be determined. 
The reactivity of the produced MCAs, expressed as the percentage of 
positive cells, with the different bone marrow subpopulations is presented in 
Table 4. 1. These percentages are determined using an arbitrary threshold 
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for fluorescence intensity, above which one percent of the cells in the 
negative control sample (GARA/FITC only) was detected as positive (Davis et 
al., 1983; Gupta et al., 1984; Parks et al., 1986). This table shows that for 
most MCAs the range of percentage positive cells is rather wide. For MCAs 
that react with large percentages of cells (group I, Table 4.1) this was not 
crucial, the variation would not give rise to erroneous interpretation, but 
for MCAs that react with small subpopulations of bone marrow cells this 
could be a problem (group II, Table 4.1). These latter MCAs seemed nega-
tive in one test, while on another occasion they seemed to be reactive with a 
small subpopulation of cells and therefore could be putative CFU-S or CFU-C 
specific. The wide range in the percentages of positive cells was also 
observed by Davis et al. (1983). They described that staining with their 
MCA MBM-1 always resulted in three distinguishable subpopulations, but the 
exact percentage of cells falling within each of these populations varied from 
one experiment to another and between different batches of mice. In the 
present study it was observed that particularly the blast cell population 
could differ in size (percentage of total nucleated cells) from one experiment 
Table 4.1 
REACTIVITY OF NEWLY PRODUCED MCAs WITH DIFFERENT 
BONE MARROW SUBPOPULATJONS 
MCA 
PV5.6 
10-2.2 
10-2.3 
10-9.6 
10-7.3 
7-15.1 
15-1.1 
13-18.2 
13-23.1 
13-19.4 
9-8.2 
15-2.4 
all cells 
65 (44-85) 
20 (11-25) 
16 ( 6-26) 
56 (47-69) 
50 (40-61) 
18 ( 3-42) 
46 (36-60) 
erythro-
cytes 
8 ( 7- 9) 
24 (11-33) 
6 ( 6- 6) 
11 ( 6-19) 
7 ( 4-14) 
4 ( 0- 6) 
9 ( 5-12) 
12 ( 7-23) 
26 (17-31) 
12 ( 6-24) 
% positive 
lympho-
cytes 
68 (52-78) 
11 ( 4-15) 
4 ( 3- 4) 
21 (10-29) 
11 ( 7-17) 
3 ( 0- 6) 
6 ( 5- 7) 
3 
5 
blast 
cells 
64 (32-94) 
12 ( 3-29) 
16 ( 6-39) 
73 (60-89) 
66 (50-74) 
29 (18-46) 
44 (35-52) 
3 ( 2- 5) 
5 ( 2- 7) 
10 ( 2-25) 
3 ( 0- 3) 
granulo-
cytes 
79 (38-94) 
15 ( 7-24) 
12 ( 6-20) 
87 (68-93) 
83 (58-93) 
28 ( 6-72) 
82 (79-85) 
6 ( 5- 7) 
8 ( 7- 9) 
11 ( 3-27) 
3 ( 0- 5) 
II 9-2.2 
5 ( 5- 5) 
11 ( 5-14) 
10 ( 5-22) 
4 ( 1- 8) 
8 ( 5-13) 
9 ( 1-15) 
4 ( 2- 7) 
3 ( 1- 5) 
3 ( 0- 5) 
1 ( 0- 4) 
7 ( 6- 8) 
7 ( 2-12) 
8 ( 6-12) 
2 ( 0- 6) 
6 ( 3-10) 
2 ( 1- 3) 
1 ( 0- 1) 
0 
11 
1 
4 
1 
1 
2 
1 
0 
3 
2- 4) 
3- 8) 
2-27) 
0- 3) 
3- 4) 
0- 2) 
1- 2) 
1- 3) 
0- 4) 
14 ( 9-16) 
9 ( 3-20) 
7 ( 0-12) 
3 ( 1- 6) 
3 ( 0- 8) 
1 ( 0- 1) 
7 ( 4- 9) 
14 ( 6-25) 
7 ( 0-13) 
2 ( 1- 4) 
3 ( 1- 5) 
6 ( 0-12) 
1 ( 0- 2) 
6 
13-5.1 
13-2.5 
13-7.1 
13-12.1 
13-3.4 7 
Cells were labelled with MCAs and GARA/FJTC as described in Chapter 
2. The percentage positive cells in each subpopulation was determined with 
regard to the negative control (GARA/FITC only). The figures represent the 
mean percentage of positive cells determined in 2-13 separate experiments. 
The numbers in parentheses represent the range of the % positive cells 
observed in the different experiments. 
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to another. The use of supernatants with different concentrations of 
antibody and the subclass, i.e., the stability of the antibody (Bethke et al., 
1987) could also have attributed to the observed variation in the percentages 
of positive cells. 
Since the frequency of CFU-S and of CFU-C is around 1% or less of all 
murine bone marrow cells (Fitchen et al., 1981; Lord and Spooncer, 1986; 
Van Bekkum et al., 1979) a MCA that reacted with more than 1% of all bone 
marrow cells could not be CFU-S or CFU-C specific. Since the blast cell 
population contains almost all CFU-S and comprises about 25% of all nucleated 
bone marrow cells a CFU-S specific MCA would react with 2-4% of all blast 
cells. Taking into account the non-specific binding of free antibody 
conjugate by dead cells and cell clumps and the non-specific binding of 
antibodies by cells expressing Fc-receptors (Dangl and Herzenberg, 1982; 
Fitchen et al., 1981; Parks et al., 1986; Sasaki et al., 1987) both giving 
rise to enhanced levels of background staining, MCAs that were reactive 
with more than 5% of all bone marrow cells and all blast cells were considered 
as not CFU-S specific, while MCAs that were reactive with less than 5% of all 
the bone marrow and blast cells were considered as putative CFU-S specific. 
For example, My-1 0, a MCA reactive with and specific for all human 
progenitor cell types stains 1-4% of all human bone marrow cells (Civin et 
al., 1984; 1987; Strauss et al., 1986a). 
Based on this criterion only the MCAs 13-18.2, 9-8.2, 13-5.1, 13-2.5, 
13-7.1 and 13-12.1 could be CFU-S or CFU-C specific, while the MCAs 
13-23.1, 13-19.4, 15-2.4, 9-2.2 and 13-3.4 are questionable in this respect. 
The other MCA listed in Table 4.1 are definitely not CFU-S or CFU-C 
specific. 
A classification of the MCAs listed in Table 4.1 can be made more 
profitably on the basis of the fluorescence distribution histograms. In Figure 
4. 2 the characteristic fluorescence distribution due to binding of represen-
tative MCAs that could not be CFU-S or CFU-C specific, because of the 
percentages of cells recognized by them (group I, Table 4.1) is shown. 
PV5. 6 reacted strongly with large percentages of cells within the lympho-
cyte, blast and granulocyte population but not or only weakly with a very 
small subpopulation of erythrocytes. Thus, this MCA seems to be directed 
against a determinant present on leukocytes only. 
MCA 10-2.2 reacted less strongly and with smaller subpopulations of all 
the leukocyte subpopulations. It reacted most clearly with cells of the 
erythrocyte population. MCA 10-9.6 was strongly reactive with large percen-
tages of blast cells and granulocytes and weakly with probably most lympho-
cytes. It reacted only weakly with a small subpopulation of erythrocytes. 
MCA 10-7.3 (Table 4.1) showed an almost identical pattern of reactivity as 
MCA 10-9.6 and like MCA 10-2.3 (Table 4.1) which showed an almost identi-
cal pattern of reactivity as 10-2.2 was therefore not shown. 
MCA 7-15.1 and 15-1.1 reacted in a very similar way. This was not 
clear from the percentages positive cells in Table 4.1. Both MCAs were only 
reactive with granulocytes and blast cells and not or very weakly with lym-
phocytes and erythrocytes. The fluorescence intensity after staining with 
15-1.1 was higher than with 7-15.1. 
In experiments in which the fluorescence of all bone marrow cells 
(including erythrocytes) and all nucleated bone marrow cells were compared. 
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13-23.1 15-2.11 9-2.11 13-5.1 
log FITC fluorescence (a.u.) 
Fluorescence of different bone marrow subpopulations treated with MCAs that 
could not be CFU-S or CFU-C specific. Bone marrow samples were incubated 
with MCAs and GARA/FITC as described in Chapter 2. The thin lines show 
the fluorescence of bone marrow cells incubated with GARA/FITC only. 
it was shown that all MCAs except 10-2.2 were not reactive with cells within 
the erythrocyte population (data not shown). 
In Figure 4.3 the fluorescence distribution histograms of the putative 
CFU-S or CFU-C specific MCAs is shown (group II, Table 4.1). MCA 13-18.2 
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and 13-23.1 had a very similar staining pattern as MCA 9-8.2 and 13-9.4 
which are not shown. These MCAs all recognized a small percentage of total 
bone marrow cells and are most clearly reactive with a subpopulation of cells 
falling within the erythrocyte window, but also recognized a subpopulation of 
granulocytes and possibly a subpopulation of blast cells and lymphocytes. 
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Figure 4.3: 
10-2.2 10-9.6 7-15.1 15-1.1 
log FITC fluorescence (a.u.) 
Fluorescence of different bone marrow subpopulations treated with MCAs that 
could be CFU-S or CFU-C specific. Bone marrow samples were incubated 
with MCAs and GARA/ FITC as described in Chapter 2. The thin lines show 
the fluorescence of bone marrow cells incubated with GARA/FITC only. 
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MCA 15-2.4 is mainly reactive with cells within the blast cell and 
granulocyte population. The same is true for MCA 9-2.2 although this MCA 
recognized smaller subpopulations. MCA 13-5.1 which is a representative of 
all the other MCAs of Table 4.1 that are not shown in Figure 4.2 and 4.3 
was reactive with only a very small percentage of bone marrow cells and 
therefore at this stage of characterization seemed most promising. 
It is clear that the fluorescence distribution histograms give more 
information about the reactivity of the MCAs than the percentage of positive 
cells (Table 4.1). For instance, staining with MCA 15-1.1 resulted in a 
strongly positive blast cell population and a moderately positive blast cell 
population. This could not be determined from Table 4.1. Interpretation of 
the fluorescence distribution of the MCAs shown in Figure 4. 2 is unequi-
vocal. In most of the cases there is a clear-cut difference between stained 
(positive) and unstained (negative) cells, which resulted in bi- or trimodal 
curves. Interpretation of the staining patterns of the MCAs shown in Figure 
4. 3 is more difficult. With these MCAs no clear distinction between negative 
and positive cells is observed. 1!1 many cases, for instance, in the 
granulocyte population after staining with MCA 15-2.4, the histogram is 
shifted somewhat to the right in comparison with the curve of the negative 
control sample. According to Parks et al. ( 1986) it is likely that in such 
cases all cells expressed the recognized antigen, but only a few of these 
cells expressed high enough quantities of antigen to be detected as positive. 
SCREENING FOR THE PRESENCE OF ANTIBODY BY MEANS OF A GOLD-
LINKED IMMUNOSORBENT ASSAY (GLISA) 
Enzyme-linked immunosorbent assays ( ISAs) are currently employed 
techniques for the screening of MCAs directed against cell surface antigens 
(Hough et al., 1986). Using an ISA many samples can be handled at once, in 
a relatively short time (Springer et al., 1979). It is often the case that 
hundreds of growing hybridoma cultures appear almost simultaneously after 
fusion, but the interval between fusion and the appearance of hybridoma 
cells is not always predictable. They all need to be rapidly screened, cloned 
and characterized to avoid the loss of interesting clones (Chapter 3). This 
cannot always be done by means of FACS analysis, e.g. when the machine is 
occupied for other experiments, and therefore a gold-linked ISA (GLISA) 
was used occasionally in this study. 
Screening by means of a GLISA was performed against normal bone 
marrow cells or low density WGA positive blast cells ( N BM-MA-WGA +) cells 
(Chapter 3). NBM-MA-WGA+ cells were sorted by means of a FACS into poly-
L-Iysin treated wells of Terasaki tissue culture trays at a density of 1000 
cells per well. Subsequently, the cells were fixed to the bottom of the wells 
with glutaraldehyde (Chapter 2). Plates with fixed cells could be stored in 
the cold before use for a period of at least two weeks and up to several 
months ( Lansdorp et al., 1980). In one day, large numbers of plates could 
be prepared allowing for the screening of very large numbers of hybridoma 
cultures (60 cultures/plate) at any time. 
The screening was performed as described in Chapter 2. The result of 
screening of MCA 15-1.1 by means of the GLISA is shown in Figure 4.4. In 
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this figure, dark, intermediate and unstained cells are present, indicating 
strong, intermediate and no expression of the antigen recognized by the 
antibody. Although the GLISA gives clear answers about the presence of this 
antibody, this was not always the case for other MCAs (results not shown). 
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Staining of normal bone marrow cells observed with the GLISA. Cells were 
fixed, incubated with MCA 15-1.1, GARA/gold and silver solution as 
described in Chapter 2. 
An advantage of the GLISA is that it can be performed with NBM-MA-
WGA+ cells which were 18-fold enriched for day-12 CFU-5 (Chapter 3). In 
contrast, the initial screening of hundreds of hybridoma supernatants by 
means of the FACS can only be performed with unseparated bone marrow in 
view of the time needed to isolate enough NBM-MA-WGA+ cells. 
A disadvantage of the GLISA is that the cells have to be chemically 
fixed to immobilize them. The fixation may affect the binding of antibody by 
altering the target antigen, which may lead to false positive results 
(especially when the antibody is of the lgM subclass) and false negative 
results (destruction of the determinant) (Drover and Marshall, 1986; Hough 
et al., 1986). By means of the GLISA it cannot be determined if and with 
what other cell population (s) the antibody is reactive. A negative result in 
the GLISA does not exclude the possibility that the antibody is present on 
other subpopulations of bone marrow cells and therefore could be of use for 
the negative selection of CFU-5 or CFU-C. 
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DETERMINATION OF THE REACTIVITY OF THE PRODUCED MCAs WITH 
CFU-S AND CFU-C BY FACS SORTING 
As described in a previous section a number of putative CFU-S or 
CFU-C specific MCAs was produced (group II, Table 4.1; Figure 4. 3). In 
adc:!ition, a number of MCAs was produced that reacted with large percen-
tages of bone marrow cells and therefore could not be CFU-S or CFU-C 
specific (group I, Table 4.1, Figure 4.2). However, these latter MCAs could 
be useful for the negative selection of these cells. To investigate the use-
fulness of the produced MCAs, the reactivity of the MCAs from both groups 
with CFU-S and CFU-C was determined. 
Normal bone marrow cells were incubated with the MCAs of interest. and 
stained with a fluorescent second antibody. Stained cells were subsequently 
run through a FACS. To investigate if the antigens that are recognized by 
the produced MCAs are expressed on CFU-S and in vitro clonogenic progeni-
tors of different lineages, the colony forming ability---o:i'sorted cell fractions 
with increasing antibody binding capacity, i.e. , fluorescence intensity 
(Springer, 1980) was investigated. The sorted fractions were tested for their 
content of day-8 and day-12 CFU-S, CFU-M, CFU-C2, CFU-GM and BFU-E. 
It has been reported that spleen colonies that appear early (day-7 to 
-8) and late (day-12 to -14) after bone marrow transplantation (Magli et al., 
1982) are derived from CFU-S that differ in the density of MHC class-1 
antigens expressed on their surfaces (Harris, 1984a; 1984b; Mulder, 1986; 
Visser et al., 1984). It cannot be excluded that a similar difference occurs 
for surface antigens recognized by certain of the new MCAs. Therefore, the 
sorted cell fractions were tested for their content of both day-8 CFU-S and 
day-12 CFU-S. Occasionally day-10 CFU-5 only were examined. 
CFU-C2 and CFU-M, which are both committed macrophage progenitors 
(Bol and Williams, 1980; Bradley et al., 1971; Burgess and Nicola, 1983; 
Van den Engh, 1975), give rise to colonies mainly consisting of mature 
macrophages. They were cultured in the presence of pregnant mouse uterus 
extract (PMUE) and a combination of crude mouse spleen cell conditioned 
medium (MSCM) and purified CSF-1 (colony stimulating factor-1) respec-
tively. CFU-GM (colony forming unit-granulocyte/macrophage) were cultured 
in the presence of recombinant GM-CSF (granulocyte/macrophage-CSF). 
CFU-GM give rise to colonies consisting of either pure granulocytes, pure 
macrophages, or mixed colonies consisting of both granulocytes and macro-
phages. It has been reported that CFU-GM are. ancestral to CFU-G which in 
turn are believed to be ancestral to CFU-M (Koizumi et al., 1982). BFU-E 
(burst forming unit-erythrocyte) were grown in the presence of MSCM and 
purified erythropoietin. These cells give rise to large colonies (burst's") 
containing (hemoglobinilized) erythroid cells (Gregory, 1976). The exact· 
culture conditions for the different clonogenic progenitor cell types ·are 
described in Chapter 2. 
Fractions of the blast cell population, blagra population or all nucleated 
cells from bone marrow suspensions labelled with MCAs were sorted in two or 
more fractions, depending on the fluorescence distribution. All fractions 
were subsequently assayed for their CFU-S and progenitor cell content. 
In this study the reactivity of the MCAs with the different CFU-S and 
in vitro clonogenic progenitor cell types was divided in three categories. 
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When more than 50% of the cells under investigation was recovered from the 
positive fraction(s), the recognized determinant was regarded to be present 
(at high density) on all cells. When less than 25% of the cells was recovered 
from the positive fraction(s), the recognized determinant was regarded to be 
absent. In cases where 25-50% of the cells under investigation were 
recovered from the positive fraction(s) the recognized determinant was 
regarded to be expressed on a subpopulation of the tested cell type. In most 
cases high percentages (80-1 00%) of the investigated cell types were found in 
either the negative or positive fraction(s). In only a few cases (see below) 
25-50% of a certain investigated cell type was found in the positive 
fraction ( s) . 
In Figure 4.5 it is shown that the determinants recognized by the MCAs 
PV5. 6 and 10-9.6 are expressed on almost all day-8 and day-12 CFU-S and 
all progenitor cell types tested. Between 90-100% of all the cell types assayed 
were recovered from the positive blagra fraction. The same was observed for 
MCA 10-7.3 (Table 4.2). However, because 10-7.3 had the same pattern of 
reactivity as 10-9.6, the former was not further investigated. The MCAs 
PV5.6 and 10-9.6 (10-7.3) recognized large amounts of bone marrow cells, 
which at first made them likely candidates for the depletion of bone marrow 
samples from mature cells. However, since these MCAs recognized all CFU-S 
and progenitor cell types tested, they could not be used for this purpose. 
MCA 10-2.2 was reactive with all bone marrow subpopulations including 
erythrocytes (Fig. 4.2), but it was not reactive with any of the CFU-S or 
progenitor cell types tested (less than 10% of any tested cell type was 
recovered from the positive frac,tion ) . Thus, 10-2.2 could be of use for the 
negative selection of CFU-S and the different progenitor cell types tested. 
MCA 7-15.1 and 15-1.1 did not react with day-8 and day-12 CFU-S, nor with 
BFU-E and CFU-M. However, 67% of the CFU-GM were recovered from the 
7-15.1 positive blagra cell fractions, while in the 15-1.1 positive blagra cell 
fractions 35% of the CFU-GM were found (mean results of two experiments). 
In addition, 33% of the CFU-C2 were recovered from the 15-1.1 positive cell 
fractions (7-15. 1 not tested for expression on CFU-C2). Based on the 
criteria used in this study, it can be concluded that 7-15.1 and 15-1.1 were 
reactive with at least a sub population of CFU-GM and CFU-C2 (15-1. 1 only), 
indicating the heterogeneity of these progenitor cell populations with respect 
to the expression of the antigens recognized by these two MCAs. MCA 7-15.1 
and 15-1.1 could be used for the negative selection of CFU-S, BFU-E and 
C FU-M. In addition, both M CAs could be used in studies concerning the 
heterogeneity of granulocyte/macrophage progenitors. 
In Fig. 4. 6, the distribution of the different CFU-S and progenitor cell 
t~pes after labelling with the MCAs of group II (Table 4.1) is shown. It is 
.Observed that none of these MCAs was reactive with any CFU-S type or any 
progenitor cell type, except MCA 15-2.4. MCA 15-2.4 was unreactive with 
·day-8 and day-12 CFU-S, CFU-M and CFU-GM. However, 15-2.4 was reactive 
with about 50% of the BFU-E, suggesting heterogeneity of this erythroid 
progenitor cell population. Gregory ( 1976), first described heterogeneity of 
the BFU-E and demonstrated the existence of primitive BFU-E and mature 
BFU-E according to the time of appearance of colonies in culture. 
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PV5.6 10-2.2. 
blagra blasts 
blagra blagra 
10-9.6 7-15.1 15-1.1 
blagra blasts all nucleated cells 
blagra blagra blagra 
log FITC fluorescence (a.u.) 
Distribution of CFU-S and different types of progenitor cells in bone marrow subpopulations treated with MCAs 
that could not be CFU-S or CFU-C specific. Bone marrow cells were labelled as described in Chapter 2. The 
cells were sorted on a FACS-11 in the fractions indicated. The sorted fractions were assayed for CFU-S and 
CFU-C content as described in Chapter 2. The straight lines and rectangular boxes show the number of CFU-S 
and CFU-C recovered in the sorted fractions as the percentage peak value of the CFU-S and CFU-C recovered 5 . per 10 sorted cells ( -- day-8 CFU-S· ----- day-12 CFU-S· -·-·-·- CFU-C1· ........... CFU-C2· +++++ 
CFU-GM; - , BFU-E). The thin lines ~how th~ fluorescence of bone :narrow in~ubated' with GARA/FITC 
only. 
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Figure 4.6: 
Distribution of CFU-S and different types of progenitor cells in bone marrow subpopulations treated with the 
produced putative CFU-S or CFU-C specific MCAs ( --, day-8 CFU-S; _,,_.,_ , day-1 0 CFU-S; 
day-12 CFU-S; -·-·-·-, CFU-C1; ........... , CFU-C2; -+++++-, CFU-GM; - , BFU-E). See legend Figure 4.5 for 
details. 
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TABLE 4.2 
REACTIVITY OF MCAs WITH CFU-S AND CFU-C DETERMINED 
BY CELL SORTING 
CFU-S 
MCA day-8 day-10 day-12 CFU-GM CFU-M CFU-C2 BFU-E 
PV5.6 ++ ++ ++ ++ ++ ++ 
10-2.2 
10-9.6 ++ ++ ++ ++ ++ ++ 
10-7.3 ++ ++ ++ 
7-15.1 + 
15-1 . 1 + + 
13-18.2 
13-23.1 
13-19.4 
9-8.2 
15-2.4 + 
9-2.2 
13-5.1 
13-2.5 
13-3.4 
13-7. 1 
13-12.1 
Bone marrow samples were incubated with MCAs and GARA/FJTC as 
described in Chapter 2. Fractions were sorted on a FACS-11 and tested for 
their CFU-S or CFU-C content (for details see subscript Fig. 4.5). 
++: more than SO% of all CFU-5 or CFU-C recovered from the positive cell 
fraction ( s) ; 
+ : 25-50% of all CFU-5 or CFU-C recovered from the positive fraction(s); 
- : Jess than 25% of all CFU-5 or CFU-C recovered from the positive 
fraction ( s) . 
The recovery of CFU-5 and the different progenitor cell types tested from 
bone marrow samples labelled with the listed MCAs and GARA/FJTC was 
90-120% of that of bone marrow samples incubated with GARA/FJTC only. 
Except for bone marrow cells labelled with the MCAs PV5.6, 10-9.6 and 
10-7.3. The recovery of CFU-5 after sorting of fractions incubated with 
these MCAs was 50-70%. 
Although none of the MCAs shown in Figure 4. 6 were reactive with 
CFU-5 and the different in vitro clonogenic cell types tested (except 
15-2.4), these MCAs did notseem very useful for the negative selection of 
CFU-5 and in vitro clonogenic progenitor cell types, because all of them 
recognized only small numbers of bone marrow cells (Fig. 4.2). 
In Table 4. 2 the reactivity with the different CFU-5 and progenitor cell 
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types of all the produced MCAs that were tested is summarized. Only three 
of the seventeen MCAs tested were reactive with CFU-S. These MCAs 
(PV5.6, 10-9.6 and 10-7.3} were also reactive with all progenitor cell types 
tested. Three other MCAs were not reactive with CFU-S, but were reactive 
with (a subpopulation of} BFU-E (15-2.4}, CFU-GM (7-15.1 and 15-1.1} and 
CFU:-C2 (15-1.1}. 
DETERMINATION OF THE REACTIVITY OF MCAs WITH CFU-S BY MEANS OF 
ANTIBODY AND COMPLEMENT DEPENDENT CFU-S REDUCTION 
By far the most used methods to investigate the expression of certain 
cell surface antigens on CFU-S and in vitro clonogenic progenitors are the 
antibody dependent cytotoxicity assay and the complement dependent cyto-
toxicity assay ( Falkenburg et al., 1984; Fitchen et al., 1981}. In this study, 
both assays were used to investigate if the results obtained by the cell 
sorting experiments could be confirmed. 
Lethally irradiated recipient mice were injected with bone marrow 
suspensions that were incubated with MCA alone, or with bone marrow sus-
pensions that were incubated with MCA as well as an appropriate dilution of 
guinea pig complement. The reduction in the number of CFU-S recovered 
from these treated bone marrow suspensions was a measure for the reactivity 
of the MCAs with CFU-S. It was assumed that the spleen seeding efficiency 
of the labelled and injected cells was not different from that of untreated 
cells, and that an altered number of CFU-S was only due to incubation with 
the MCAs. 
It has been described that there was no significant difference between 
the number of CFU-S that was recovered from samples treated with (mono-
clonal} antibody alone, and samples treated with (monoclonal} antibody and 
complement (Berridge, 1982; Berridge and Okech, 1979; Daley et al., 1984; 
Ralph and Berridge, 1984; Van den Engh et al., 1981}. In vivo opsonization 
of the antibody coated CFU-S followed by phagocytosis by macrophages in 
the reticuloendothelial system may lead to a reduction in the number of 
CFC-S that settles in the spleen and thus to a reduction of CFU-S (Berridge 
et al., 1984; Berridge and Okech, 1979; Russell and Van den Engh, 1979; 
Van den Engh et al., 1983}. This hypothesis is supported by the obser-
vation that inactivation of the host macrophages by injection of carrageenan 
partly prevented the reduction in the number of CFU-S following incubation 
with antibodies (Van den Engh et al., 1983}. In some cases, complement 
activity in vivo may contribute to a further reduction of CFU-S by the 
binding of complement to its receptors on phagocytic cells or by cell lysis 
(Berridge and Okech, 1979; Ralph and Berridge, 1984}. 
In most experiments described here, the reactivity of the MCAs with 
CFU-S was determined by preincubation of bone marrow cells with the MCA 
of interest without the addition of. complement (C'}. This was not only more 
rapid than subsequent incubation with complement, but it also avoided 
problems arising about the quality and the availability of complement and 
about the isotypes of the MCAs, which were not always known at the time 
the experiments were done. Complement mediated cytotoxicity in contrast 
with antibody dependent reduction of CFU-S has been shown to be 
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dependent on the isotype of the MCAs (Ralph and Berridge, 1984; Sieff et 
al., 1982). Rat antibodies of the lgG1 and lgG2a isotype are incapable to fix 
complement, while lgG2b, lgG2c and lgM antibodies can fix complement and 
thus can cause lysis of antibody coated cells, when the density of the 
recognized antigen is sufficiently high (Ledbetter and Herzenberg, 1979; 
Springer, 1980) • 
In Table 4.3 the reactivity of the MCAs with CFU-S as determined by 
means of the antibody and complement dependent cytotoxicity assay is 
summarized. The mean results of 2-3 experiments are shown. It was 
observed that the percentage reduction of CFU-S for the same MCA varied 
considerably from one experiment to another. This large variation was not 
only observed after treatment with MCA alone, but also after treatment with 
MCA and complement. According to Berridge and Okech (1979) the. large 
variation in the percentages of CFU-S reduction is inherent to bone marrow 
and could have been caused by differential efficiency of opsonization 
(content of macrophages) and complement lysis (same batch, stored for 
different intervals) in different experiments (Ralph and Berridge, 1984). It 
can be seen that none of the MCAs that were binding to a large percentage 
of bone marrow cells (group I, Table 4.1), except PV5.6, were reactive with 
CFU-5. In two experiments, PV5.6 caused a 70% reduction in the number of 
recovered day-12 CFU-5. In one of these experiments the number of day-8 
CFU-S was also reduced by 70%, while in the other experiment the number of 
recovered day-8 CFU-S was higher than that recovered from the negative 
control. A hundred percent reduction of CFU-S was not observed, although 
all CFU-S were gained from the positive fraction in the cell sorting experi-
ments. 
MCA 10-9.6 and 10-7.3 which were strongly reactive with day-8 and 
day-12 CFU-S in the cell sorting experiments were not reactive with both 
types of CFU-S in the antibody dependent cytotoxicity assay. It has been 
described that the degree of reduction of CFU-S in the latter assay, was 
dependent on the amount of antibody bound. The more antibody bound, the 
higher the reduction in the number of C FU-S (Berridge and Okech, 1979; 
Cannistra et al., 1985; Koizumi et al., 1982; Ledbetter et al., 1980; Pillai et 
al., 1986) The lack of reactivity of 10-9.6 and 10-7.3 in the antibody 
dependent cytotoxicity assay, might indicate that the amount of 10-9.6 and 
10-7.3 bound to CFU-S was too low. This suggests that determination of the 
reactivity of MCAs with CFU-S by means of cell sorting is more sensitive and 
thus more reliable than the antibody dependent cytotoxicity assay. 
None of the MCAs from group II (Table 4.1) were reactive with day-8 
and day-12 CFU-S. In one experiment in which the reactivity with day-1 0 
CFU-S was determined, incubation with MCA 13-18.2 and 13-23.1 caused a 
more than SO% reduction of day-1 0 CFU-S. However, these 2 MCAs lacked 
reactivity with day-1 0 CFU-S in the cell sorting experiments. Because of the 
higher sensitivity of the FACS assay, particularly for low density antigens 
(Berridge and Okech, 1979; Cannistra et al., 1985; Falkenburg et al., 1984; 
Fitchen et al., 1981; Pillai et al., 1986) it is concluded that 13-18.2 and 
13-23.1 are not reactive with day-10 CFU-5. For the same reason it seems 
also unlikely that 9-2.2 is reactive with day-8 CFU-S and that 13-3.4 is 
reactive with day-12 CFU-S (compare Tables 4.2 and 4.3). 
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Table 4.3 
REACTIVITY WITH CFU-S DETERMINED BY ANTIBODY DEPENDENT 
CYTOTOXICITY AND COMPLEMENT MEDIATED CYTOTOXICITY 
MCA lg-(sub)class day-8 day-10 day-12 
CFU-S CFU-S CFU-S 
PVS.6 lgG2b +!-* + 
10-2.2 lgG2b 
10-2.2 + C' 
10-9.6 lgG2b 
10-7.3 lgG2a 
7-1S.1 lgM 
1S-1.1 lgG2a 
1S-1 • 1 + C' 
13-18.2 lgM +? 
13-18.2 + C' 
13-23.1 lgM +7 
13-23.1 + C' 
13-19.4 lgM 
13-19.4 + C' 
9-8.2 
1S-2.4 lgM 
1S-2.4 + C' 
9-2.2 lgG2b +I-* 
13-S. 1 lgM 
13-2.S ? 
13-3.4 lgM +? 
13-7. 1 lgG2c 
13-12.1 
13-12.1 + C' 
Bone marrow samples were incubated with either MCA alone, or with MCA 
and guinea pig complement (C') as described in Chapter 2. The CFU-S 
content of the treated samples was compared with that in control samples; 
untreated bone marrow, respectively bone marrow incubated with C' only. 
Lethally irradiated mice (7-8 per group) were injected with S x 104 control 
cells or with equivalents thereof from the treated samples. 
- = less than SO% reduction in the number of CFU-S in comparison with 
control values; + = more than SO% reduction in the number of CFU-5 in 
comparison with control values. * +/- = results of two different experiments; 
+? = inconclusive/ disputed. Results of 2 to 3 experiments. 
The lg (sub)class of the MCAs was determined by an Ouchterlony immuno-
. diffusion reaction (Chapter 2). N. B.? Subclass not known. 
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In a number of cases the antibody dependent and the complement 
mediated cytotoxicity assay was performed with the same MCAs (Table 4.3). 
In agreement with data in the literature no differences were observed, 
showing that the cytotoxic effect of the MCAs on CFU-S is independent of 
complement treatment in vitro (Berridge, 1979; 1982; Daley et al., 1984; 
Ralph et al., 1982; Ralph and Berridge, 1984; Van den Engh et al., 1981). 
SCREENING OF MCAs AGAINST A PANEL OF TUMOUR CELL LINES 
Tumour cell lines are made up of one particular cell type which is 
adapted to in vitro replication and is arrested in a particular stage of 
differentiation during normal development (Ledbetter and Herzenberg, 1979; 
Schmidt et al., 1986; Springer, 1980). Leukaemic cells do not express 
aberrant "new leukaemia" antigens, but are strikingly similar to normal 
precursor cells. Often, however, they differ from the latter by over-
expression of certain antigens (Schmidt et al., 1986). They then may re-
express antigens which were only (weakly) expressed at an early stage of 
normal differentiation, but were suppressed during the progress of 
differentiation ( Fukada, 1985; Ledbetter and Herzenberg, 1979; Schmidt et 
al., 1986). 
Screening against tumour cells has proven to be a useful and sensitive 
method for the detection of (monoclonal) antibodies reactive with cell surface 
antigens that are only rarely expressed on normal precursor cells (Civin et 
al., 1987; Delwel et al., 1987; Fukada, 1985; Milstein et al., 1979; Schmidt 
et al., 1986; Sela, 1986; Springer, 1980; Springer et al., 1979). An example 
of the usefulness of screening against tumour cells is the detection of a MCA 
named My-10. My-10 was raised and screened against a human immature 
myeloid leukaemic cell line (KG1a). This My-10 antibody appeared to be 
strongly reactive with these KG1a cells, but in normal human bone marrow it 
only stained about 1% of the cells (Civin et al., 1984; 1987; Strauss et al., 
1986a; b). Among the cells recognized by the My-1 0 MCA are the human 
equivalents of the murine CFU-S (CFU-GEMM) and progenitors of all differ-
entiation lineages, including lymphoid progenitors (Strauss· et al., 1986b). 
Thus, My-10 is a stage specific rather than a lineage specific MCA (Civin et 
al., 1984). According to Fukada ( 1985) it should be possible to identify pre-
sumptive stage specific and cell lineage specific antigens, when MCAs are 
screened against a panel of tumour cell lines. 
To investigate if any of the produced MCAs was differentiation-stage or 
-lineage specific, they were screened against a panel of murine tumour cell 
lines of which the characteristics are shown in Table 4. 4. P388 is a lymphoid 
leukaemia. It is not known if this is a T- or B-lymphoid leukaemia, EL-4 is a 
T-cell lymphoma. DA-1 is an lnterleukin-3 (IL-3) dependent myeloid leukae-
mia and WEH I-3B is either a myelomonocytic leukaemia, a T -lymphocytic 
leukaemia (Thy-1 expression) or a "mixed lymphoid-myeloid" leukaemia, 
indicating the transformation of a bipotent progenitor cell (Lee et al., 1982; 
Umiel et al., 1987). WEHI-38 cells, among other growth factors, produce 
IL-3. 
In Fig. 4.7 the reactivity is shown of the MCAs from group I (Table 
4.1). Again, the binding was determined by means of FACS analysis. In this 
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cell line 
P388 
DA-1 
EL-4 
WEHI-38 
Table 4.4 
MURINE TUMOUR CELL LINES USED FOR SCREENING 
origin 
DBA/2 
C57BI/6 
BALB/c 
nature 
lymphocytic leukaemia, 
with lymphoblast like 
morphology 
myeloid leukaemia, 
I L-3 dependent 
T -lymphoma, secretes 
I FN-y, I L-2 and MAF 
after PMA stimulation 
myelomonocytic, macro-
phage like leukaemia, 
or lymphocytic, or 
mixed lymphocytic-
myelocytic leukaemia, 
IL-3 producing 
cell surface antigens 
Fc-receptor+, complement 
receptor+ 
Thy-1+, Ly-5-, Ia-, IL-4 
receptor+ 
Thy-1+, Ly-1-, Lyt-2-, 
L3T4+, TL-, slg-, 
14.8-, Ia-, H-2K/D+ 
Thy-1 +, Lyt-1-, Lyt-2-, 
slg-, 14.8+, Ia-, 
MAC-1+ (78%), MBM-1+ 
All cell lines were grown in the same medium as hybridomas were 
cultured (Chapter 2). MAF = macrophage activating factor; PMA = phorbol 
myristate acetate. 
figure, the cell lines are ranked according to increasing autofluorescence 
intensities (increasing from top to bottom). 
MCA PV5.6 is strongly reactive with all cell lines tested. EL-4 lymphoma 
cells were most brightly stained by PVS. 6. This strong reactivity of PVS. 6 
with the panel of leukaemic cell lines of different origins was expected on 
basis of the staining profiles of the different bone marrow subpopulations. 
MCA 10-2.2 that was reactive with small percentages of all bone marrow 
subpopulations distinguishable by means of light scatter characteristics 
(Figs. 4.1 and 4.2), was also reactive with all· tumour cell lines tested. 
Since these tumour cells are actively proliferating this could indicate that 
MCA 10-2.2 is directed against an antigenic determinant that is expressed on 
actively proliferating cells. 
MCA 10-9.6 reacted with all tumour cell lines tested. It strongly stained 
the lymphocytic leukaemias P388 and EL-4 whereas this MCA only weakly 
stained lymphocytes in normal murine bone marrow (Fig. 4.2). This suggests 
that the determinant recognized by MCA 10-9.6 is expressed in a lower 
density on normal bone marrow lymphocytes than on the lymphocytic leukae-
mic cell lines. 
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Figure 4. 7: 
10-2.2 10-9.6 7-15.1 15-1.1 
log FITC fluorescence (a.u.) 
Fluorescence of different tumour lines labelled with the MCAs that could not 
be CFU-5 or CFU-C specific. Tumour cells were incubated with MCAs and 
GARA/FITC as described in Chapter 2. The thin lines show the fluorescence 
of tumour cells incubated with GARA/FITC only. 
When WEHI-38 cells are stained with PV5.6, 10-2.2 and 10-9.6 and 
analyzed on the FACS, a small negative and a large positive population was 
observed. An explanation for this could be the mixed lymphoid myelocytic 
nature of WEHI-38 cells. It could also indicate that the cell line was not 
homogeneous (and should be subcloned). These possibilities were not further 
investigated in this study. 
MCA 7-15.1 and 15-1.1 reacted very similarly on bone marrow cells 
(Fig. 4.2). Both MCAs hardly stained lymphocytes. The lack of reactivity of 
both MCAs with lymphocytes was confirmed by the analysis of the tumour 
cell lines. MCA 7-15.1 and 15-1.1 did not react with the two lymphocytic 
leukaemia cell lines, EL-4 and P388. A difference not earlier observed 
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between MCA 7-15.1 and 15-1.1 was noticed after screening both MCAs 
against the DA-1 cell line. MCA 7-15.1 did not react with this myeloid 
leukaemia, while 15-1.1 reacted strongly with DA-1 cells. Because DA-1 cells 
are dependent on IL-3 for their growth it could be that 15-1.1 was directed 
against the I L-3 receptor. This was examined by culturing the same amount 
of viable DA-1 cells in the presence of I L-3 (WEH 1-38 conditioned medium) 
and in the absence or presence of different concentrations of MCA 15-1.1. 
After four days the cultures were terminated and the total number and the 
number of viable cells in each culture were counted. There was no difference 
observed between the cell numbers in cultures expanded in the presence or 
absence of 15-1 • 1 • Thus, 15-1 . 1 was not reactive with the I L -3 receptor or 
at least did not inhibit the binding of IL-3 to its receptor. 
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Figure 4.8: 
13-23.1 15-2.~ 9-2.2 13-5.1 
log FITC fluorescence (a.u.) 
Fluorescence of different tumour lines labelled with the MCAs that were 
reactive with only small amounts of bone marrow cells. Tumour cells were 
incubated with MCAs and GARA/FITC as described in Chapter 2. The thin 
lines show the fluorescence of tumour cells incubated with GARA/FITC only. 
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The observed difference between the reactivity of 7-15.1 and 15-1.1 
with DA-1- cells suggests, but does not necessarily mean, that these two 
MCAs are directed against different antigens_. Because 7-15.1 is an lgM 
antibody and 15-1.1 an lgG2a (Table 4.3), and the latter is much smaller 
than the former, which is a pentameric molecule complex, it could be that 
the determinant on DA-1 cells is more easily accessible for 15-1.1 than for 
7-15.1. This might be an alternative explantation for the observed difference 
in reactivity of both MCAs with DA-1 cells. In addition, the affinity of the 
two MCAs for their determinants might be different. It has been described 
that lgM antibodies in general are characterized by a high avidity but .a low 
affinity (Gosh and Campbell, 1986). These possibilities were not further 
investigated in this study. 
In Fig. 4.8 the reactivity of the MCAs from group II (Table 4.1) with 
the panel of tumour cell lines is shown. MCA 13-18.2 and 13-23.1 which 
reacted similarly with normal bone marrow subpopulations (Fig. 4. 3), both 
reacted with only a small subpopulation of DA-1 and WEHI-38 cells. They did 
not stain EL-4 cells. MCA 13-23.1 clearly stained a subpopulation of P388 
cells, while MCA 13-18.2 was not reactive with these cells. Thus, MCA 
13-18.2 did not react with lymphocytic cells as was already shown in Fig. 
4. 3, while MCA 13-23.1 seemed to be reactive with a subpopulation of 
lymphocytic P388 cells. MCA 9-8.2 and 13-19.4 that reacted similarly to MCA 
13-18.2 and 13-23.1 with bone marrow subpopulations reacted similar to MCA 
13-18.2. i.e. not with P388 cells. 
MCA 15-2.4 reacted very much like 13-18.2 with the tumour cell line 
panel, while the reactivity pattern of both MCAs with normal bone marrow 
subpopulations was different (Fig. 4.3). 
MCA 9-2.2 was not reactive with any of the tested leukaemic cell lines, 
whereas MCA 13-5.1 was only weakly reactive with a small number of 
WEHI-3B cells. 
SCREENING OF MCAs AGAINST DIFFERENT ORGANS AND TISSUES 
Each organ or tissue is characterized by a typical composition with 
regard to the cell types present, the amount of each cell type a-nd the 
differentiation stage(s) of the cells (Table 4.5). 
During embryogenesis the fetal liver is the major site of erythropoiesis, 
a function which is later taken over by the bone marrow and spleen (Metcalf 
and Moore, 1971; Lowenberg, 1975; Moore and Owen, 1965). In the fetal 
liver 70-90% of all cells belong to the erythroid series, including reticulo-
cytes and erythrocytes. The other cells present mainly belong to the myeloid 
(granulocytic) series. 
The thymus is a primary lymphoid organ which can microscopically be 
devided in a cortex and a medulla. The cortex is very densily packed with 
thymocytes, while the medulla has a lower density of lymphoid cells with 
many epithelial cells in between (Mathieson and Fowlkes, 1984). However, 
thymus cell suspensions contain a low number of non lymphoid cells ( Papiernik 
et al., 1987). According to data in the literature the murine thymus consists 
for more than 95% of T-lymphocytes of different maturation stages 
(Hammerling et al., 1979; Hogarth et al., 1985; Oliveira and Thomas, 1985). 
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Table 4.5 
DIFFERENTIAL COUNTS OF MURINE ORGANS AND TISSUES 
% of total 
organ/ immature mature nucleated 
tissue myeloid myeloid lymphoid monocytic erythroid 
fetal liver* 10 90 
thymus 0 0 99 1 0 
PBL 0 16 77 2 5 
spleen 0 0 85 2 13 
PEC 0 11 24 57** 8 
*data from Lowenberg, 1975. 
**mainly macrophages. 
PBL (peripheral blood leukocytes) and PEC (peritoneal exudate cells) were 
isolated as described in Chapter 2. Unlabelled cell suspensions were run 
through a FACS-11 and only nucleated cells were sorted. Cytocentrifuge 
preparations were made and stained as described in Chapter 2. BC3 female 
mice of 7-8 weeks of age were used. Figures represent mean of 2 
experiments. 
immature myeloid: myeloblasts, promyeloblasts and myelocytes. 
mature myeloid: metamyelocytes, banded-, segmented-, and eosinophilic 
granulocytes. 
monocytic: mainly monocytes, hardly any monoblasts and macrophages. 
nucleated erythroid: mainly normoblasts, some erythroblasts. 
In most cases, this was based on the percentage of a-Thy-1 (Reif and Allen, 
1963) positive thymocytes. Erythroid and granulocytic cells are normally 
absent from the thymus (Metcalf and Moore, 1971): The thymus suspension 
analyzed in the present study consisted exclusively of lymphocytes. The 
major cell populations present in blood (peripheral blood leukocytes; PBL) 
are lymphocytes and to a lesser extent granulocytes, while virtually no 
normoblasts are present (Austyn and Gordon, 1981'; Hirsch and Gordon, 
1983). In the blood suspensions analyzed in this study· the number of 
lymphocytes was about 5 times higher than that of granulocytes (mature 
myeloid cells). 
The spleen is a secondary lymphoid organ and an important site of 
erythropoiesis in abnormal situations (Lord, 1967; Fruhman, 1966a; 1966b). 
The major cell type constituting the spleen is lymphocytes, while erythroid 
cells, which are present in scattered aggregates throughout the red pulp, 
form a minor subpopulation of spleen cells, like monocytes and granulocytes 
do (Hirsch and Gordon, 1983; Metcalf and Moore, 1971; Ralph et al., 1987). 
The data presented here are in agreement with these findings. By the use of 
(monoclonal) antisera it was determined that of all lymphocytes present in 
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the spleen, about 60% were B-lymphocytes and 40% were T -lymphocytes 
(Fultz et al., 1982; Hammerling et al., 1979; Hogarth et al., 1985; McKearn 
et al., 1984; 5hen et al., 1982). 
Peritoneal exudate cells ( PEC) were studied because the peritoneal 
cavity is the major source of mature macrophages. In PEC suspensions also a 
considerable amount of lymphocytes are present, while granulocytes and 
nucleated erythroid cells are minor constituents (Austyn and Gordon, 1981; 
Hirsch and Gordon, 1983). It was thought that screening of MCAs against 
the above discussed panel of organs and tissues might reveal possible lineage 
restriction of the MCAs. 
In Fig. 4.9 the reactivity with the different organs and tissues of the 
MCAs that could not be CFU-5 or progenitor cell specific is shown. PV5. 6 
strongly reacted with large populations of all organs and tissues except fetal 
liver. In fetal liver only 11% of the cells were stained which coincides well 
with the amount of myeloid cells in this organ. Its lack of reactivity with the 
majority of fetal liver cells and erythrocytes· in normal bone marrow (Fig. 
4.2) suggests that PV5.6 is not reactive with maturing and mature erythroid 
cells. The strong reactivity with large numbers of cells present in the other 
organs and tissues supports the notion that PV5. 6 may be reactive with an 
antigen common to all leukocyte types. 
MCA 10-2.2 reacted with most fetal liver cells. After staining with this 
MCA two subpopulations of fetal liver cells could be recognized. One large 
strongly positive population and a smaller weakly positive population. The 
latter consisted of more than 1 O% of all fetal I iver cells, and therefore, must 
contain erythroid cells (Table 4.5). This suggests a heterogeneity of the 
erythroid cells in fetal liver with respect to the expression of the deter-
minant recognized by MCA 10-2.2. This MCA also recognized a considerable 
proportion of spleen cells and PEC and only weakly stained PBL, but was 
not reactive with thymocytes. 
MCA 10-9.6 weakly stained probably all fetal liver cells, while a small 
subpopulation is more intensely stained. MCA 10-9.6 also reacted (weakly) 
with large percentages of cells present in the thymus and PEC suspension, 
whereas in the spleen and in PBL distinct positive and negative subpopula-
tions were observed. MCA 10-9.6 must therefore recognize a determinant 
shared between erythroid cells (fetal liver), T-lymphocytes (thymus, EL-4), 
granulocytes (bone marrow) and macrophages (PEC). 
MCA 7-15.1 and 15-1.1 both reacted weakly with a small subpopulation 
of fetal liver cells. MCA 7-15.1 weakly stained cells present in peripheral 
blood, whereas after labelling with 15-1.1 a clear distinct positive sub-
population could be distinguished. Both MCAs did not stain thymus cells but 
they weakly stained a subpopulation of cells present in the spleen and PEC. 
In Fig. 4.10 the reactivity with the different organs and tissues of the 
initially putative CFU-5 or progenitor cell specific MCAs (group II, Table 
4.1) is shown. MCA 13-18.2 stained a subpopulation of fetal liver cells, that, 
on basis of the reported percentage of myeloid cells present in fetal liver. 
must consist for at least a part of erythroid cells. MCA 13-23.1 was not 
screened against fetal liver cells, but reacted in the same way as MCA 
13-18.2 with the other organs and tissues, except with PBL. MCA 13-18.2 
did not stain PBL, whereas 13-23.1 reacted weakly with these cells. Both 
MCAs clearly reacted with a subpopulation of spleen cells and a proportion of 
PEC. 
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Figure 4.9: 
10-2.2 10-9.6 7-15.1 15-1.1 
log FITC fluorescence (a.u.) 
Fluorescence of different organs and tissues labelled with the MCAs that 
could not be CFU-S or CFU-C specific. Organ and tissue suspensions were 
incubated with MCAs and GARA/FITC as described in Chapter 2. Organs and 
tissues were obtained from adult mice (8 weeks old). Fetal liver cells were 
obtained from fetuses at the 17th day of gestation. Only nucleated cells were 
analyzed except for fetal liver. All fetal liver cells were analyzed. The thin 
line shows the fluorescence of organ and tissue samples incubated with 
GARA/FITC only. 
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MCA 15-2.4 reacted with a small subpopulation of fetal liver cells, 
spleen cells, and PEC, but not with thymocytes and only very weakly with 
PBL. MCA 9-2.2 only weakly stained PBL and a small population of spleen 
cells, while cells from the other· organs and tissues were not stained. MCA 
13-5.1 recognized a very small percentage of PBL and spleen cells and a 
higher number of PEC. 
Screening against a panel of different organs and tissues did not result 
in a clear picture about the reactivity of the MCAs from group II (Table 
4.1) with regard to the lineage and differentiation stage restriction. 
DIFFERENTIAL COUNTS OF BONE MARROW SUBPOPULATIONS AND SORTED 
FRACTIONS OF TOTAL BONE MARROW AND BLAST CELLS AFTER 
LABELLING WITH MCAs 
Murine bone marrow is a very heterogenous organ with respect to the 
number of different cell types and maturation stages of the cell types that 
are present. In Table 4.6 the results of the differential counts of all 
nucleated bone marrow cells and those of the four different subpopulations, 
that can be distinguished on basis of light scatter characteristics (Fig. 4.1), 
are shown. The cells in each subpopulation were sorted on a cell sorter. Of 
the sorted cell populations cytocentrifuge slides were made which were sub-
sequently stained for morphological analysis (Chapter 2). 
Table 4.6 
DIFFERENTIAL COUNTS OF BONE MARROW SUBPOPULATIONS 
cytological differentiation (%) 
subpopula- immature mature lymphoid monocytic nucleated 
tion myeloid myeloid erythroid 
all nucleated 5 40 35 8 12 
erythrocytes* 2 35 41 3 19 
lymphocytes 0 93 5 
blast cells 5 27 35 12 21 
granulocytes 4 61 11 12 12 
Bone marrow subpopulations were sorted on a FACS-11, cytocentrifuged and 
stained as described in Chapter 2. For details see subscript Table 4.5. 
Values represent mean result of 5 experiments. 
*nucleated cells represent only a small contamination (less than 2%) of the 
cells in the erythrocyte cluster. 
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Figure 4.10: 
log FITC fluorescence (a.u.) 
Fluorescence of different organs and tissues labelled with the MCAs reactive 
with only small amounts of bone marrow cells. See legend Figure 4.9 for 
details. 
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It is clear that murine bone marrow is a major site for myelopoiesis. Of 
all nucleated bone marrow cells (erythrocytes were excluded from the 
analysis) 40% are maturing and mature myeloid cells, i.e. metamyelocytes, 
banded-, segmented-, and eosinophilic-granulocytes. In addition, 5% of the 
bone marrow cells are immature myeloid cells, i.e., myeloblasts, promyelo-
cytes and myelocytes. This percentage of myeloid cells is in agreement with 
data in the literature (Austyn and Gordon, 1981; Berton cello et al., 1986; 
Hirsch and Gordon, 1983; Hoang et al., 1983). In these studies, estimations 
on the number of cells of a certain lineage were either done by morphological 
analysis ( Bertoncello et al., 1986; Hoang et al., 1983). or by labelling with 
MCAs specific for the myeloid series (Austyn and Gordon, 1981; Hirsch and 
Gordon, 1983). Another major constituent of murine bone marrow is formed 
by lymphocytes. Thirty-five percent of all bone marrow cells belong to the 
lymphoid lineage. This percentage of lymphocytes falls in the range (20-40%) 
reported by others (Opstelten et al., 1986; Shen et al., 1982). By means of 
MCAs that were reported to be specific for cells of either the 8-lymphocytic 
or the T -lymphocytic series, it was determined that most lymphoid cells in 
the bone marrow belong to the former class. The percentage T -lymphoid cells 
(determined by the percentage a-Thy-1 positive cells) varied from 0% 
(Oliveira and Thomas, 1985) to 10% (Hogart et al., 1985), while the percen-
tage of 8-lymphoid cells varied from 19% to 40% (Hog art et al., 1985) 
depending on the MCA used. Eight percent of the bone marrow cells 
belonged to the monocytic series, which is in agreement with data found by 
others (Austyn and Gordon, 1981; Hirsch and Gordon, 1983). Most cells of 
the monocytic series were monocytes. It was observed in the present study, 
but also by others, that in bone marrow very few monoblasts, promonocytes 
and macrophages were present (Nibbering et al., 1987). Twelve percent of 
the bone marrow cells belonged to the erythroid lineage. Most of them were 
normoblasts, the latest stage during erythrocyte differentiation in which the 
cells are nucleated, while some erythroblasts were also present. The 
observed percentage of erythroid cells was in agreement with that found by 
others (Bertoncello et al., 1986; Hoang et al., 1983). 
Thusfar, it was assumed that the subpopulations in murine bone marrow 
that could be distinguished on a cell sorter on basis of FLS and PLS 
characteristics (Fig. 4.1) were homogeneous. However, it is shown in Table 
4. 6 that most of the subpopulations were heterogeneous in this respect. The 
cells falling in the erythrocyte population contained cells of all differentiation 
lineages, especially lymphoid and mature myeloid cells and to a lesser extent 
nucleated red cells. However, these cells were greatly outnumbered by ery-
throcytes, but also reticulocytes, which were not counted. The lymphocyte 
population consisted almost entirely of lymphocytes. It could be that the 
number of erythroid cells (normoblasts) in this lymphocyte cluster was 
underestimated. It has been described that normoblasts are present in the 
lymphocyte population that can be distinguished on a cell sorter ( Civin et 
al., 1987; Hoang et al., 1983). The major cell types present in the blast cell 
population are lymphoid cells (large lymphocytes, plasma cells) and mature 
myeloid cells, while erythroid cells and monocytic cells were present in 
somewhat smaller numbers. Immature myeloid cells comprise only 5% of all 
blast cells. 
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In the granulocyte cluster more than 60% of the cells are maturing and 
mature myeloid cells, while cells of the lymphoid, monocytic and erythroid 
series each account for about 12% of the cells present in this cluster, 
whereas immature myeloid cells form only about 5% of. the cells. 
Knowing the heterogeneity of the different bone marrow subpopulations, 
it was of interest to study with what cell types the MCAs that could not be 
CFU-5 or progenitor cell specific were reactive. Only those MCAs were 
studied because some of them could be applied for the negative selection of 
these cell types, in contrast with the MCAs that were reactive with only 
small amounts of bone marrow cells. 
The percentage of each cell type present in the negative or positive cell 
fraction(s} of all nucleated cells and the blast cell population are shown in 
Table 4. 7. More than 90% of all immature and more mature myeloid cells and 
monocytic cells, and 80% of all the lymphoid cells present in total bone 
marrow were recovered from the PV5.6 positive fraction. In addition, 19% of 
all erythroid cells were recovered from the PVS. 6 positive fraction. When 
PVS. 6 labelled blast cell fractions were sorted, the majority !)f the myeloid 
cells, both immature and mature, and the monocytic cells was recovered from 
the positive fraction. In addition, about SO% of the lymphoid cells and the 
erythroid cells (1% of all cells present in bone marrow} were found in the 
positive fraction. 
Virtually, 100% of the cells of all lineages except erythroid cells were 
recovered from the 10-2.2 negative fraction of all nucleated cells and of the 
blast cells. In both cell populations, 40-50% of the erythroid cells were 
recovered from the positive fractions. The absence of other cell types except 
normoblasts and erythroblasts in the 10-2.2 positive cell fractions suggests 
that this MCA is specific for these developmentally late erythrocyte 
precursor cells. The fact that about 50% of the erythroblasts and normoblasts 
are recovered from the 10-2.2 positive fraction indicates that these cell types 
are heterogeneous with respect to the expression of the antigen recognized 
by 10-2.2. 
In total nucleated bone marrow samples MCA 10-9.6 stained almost 
hundred percent of the immature myeloid cells, more mature myeloid cells and 
monocytic cells. The number of immature myeloid cells in the 10-9.6 stained 
sample was very low in comparison with the mean value of these cells found 
in unstained bone marrow (Table 4.6} which makes the percentage of 
stained immature myeloid cells not very reliable. Only 1 O% of the lymphocytes 
were found in the 10-9.6 positive fraction and about 50% of the erythroid 
cells were present in this fraction. Analysis of the sorted blast cell fractions 
learned that about 90% of the mature myeloid and monocytic cells were 
recovered from the 10-9.6 positive fraction, whereas 56% of the immature 
myeloid cells and 40% of the lymphoid cells were recovered from this blast 
cell fraction. 
Of all mature myeloid cells 97% were found in the MCA 7-15.1 negative 
blast cell fraction, and also about 80% of the lymphoid and erythroid cells 
were recovered from this fraction. In contrast, 90% of the monocytic cells 
and 42% of the immature myeloid cells were recovered from the 7-15.1 
positive blast cell fraction. 
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Table 4.7 
DIFFERENTIAL COUNTS OF FRACTIONS SORTED FROM ALL NUCLEATED 
BONE MARROW CELLS AND BLAST CELLS AFTER LABELLING WITH MCAs 
MCA population sorted 
PV5. 6 all nucl. 
blasts 
10-2.2 all nucl. 
blasts 
10-9.6 all nucl. 
blasts 
7-15.1 blasts 
15-1.1 all nucl. 
blasts 
fraction 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
cytological differentiation (%) 
immature 
myeloid 
0.3 
4.4 
1.3 
4.0 
5.3 
0 
2.6 
0 
0 
0.5 
2.2 
3.2 
3.3 
2.4 
3.6 
2.1 
0.1 
3.0 
0 
0.1 
mature 
myeloid 
0.5 
32.1 
11.7 
20.9 
40.1 
0.9 
28.7 
0 
0.5 
32.9 
1. 5 
24.8 
44.2 
1.4 
1.0 
34.4 
1.1 
1.0 
4.1 
0.5 
lym-
phoid 
6.8 
27.0 
20.4 
18. 1 
17.8 
0.1 
23.5 
0.8 
37.6 
3.7 
20.4 
14.0 
24.5 
5.1 
36.7 
3.8 
2.0 
24.0 
6.0 
3.6 
mono-
cytic 
0.3 
5.1 
1.3 
6.2 
15.1 
0.4 
14.8 
0.5 
0.5 
8.5 
1.1 
10.2 
0.8 
6.9 
0 
0.4 
1.1 
1.0 
20.2 
5.5 
nucl. 
ery-
throid 
19.2 
4.4 
8.7 
7.3 
10.7 
9.6 
17.4 
11.7 
8.5 
7.4 
11.3 
11 . 5 
9.0 
2.4 
9.7 
1.3 
2.7 
21.0 
7.1 
2.8 
Bone marrow cells were incubated with MCAs and GARA/FITC and were 
sorted (-, negative; +, positive; ++, strongly positive) as described in 
Chapter 2. For details, see subscript Fig. 4.5 and Table 4.5. 
The percentage of each cell type in each fraction was calculated with regard 
to the total amount of cells in either all nucleated cells or all the blast cells. 
Of each fraction hundred cells were counted. 
Figures represent mean results of 2 experiments. 
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In all nucleated cell preparations, 15-1.1 did not react with the majority 
of lymphoid, erythroid and immature myeloid cells. However, it did react 
with almost all mature myeloid and monocytic cells. MCA 15-1.1 that reacted 
similar to 7-15.1 except with DA-1 cells and perhaps PBL, appeared to be 
different with respect to the reactivity with immature and mature myeloid 
cells in the blast cell fractions. MCA 15-1.1 did not recognize immature 
myeloid cells, whereas 7-15.1 reacted with about 40% of these cells. In 
addition, 15-1.1 reacted with about 80% of the mature myeloid cells, while 
7-15.1 does not seem to be reactive with mature myeloid cells. In the blast 
cell fraction the majority of the monocytic cells were gained from the 
moderately 15-1.1 positive fraction, whereas in preparations of all nucleated 
cells the majority of the monocytes were recovered from the strongly positive 
fraction. 
DISCUSSION 
Murine pluripotent haemopoietic stem cells (CFU-S) and early committed 
progenitor cells (CFU-C) cannot be distinguished on basis of their morpho-
logical characteristics and physical properties (Van den Engh et al., 1981). 
CFU-S and the different types of CFU-C can be identified only by colony 
forming unit assays ( CFU assays) ( Civin et al., 1984). It is therefore of 
interest to identify specific cell surface markers on these cells. Such 
markers would make it possible to study CFU-S and CFU-C more directly. In 
addition, knowledge of the antigenic structure of CFU-S and CFU-C might 
help to understand the process of cell differentiation, the function of 
specific cell surface antigens in this process, and the molecular mechanisms 
controlling differentiation (Fitch en et al., 1980; 1981; Fukada, 1985; Koizumi 
et al., 1982; Till and McCulloch, 1980). 
In spite of many attempts by a number of investigators no CFU-S or 
CFU-C specific antigens have been discovered (Heyman, 1985; Micklem, 1986; 
Watt et al., in press). A number of cell surface markers expressed on 
CFU-S and CFU-C have been described, but none of them were specific for 
these cell types. In fact, very few MCAs have been described that are 
differentiation stage or cell lineage restricted (Watt et al., in press). 
Perhaps the only known stage specific MCA is My-1 0 which is reactive with 
and specific for human haemopoietic progenitor cells of most, if not all, 
differentiation lineages ( Civin et al., ·1984; 1987; Strauss et al., 1986a; b). 
Two diametrically opposed hypotheses have been put forth concerning 
the existence of CFU-S or CFU-C specific cell surface markers. Davis (1975) 
proposed that the pluripotent stem cell expresses none of the surface 
antigens of mature cells and therefore is a null cell. During the progress of 
differentiation maturing cells acquire differentiation antigens. In contrast, 
Till (1976) proposed that because of the multipotentiality of CFU-S, they 
must express antigens of all haemopoietic lineages. In this view the CFU-S 
are characterized by an abundance of surface markers, rather than a paucity 
of markers. None of these markers need necessarily be unique, nor need 
they be expressed at other than (very) low levels and with limited functional 
capacity. According to Watt et al. (in press) it is possible that neither of 
the two views is correct. 
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If the hypothesis proposed by Davis (1975) is correct then it is com-
prehensible that no CFU-S (or CFU-C) specific MCAs were identified. 
However, a number of antigens expressed on subpopulations of mature cells 
was also shown to be present on CFU-S (Fitch en et al., 1981; 1982; Harris 
et al., 1984a; Miller et al., 1985b; Ralph and Berridge, 1984; Russel and 
Van den Engh, 1979; Van den Engh et al., 1983). The determinants 
recognized by the in this study produced MCAs PV5.6, 10-9.6 and 10-7.3 
were expressed on both CFU-S, various types of in vitro clonogenic pro-
genitor cells and mature cells (Fig. 4.2). This indicates that the hypothesis 
proposed by Davis is most likely incorrect. 
According to Till (1976) there might exist CFU-S specific antigens. 
Since no CFU-S specific antigens have been described this could mean that 
the hypothesis of Till was not correct, although the fact that no CFU-S 
specific MCAs have been produced does not necessarily mean that CFU-S 
specific antigens do not exist. Technical imperfections might be the reason 
for the fact that no CFU-S or CFU-C specific antigens have been identified 
and no CFU-S or CFU-C specific MCAs have been described. 
A major obstacle in the production of CFU-S or CFU-C specific MCAs is 
that these cells are rare cells in the very heterogeneous bone marrow, and 
that antigens specific for these cells, like for instance certain growth factor 
receptors, will be expressed at very low densities (Berridge, 1979; Berridge 
and Okech, 1979; Metcalf, 1985c; Till 1976). Therefore, it is difficult to 
obtain enough of these antigens (CFU-S) to evoke strong immune responses 
against them. 
In this study, animals were immunized with bone marrow suspensions up 
to 80-fold enriched for CFU-S to enhance the chance to obtain MCAs speci-
fically directed against a determinant on these cells (Chapter 3). It could be 
that the degree of enrichment was not high enough to evoke immune 
responses against CFU-S specific antigens, assuming that such antigens 
exist. In addition, since all membranes consist of a large number of antigenic 
structures the probability to raise an immune response against immuno-
dominant antigens expressed on the injected cells existed (Thalhamer and 
Freund, 1985). lmmunodominant antigens mask the existence of weakly or 
non-immunogenic antigens, especially when the amount of these latter 
antigens is low (Dresser, 1986). The result of the presence of immuno-
dominant antigens will be that no MCAs are produced against the other 
antigens which may be the CFU-S or CFU-C specific ones (O'Connor et al., 
1987; Springer, 1980) • 
Another major factor that could have been the reason why no CFU-S or 
CFU-C specific MCAs were detected is the lack of sufficient sensitivity of 
the screening techniques. In this study a number of screening assays has 
been used, many of which have also been used by others. FACS analysis 
and sorting are in general considered to be the most sensitive and most 
objective ways of screening ( Civin et al., 1987; Hessian et al., 1986; Hough 
et al., 1986; Ledbetter and Herzenberg, 1979). Still there are some dis-
advantages of this way of screening. Nonspecific fluorescence of dead cells 
and cells which express Fc-receptors on their membranes, especially mono-
cytes, macrophages and granulocytes, but also B-cells, NK-cells and a minor 
population of T-lymphocytes, might give false positive results (Dang! and 
Herzenberg, 1982; Fitchen et al., 1981; Parks et al., 1986; Sasaki et al., 
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1987). On the other hand, the arbitrary set threshold to discriminate 
between the presence or absence of antibodies might have given rise to false 
negative results in cases where supernatants gave only minimal fluorescence 
as was observed for the MCAs from group II (Table 4.1). 
Although specific markers for CFU-S and CFU-C have not been identi-
fied, quantitative differences in expression of cell surface markers have been 
used to define different stages of maturation and for the enrichment of 
CFU-S and different types of CFU-C (Bertoncello et al., 1986; Harris et al., 
1984a; Hasthorpe et al., 1985a; Hoang et al., 1983; Micklem, 1986; Miller et 
al., 1985a; Muller-Sieburg, 1986; Nibbering et al., 1987; Nicola, 1982; Nicola 
et al., 1981; Springer et al., 1979). It was therefore of interest to charac-
terize the 5 MCAs that reacted with large percentages of bone marrow cells 
(Fig. 4.2) because these MCAs essentially could be of use for the depletion 
of mature cells from bone marrow samples and for the negative selection of 
CFU-S or different in vitro clonogeneic progenitor cell types. The pattern of 
reactivity of one such MCA, PV5.6, is schematically summarized in Fig. 4.11. 
This scheme is designed to allow a visual comparison of all data obtained 
with this MCA. Similar schemes were designed for the other four MCAs that 
reacted with large percentages of bone marrow cells (Figs. 4.12-4.15). 
MCA PV5.6 reacted strongly with large percentages of T-lymphocytes 
(thymus, EL-4, PBL), B-lymphocytes (bone marrow, spleen, PBL), granulo-
cytes (bone marrow, PEC, PBL) and monocytes/macrophages (bone marrow, 
PEC, WEHI-38?). PV5.6 was not reactive with erythrocytes in bone marrow 
and most likely not with erythroid cells present in fetal liver. This pattern 
of reactivity is very similar to that described for antibodies directed against 
a heterogeneous group of high molecular weight glycoprotein antigens known 
as leukocyte common antigens ( LCAs). These antigens were first described 
by Kumoro et al. (1975) and are encoded by the Ly-5 locus on chromosome 1 
( LeCorre et al., 1987). Originally, it was thought that Ly-5 encoded 
antigens were expressed on thymocytes and T-lymphocytes only (Omary et 
al., 1980; Shen et al., 1982), but it has been proven that these antigens 
are also expressed on B-lymphocytes, granulocytes and monocytes/macro-
phages, but not on mature erythrocytes and their immediate precursors 
(LeFrancois et al., 1986; Ralph et al., 1987; Springer, 1980). In addition, it 
has been reported that LCAs are expressed on CFU-S, CFU-GM and BFU-E 
(Delwel et al., 1987; Miller, 1985a; Omary et al., 1980; Ralph et al., 1982; 
Ralph and Berridge, 1984; Van den Engh et al., 1983), which was also 
observed for the determinant recognized by PV5. 6 and supports the notion 
that PV5.6 is directed against a LCA. The only observation which does not 
support this view is that 19% of the nucleated erythroid cells present in bone 
marrow were recovered from the PV5. 6 positive fraction. 
It has been described that LCAs are not expressed on the late ery-
throid progenitor cell; CFU-E (colony forming unit-erythroid) (Miller et al., 
1985a; Van den Engh et al., 1983; Watt et al., 1983). Thus, if PV5. 6 was 
directed against a LCA it could be of use for the negative selection of these 
progenitor cells. CFU-E were not assayed in the present study, because 
they have been reported to be selectively lost in cell sorting experiments 
(Lesley et al., 1984). Definite prove for the assumption that PV5. 6 is 
directed against a LCA would have been obtained by means of immunoprecipi-
tation, which was not done in the_ present study. 
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It can be excluded on basis of the known reactivity of the antigens 
expressed on the tumour cell panel that PV5.6 is directed against any of 
these antigens, except Ly-5: Thy-1 is expressed by only 0-10% of murine 
bone marrow cells (Hogarth et al., 1985; Oliveira and Thomas, 1985; 
Tidmarch et al., 1985); The lnterleukin-4 receptor, like all other growth 
factor receptors, will only be present in very low densities on IL-4 
responsive cells, e.g., (pre-)B and (pre-)T-Iymphocytes, mast cells and 
macrophages (Metcalf, 1985c; Nicola, 1987a; O'Garra et al., 1988; Whetton 
and Dexter, 1986); MCA 14.8 specifically stains all 8-lineage cells, including 
pre-B cells ( Fulz et al., 1982); MAC-1 is identical to the complement 
receptor type 3 ( CR3b) (Beller et al., 1982) and is specifically expressed on 
granulocytes and macrophages (Springer et al. , 1979; Springer, 1980) , but 
is absent from CFU-GM (Miller et al., 1985a) and erythroid and lymphoid 
cells (Springer, 1980); MBM-1 is absent from CFU-GM and BFU-E (Davis et 
al., 1983); L3T4 ( CD4) is expressed on 90% of thymus cells (Reichert et al., 
1986), T-helper cells and on some macrophages, but not on 8-lymphocytes 
and granulocytes (Williams et al., 1985); MHC class !-antigens (H-2K and 
H-2D) are found on almost all cell types (Mellor, 1986). However, their 
density varies considerably. CFU-S and CFU-C2 express high amounts of 
H-2K antigens, whereas thymocytes, macrophages and granulocytes express 
considerably lower amounts of these antigens (Fitch en et al., 1982; Harris et 
al., 1984a; Russel and Van den Engh, 1979; Van den Engh et aL, 1983; 
Williams et al., 1985); Nineteen percent of all bone marrow cells, but almost 
all PEC express Fc-receptors (Metcalf et al., 1975). 
The pattern of reactivity of MCA 10-2.2 is depicted in Fig. 4.12. This 
MCA seems to be specific for erythroid cells and a determinant expressed on 
the panel of leukaemic cell lines. MCA 10-2.2 on the average stains 25% of 
the cells in the erythrocyte cluster in normal bone marrow (Table 4.1). 
However, probably most of the cells present in this cluster are positive for 
this MCA (Fig. 4.2), but only a part of them bound high enough quantities 
of 10-2.2 to be detected as positive (Parks et al., 1986). Almost 50% of the 
Figure 4.11: 
Schematic representation of the reactivity pattern of MCA PV5. 6. The square 
boxes represent 100% of each indicated cell type. The black area in each box 
represents the percentage reactivity of the MCA. The reactivity of the MCA 
with CFU-S and progenitor cell types was determined by FACS sorting 
experiments. The percentage positive cells in the four bone marrow cell 
subpopulations are the mean percentages listed in Table 4.1. In the differ-
ential counts, the black areas represent the percentage of each cell type 
present in the positive fraction of all nucleated bone marrow cells labelled 
with MCA. The percentages were calculated from the figures in Table 4. 7. 
The percentages positive cells in each· organ and tissue and the percentage 
positive tumour cells were determined by FACS analysis. The antigens 
expressed on each tumour cell line are listed in Table 4.4 
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(H129.121, Van Agthoven et al., 1984) known to be directed against the 
TFR. The positive cells in the erythrocyte cluster are most likely reticu-
locytes present in this population and capable to take up iron, a process in 
which the TFR is involved (Van Agthoven et al., 1984). 
Because 10-2.2 is not expressed on BFU-E it could be of use for the 
negative selection of these primitive erythroid progenitor cells. In addition, 
it could be of use in the study of the growth control of leukaemic cells. 
Sauvage et al. (1987) showed that an anti-TFR MCA had an inhibitory effect 
on the growth of a leukaemic cell line (SL-2). lmmunoprecipitation would 
have proven if 10-2.2 is indeed directed against the TFR. However, this was 
not done in this study. 
On basis of the reactivity of 1 0-2. 2 and the expression of the antigens 
on the 10-2.2 positive tumour cell lines it can be excluded that 10-2.2 is 
directed against one of these antigens. Thy-1 is expressed on almost all 
thymus cells (Ledbetter et al., 1980; Ledbetter and Herzenberg, 1979; 
Sarmiento et al.. 1982); Ly-5 is expressed on all leukocytes, but not on 
erythroid cells (Williams et al., 1985; Fig. 4.11); the IL-4 receptor is not 
expressed on erythroid cells (O'Garra et al., 1988); 14.8 is reactive with all 
B lineage cells (Fultz et al., 1982); MAC-1 is not expressed on erythroid 
cells (Springer, 1980); MBM-1 is expressed on 58% of bone marrow cells and 
30% of spleen cells (Davis et al., 1983); L3T4 is expressed on thymocytes 
(Williams et al .• 1985); H-2K and H-20 antigens are not or only weakly 
expressed on red blood cells (Fitchen et al., 1982; Harris and Gill Ill, 1985) 
and FcRs are not expressed on erythroid cells (Parks et al., 1986). 
The reactivity of MCA 10-9.6 is shown in Fig. 4.13. This MCA did not 
or only weakly stained a very small percentage of cells in the erythrocyte 
cluster present in bone marrow. It did react with about 50% of the nucleated 
erythroid cells present in bone marrow and with probably most nucleated 
erythroid cells in fetal liver suspensions. This suggests a difference between 
these cells with respect to the the expression of the determinant recognized 
by 10-9.6 in these different organs. Nine percent of the lymphocytic cells 
present in bone marrow were recovered from the 10-9.6 positive fraction. 
This percentage coincides well with the % T -lymphocytes present in bone 
marrow as determined by means of a MCA directed against Thy-1 antigens 
(Hogarth et al., 1985; Tidmarch et al., 1985). However, 10-9.6 weakly 
stained most cells present in the lymphocyte cluster as distinguished on the 
FACS (Fig. 4.2). This indicates that other cells than lymphocytic cells must 
be present in this cluster, which are weakly 10-9.6 positive. It has been 
reported for human bone marrow that in the lymphocyte cluster also norma-
blasts were present ( Civin et al., 1987). This also implies that the per-
centage nucleated erythroid cells in the lymphocyte population was under-
estimated (Table 4.6). The reactivity of 10-9.6 with most thymus cells and 
all T -lymphocytic leukaemic EL-4 cells is in favour of the assumption that 
10-9.6 was directed against a determinant expressed on cells of the T -cell 
Figure 4.13: 
Schematic representation of the reactivity pattern of MCA 10-9.6. See 
legend, Fig. 4.11 for details. 
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lineage. In addition, about 60% of the lymphocytes in peripheral blood and 
40% of the lymphocytes in the spleen are a-Thy-1 positive (Ledbetter and 
Herzenberg, 1979). Together with the percentages of 10-9.6 positive cell 
types present in these organs, these percentages support the notion that 
1 0-9. 6 was directed against a determinant expressed on T -I ineage cells but 
not on B-lineage cells. Because 10-9.6 is reactive with all CFU-S and in 
vitro clonogenic progenitor types tested and the determinant remained 
expressed on most of the mature cell types, this MCA seems not of much use 
for the purification of these cells. 
It can be excluded that 10-9.6 is directed against the antigens present 
on the tumour cell lines, because Thy-1 is not expressed on fetal liver cells 
( Habu and Okumura, 1984); Ly-5 is not reactive with erythroid cells 
(Williams et al., 1985); the IL-4 receptor is expressed on low percentages of 
cells including B cells (Palacios et al., 1986; Ohara and Paul, 1987); 14.8 is 
B cell lineage specific; MAC-1 is absent from CFU-GM (Miller et al .• 1985a) 
and lymphoid cells (Springer et al.. 1979); MBM-1 is not expressed on 
B FU-E and CFU-GM (Davis et al., 1983); L3T4 is not expresssed on granu-
locytes (Williams et al., 1985); H-2K and H-20 are weakly expressed on 
granulocytes (Van den Engh et al., 1983) and because FcRs are present on 
only 19% of the bone marrow cells (Metcalf et al., 1975). 
The pattern of reactivity of MCA 7-15.1 is schematically presented in 
Fig. 4. 14. This MCA stained a large proportion of the cells present in the 
granulocyte cluster, and two clusters (together about 40%) of the cells 
present in the blast cell population, but did not stain, or very weakly 
stained cells in the erythrocyte and lymphocyte cluster (Fig. 4. 2). Lack of 
reactivity with lymphocytes was also suggested by the fact that only very 
small numbers of thymus cells, spleen cells and PBL were stained, and the 
EL-4 and P388 cells were not stained. In Fig. 4.14 the differential counts of 
blast cells are shown. Of all nucleated erythroid cells present in the blast 
cell population, 21% was gained from the 7-15.1 positive blast cell fraction. 
Therefore, it cannot be excluded that 7-15.1 recognized a determinant 
expressed on these cells, although this does not seem very likely on basis of 
the small percentage of 7-15.1 positive fetal liver cells. This implies that this 
MCA could be reactive with both immature and mature myeloid cells and mono-
cytes (Table 4.6). It is clear from the results of the differential counts on 
the blast cell fraction that 7-15.1 is reactive with monocytes. However, the 
determinant recognized by 7-15.1 seems to be lost from mature macrophages 
present in PEC suspensions, because 57% of the cells in these suspensions 
are macrophages (Table 4.5) and 7-15,1 only weakly stains a small population 
Figure 4.14: 
Schematic representation of the reactivity pattern of MCA 7-15.1. See 
legend, Fig. 4.11 for details. 
* CFU-C2 not determined. 
** blast cells instead of all nucleated cell fraction. 
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of PEC. From the constitution of PEC suspensions it follows that 7-15.1 must 
react with mature granulocytes which was also suggested by the weak reacti-
vity with PBL, but is in contrast with the results of the differential counts. 
It could be that the determinant recognized by this MCA becomes earlier 
expressed on granulocytic progenitor cells than on monocyte progenitor cells, 
since a larger subpopulations of the CFU-GM, that can give rise to both 
granulocytes and macrophages, is stained by 7-15.1 than of the less 
primitive CFU-M, which exclusively differentiates along the monocytic 
lineage. It could be, although no evidence for this was obtained, that the 
CFU-GM stained by 7-15.1 are capable to give rise to granulocytes only. 
MCA 7-15.1 could be of use to study the hierarchical organisation of granu-
locyte and macrophage progenitors and to study the divergence of the 
granulocyte and macrophage lineages. In addition, because this MCA is not 
reactive with CFU-S, BFU-E and most CFU-M, it can be used for the 
negative selection and purification of these cells. 
The determinant recognized by MCA 15-1,1 appears at the CFU-GM 
stage during granulocytic development (Fig. 4. 15). During the progress of 
differentiation along the granulocytic pathway the density of the determinant 
recognized by 15-1.1 increases (Table 4. 7): it is expressed on 38% of the 
immature granulocytic cells, whereas the more mature granulocytic cells in 
bone marrow are all positive for 15-1.1. It can be deduced from the reacti-
vity with PBL and PEC and the percentage of granulocytic cells in these 
suspensions, that 15-1.1 is also reactive with mature granulocytes in these 
tissues. The expression of the determinant recognized by 15-1.1 in the 
monocytic lineage first appears ilt the CFU-C2/CFU-M stage of development. 
Monocytes in bone marrow express this determinant in higher densities than 
granulocytes do (Table 4. 7). It can be deduced from the weak reactivity of 
15-1 .1 with a small percentage of PEC that the 15-1.1 determinant, abun-
dantly present on bone marrow monocytes, is lost from mature macrophages. 
Thus, 15-1.1 seems to be a monocytic and granulocytic marker but it 
cannot be excluded that 15-1.1 is also weakly reactive with a very small 
subpopulation of nucleated erythroid cells and/or lymphocytes present in 
bone marrow. This MCA can be used for the depletion of mature myeloid 
cells and monocytes, and for the purification by means of negative selection 
of BFU-E and CFU-S. The latter application will be extensively discussed in 
Chapters 5 and 6. It could also be useful for studies on the heterogeneity of 
CFU-GM and CFU-C2/CFU-M in combination with 7-15.1. 
It can be excluded that 15-1.1. is directed against the Thy-1 antigen 
because it is not reactive with thymus cells (Lanier, 1984). For the same 
reason, it can be concluded that 15-1.1 is not directed against an antigen 
encoded by the Ly-5 locus (Williams et al., 1985). Because 15-1.1 is absent 
from bone marrow ( 8) lymphocytes, but is reactive with a large percentage 
of other bone marrow cells it can be excluded that this MCA is directed 
against the IL-4 receptor. 
Figure 4.15: 
Schematic representation of the reactivity pattern of M CA 15-1 . 1 . See 
legend, Fig. 4.11 for details. 
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MCA 15-2.4 reacted with only small percentages of bone marrow cells 
and cells from other organs and tissues (Table 4.1; Fig. 4.10). It is the 
only MCA of group II (Table 4.1) that is reactive with an in vitro clonogenic 
progenitor cell type tested in this study (Table 4.2). -MCA 15-4.2 was 
reactive with half of the BFU-E population assayed after 10-14 days culture 
and therefore, could be used for studies concerning the heterogeneity of 
this progenitor cell type. The determinant recognized by 15-2.4 is probably 
not expressed on nucleated erythroid cells in fetal liver and on cells in the 
erythrocyte cluster present in bone marrow, and therefore, seems directed 
against an antigen present on only part of the immature erythroid cells. 
The other MCAs that reacted with only small percentages of bone 
marrow cells did not react with CFU-S or any of the progenitor cell types 
tested (Table 4.2) .· Because of the low percentages of cells recognized by 
these MCAs they are not of much use for the negative selection and enrich-
ment of these cell types. Due to the small percentages of positive cells 
present in the various bone marrow subpopulations and organs and tissues 
after staining with this group of MCAs it was not possible to determine with 
what type(s) of cells these MCAs were reactive. 
MCA PV5.6 and 10-2.2 are probably the only MCAs obtained in this 
study that are directed against previously described antigens, e.g. leuko-
cyte common antigen and transferrin receptor, respectively. All other MCAs 
produced here (Table 4.1) are directed against unknown and thusfar un-
described antigens. 
No CFU-S or in vitro clonigenic cell type specific MCAs were developed 
in this study. This could have been due to technical imperfections and 
insufficient sensitivity of the procedures employed to screen the MCAs, the 
not very high enrichment factor of CFU-S in the suspensions used for 
immunization (Chapter 3), but it could also be that in contrast with the 
human system, where a progenitor cell specific antigen seems to exist (Civin 
et al. , 1984; 1987; Strauss et al. , 1986a; 1986b) there exists no such 
antigen for murine haemopoietic stem cells. Such a situation may be ana-
logous to that observed for tumour antigens. Those are often more tumour 
selective than tumour specific (Schmidt et al., 1986; Sela, 1986), i.e., 
antigens present on tumour cells are also expressed on normal healthy cells, 
but in different density allowing the identification and separation of tumour 
cells from normal cells. Similarly, alterations in cell surface antigens 
expressed on haemopoietic stem cells, that might be involved in the process 
of differentiation, may represent quantitative changes or structural changes 
of an antigenic array at the cell surface, rather than an absolute loss or 
gain of stem cell specific (types of) antigen(s) (Fitchen et al., 1981; Milstein 
et al. , 1979). 
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CHAPTER 5 
PURIFICATION AND ANALYSIS OF CFU-S BY 
BY MULTI-PARAMETER AND MULTI-COLOUR 
IMMUNOFLUORESCENCE FLOW CYTOMETRY 
INTRODUCTION 
The combination of immunofluorescence and flow cytometry has become 
an integral tool in the study of biological systems, especially in the 
discrimination between cells in heterogeneous populations like bone marrow 
(Civin et al., 1987; Lanier and Loken, 1984). This combination not only 
allows different subpopulations of cells to be distinguished in normal bone 
marrow on the basis of forward and right angle light scattering (Van den 
Engh and Visser, 1979), but at the same time, the enumeration of selected 
cells expressing a certain cell surface antigen and the determination of the 
quantity of the antigen expressed (Loken et al., 1987a; Civin and Loken, 
1987). Quantitation of immunofluorescence is very important because a 
(sub) population of cells is often identified on the basis of the amount of a 
particular antigen, rather than simply on its presence or absence (Parks et 
al., 1986; Chapter 4). 
A number of investigators exploited quantitative differences in the level 
of cell surface expression of lectin binding sites, or antigens, or a combi-
nation of both fluorescently labelled lectins and MCAs to purify CFU-S or 
CFU-C by means of flow cytometry (Nicola et al., 1981; Nicola, 1982; Watt et 
al., 1983; Visser and Bol, 1981; Hoang et al., 1983; Harris et al., 1984a; 
1984b; Springer et al., 1979; Micklem, 1986; Mouchiroud et al., 1985; 
Bauman et al., 1986; Bauman and Chen, 1987; Lord and Spooner, 1986; 
Bertoncello et al., 1986; 1987). 
Most methods to enrich CFU-S or CFU-C subsets consist of several 
steps and are of long duration and result in a low recovery of selected cells 
( Mouchiroud et al., 1985; Lord and Spooner, 1986). A MCA specific for 
CFU-S or different subsets of CFU-C, would be an ideal reagent for the 
identification and purification of CFU-S or CFU-C. It would also reduce the 
number of steps in enrichment procedures and thus would speed up such 
procedures. However, despite many extensive studies no such MCAs have 
been described (see Chapter 4), at least for murine stem cells. 
Multicolour immunofluorescence and multiparameter flow cytometric 
analysis, in combination with measurements of forward and perpendicular 
light scatter intensities, allows for direct examination of the correlated 
expression of multiple antigens on the surface of individual cells (Lanier et 
al., 1986; Lanier and Loken, 1984; Loken and Lanier, 1984). Multicolour and 
multiparameter flow cytometry has proven very valuable for the detection of 
previously unidentified subpopulations of B- and T -lymphocytes in blood and 
bone marrow (Ledbetter et al., 1980; Hardy et al., 1982; Mathieson and 
Folwkes, 1984; Reichert et al., 1986; Crispe et al., 1987; Herzenberg et al., 
1987; Lanier and Loken, 1984), and for the determination of the maturational 
sequence of antigen expression of erythroid cells and B-lymphocytic cells 
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present in unfractionated bone marrow (Parks et al., 1984; Loken et al., 
1987a; 1987b). In addition, multicolour and multiparameter analysis has 
proven to be an alternative approach to identify CFC-5, making use of 
list mode data aquisition and processing which obviates the need for sorting 
of cells, and to purify CFU-5 or CFU-C more rapidly than is possible with 
the sequential multistep procedures (Pallavicini, 1985a; 1985b, 1987; 
McCarthy et al., 1987; Civin et al., 1987). 
In this chapter, a multicolour and multiparameter flow cytometric 
procedure is described that enables the in vitro identification of CFC-5 
present in unseparated bone marrow suspensions. This method makes it 
possible to directly determine the presence of certain cell surface antigens 
on CFC-5, and precludes the need to sort labelled cell fractions and to do a 
CFU-5 assay. This approach represents a considerable saving of mice, and 
was exploited to rapidly and accurately screen riewly produced MCAs 
(Chapter 4). Finally, a widely applicable procedure for the negative selection 
of CFU-S employing MCA 15-1.1 will be described. 
TWO-COLOUR IMMUNOFLUORESCENCE MULTIPARAMETER FLOW CYTO-
METRIC IDENTIFICATION AND ISOLATION OF CFU-5 
The number of murine pluripotent haemopoietic stem cells is traditionally 
determined by means of the spleen colony forming assay (CFU-5 assay; Till 
and McCulloch, 1961). This assay does not allow a direct enumeration of the 
stem cells (CFC-S), since the colonies that appear after 6 to 14 days in the 
spleens of lethally irradiated recipients are the progeny of individual CFU-S 
(Wu et al., 1967) and only a fraction of the injected stem cells in known to 
home to the spleen and form a colony there ( Lahiri et al., 1970). 
Direct measurements on CFC-S are only possible when highly purified 
CFC-S suspensions are available (Bodger et al., 1984; Hoang et al., 1983; 
Strife et al., 1987; Van Bekkum et al., 1971). In 1984, Visser and collea-
gues described such a procedure. This method consists of three subsequent 
separation steps. First, bone marrow cells are separated on a discontinuous 
density gradient of metrizamide and simultaneously labelled with the FITC 
conjugated sialic-acid binding lectin wheat germ agglutinin (WGA/FITC). 
Secondly, the low density cells ( 1.078 g/cm 3 ) are analysed on a FACS-11 
and the WGA/FITC positive cells with medium forward and low perpendicular 
light scatter intensities are sorted. The WGA/FITC is removed from the cells 
by incubation with the competing sugar N-acetyi-D-glucosamine. Finally, the 
sorted cells are incubated with a biotinylated MCA directed against H-2Kk 
antigens (a-H-2Kk-biotin) and FITC conjugated avidin (Av/FITC) and sorted 
a second time to select the strongly a-H-2Kk positive cells. In the second 
sorting run, the sam~ light scatter windows as in the first sort were used 
(for details, see Chapter 2). 
Based on the fact that multicolour immunofluorescence and multi-
parameter flow cytometric analysis enables the direct examination of the 
correlated expression of multiple antigens on the surface of individual cells 
(Lanier and Loken, 1984; Loken and Lanier, 1984; Lanier et al., 1986) and 
the high degree of purity of CFC-S that was obtained with the procedure 
described above, it was investigated if CFC-S could be identified and 
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isolated on the basis of simultaneous expression measurements of WGA 
binding sites and H-2Kk antigens. Therefore, WGA and a-H-2Kk-biotin must 
be labelled with different fluorophores. Low density bone marrow cells were 
incubated with a-H-2Kk-biotin and phycoerythrin conjugated avidin (Av/PEJ 
and with WGA/FITC (see· Chapter 2). The labelled cells were analyzed and 
sorted on the RELACS, a dual laser flow cytometer built and developed at 
the Radiobiological Institute TNO (Stokdijk et al., 1985). 
For the simultaneous measurement of the green FITC fluorescence and 
the orange PE fluorescence only one laser is needed. Both fluorescent dyes 
can efficiently be excited by light of the same wavelength, i.e. 488 nm (Fig. 
5.1A). FITC and PE, a photosynthetic pigment isolated from red algae 
(Glazer, 1982; Oi et al., 1982) emit light at different wavelengths. This 
makes it possible to use both dyes simultaneously when the total emission 
spectrum is separated into its two components through the use of optical 
filters (Dean and Pinkel, 1978). In Fig. 5.18 it is shown that the two 
fluorescence signals can be separated when the right filter combinations are 
used. In this study, the FITC and PE fluorescence were separated with a 
570 nm dichroic mirror and selectively collected using a 530 nm BP filter for 
FITC fluorescence and a 577 nm BP filter for PE fluorescence. 
As can be seen in Fig. 5.18, a part of the FITC fluorescence will be 
detected by the detector for the PE fluorescence. To yield "true" FITC and 
PE signals on each detector, the spill over of the FITC fluorescence into the 
detector of the PE fluorescence must be electronically corrected (Lanier et 
al., 1986; Parks et al •• 1986, 1983; Preffer et al.. 1986). The signals from 
FITC into the detector used to measure PE fluorescence were electronically 
compensated to background levels using samples that were stained with 
WGA/FITC only (Loken and Lanier, 1984; Parks et al., 1986; Wognum et al., 
1987). 
Forward and perpendicular light scatter intensities (FLS and PLS) were 
measured through 488 nm BP filters and were linearly amplified. The FLS 
signal was used to generate a light scatter pulse width or time of flight 
(TOF) signal. TOF can be used to distinguish single cells from coincident 
arrivals of clumps of two cells or more ( Civin and Loken, 1987; Sharpless et 
al., 1975). FITC and PE fluorescence signals were processed using logarith-
mic amplifiers. The correction of the FITC spill over into the PE detector 
was done before logarithmic conversion (Parks et al., 1986). 
Of each cell five parameters, i.e,, TOF, FLS, PLS, FITC- and PE 
fluorescence were measured and stored in a list mode file by a HP9000-200 
computer. Subsequential reanalysis of the data was performed with the 
ELDAS software package written in the Radiobiological Institute by R. 
Jonker. Analysis of the I ist mode data was done using window settings which 
were derived from the FACS analysis and sorting experiments on the indi-
vidual markers separately (Visser et al .• 1984). 
In Fig. 5. 2A the bivariate contour plot of the FLS versus the PLS 
intensities of all nucleated low density bone marrow cells is shown. This 
contour plot was computer generated from list mode data of 1 o5 cells after 
exclusion of cell clumps by means of TOF (7. 2% of all events in this case). 
Erythrocytes were gated out electronically before data storage to prevent the 
storage of irrelevant events in the list mode file. In this figure also the FLS 
and PLS windows that were set to select the blast cells, indicated by the 
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a. Excitation spectra (solid lines) and emission spectra (broken lines) of 
dyes used in flow cytometric immunofluorescence studies. The arrows 
mark the argon-ion laser lines normally used to excite the dyes. The 
arrowed ranges mark the best range for excitation using a tunable 
dye-laser. Adapted from Parks et al. ( 1986). 
b. The emission curves of FITC. PE and TxR. The rectangles approximate 
the transmission windows of the filters used to separate the emission 
from the three dyes. Adapted from Loken and Lanier (1984). 
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(shaded) rectangle, are shown. The windows shown were the same for 
computer reanalysis of the data and for the one sort procedure (see below). 
The fluorescence of these selected cells was further analyzed. In Fig. 5.2B 
the bivariate contour plot of the FJTC fluorescence (due to WGA binding) 
versus the PE fluorescence (due to a:-H-2Kk binding) distribution of the 
selected low density blast cells from Fig. 5.2A is shown. Fig. 5.2B also 
shows the FITC and PE fluorescence windows that were set to select the 
CFU-S from all the blast cells. First. the brightly WGA/FITC positive blast 
cells were selected; about 4 to 8 percent of the total low density cells. 
Subsequently, the PE fluorescence distribution of the selected WGA positive 
low density blast eel Is was analysed. A PE threshold was set so that 20 to 30 
percent of the remaining WGA positive low density blast cells with high PE 
fluorescence intensities were selected. In this way, between 0. 8 and 2. 4% of 
the low density cells were selected. In the present study the mean yield of 
low density cells in three experiments was 15% of all bone marrow cells. This 
indicates that between 0.1 and 0.4% of all nuCleated bone marrow cells were 
selected by the density separation and the light scatter and fluorescence 
windows. This percentage selected cells is the same as that selected by two 
sequential sorting runs as described earlier (Visser et a!., 1984). 
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Figure 5.2: 
a. Bivariate distribution of the forward versus the perpendicular light 
scatter of nucleated low density mouse bone marrow cells. This plot was 
generated from listmode data of 105 cells. ·The rectangle indicates the 
selected blast cell population. Contour lines were drawn at 2.6, 10.0, 
21 .0, 31.0 and 63% of peak value. 
b. Bivariate logarithmic distribution of the FITC(WGA) versus the 
PE(a:-H-2Kk) fluorescence distribution of the blast cells, selected as 
indicated in A. The rectangle indicates the fluorescence windows to 
select for CFC-5. Contour lines were drawn at 2.7, 8.2, 16.0 and 44.0 
percent of peak value. Cells were stained and analysed on the RELACS 
as described in Chapter 2. 
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The CFU-S specificity of the staining and analysis procedure was tested 
by sorting the cells on the RELACS according to FLS, PLS, FITC (WGA) and 
PE (a-H-2Kk) intensities as shown in Fig. 5.2. In Table 5.1 the results of 
three different experiments, in which the cells were sorted in a single run, 
are presented. The sorted cells with medium FLS, low PLS, high FITC- and 
high PE-fluorescence intensities contained about 42 times more day-12 CFU-S 
and 10-20 times more day-8 CFU-S than control bone marrow samples ( N BM). 
Similar to the sequential two sort procedure described by Visser et al. 
(1984), the one sort procedure resulted in 2-3 times more day-12 CFU-S 
than day-8 CFU-S. However, the enrichment of CFU-S obtained with the 
latter procedure is a factor 3 to 4 lower. The same holds for the recovery of 
mouse 
strain 
C3H 
BC3 
BC3 
Table 5.1 
ENRICHMENT AND RECOVERY OF CFU-S USING 
THE ONE SORT PROCEDURE 
sorted % CFU-S/105 nucleated enrichment 
fraction nucleated cells (% recovery) CFU-S 
cells 
day-8 day-12 day-8 day-12 
NBM 100 26.4±3.5 25.7±3.7 (1 00) (1 00) 
WGA+/a-H-2Kk+ 0.3 550 ±183 1100 ±305 21 (6.3) 43 (12.8) 
NBM 100 24.4±3.4 28.9±3.5 ( 1 00) (1 00) 
WGA + /a-H-2Kk+ 0.4 250 ±125 1188 ±272 10 (4.5) 41 (18 .1) 
NBM 100 n.d. 25.6±2.2 1 ( 1 00) 
WGA+/a-H-2Kk+ 0.1 n.d. 1000 ±354 39 (3.1) 
WGA+ /a-H-2Kk+* 0.1 n.d. 1200 ±275 47 (4.7) 
Low density bone marrow cells were labelled with WGA/ FITC, a-H-2Kk-biotin 
and Av/PE as described in Chapter 2. Cells indicated by an asterisk (*) 
were labelled with WGA conjugated to the red fluorescent dye Texas Red 
(WGA/TxR) instead of WGA/FITC. Cells were analysed and sorted on the 
RELACS as described in the text. For enumeration of the number of CFU-S 
in normal (unseparated, unstained) bone marrow (NBM) and the sorted 
fractions, irradiated mice ( 6-8 per group) were injected with 3 x 1 o4 
respectively 150 cells. Spleen colonies were counted at 8 and 12 days post 
transplantation. Recovery of CFU-S was calculated as follows: 
(% nucleated cells in fraction x CFU-5/1 05 nucleated cells in fraction) 
CFU-S/105 nucleated cells in NBM 
n.d.: not done 
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CFU-5. The recovery of day-8 CFU-S and day-12 CFU-S on the average was 
5.4% and 10%, respectively. Assuming that the day-12 CFU-S isolated by the 
one sorting run procedure have the same spleen seeding efficiency (1 0%) 
upon transplantation as those isolated by the procedure of Visser et al. 
(1984), it can be calculated that the isolated cell suspension consisted for 
10% of day-12 CFU-5. 
An explanation for the low enrichment factors and recoveries of CFU-S 
obtained with the one sort procedure could be that the recovery of low 
density cells after the density cut was rather high (15%), so that no optimal 
pre-enrichment of CFU-S was obtained. In three experiments, the enrichment 
factor of day-8 and day-12 CFU-S after a density cut was 2 and 2. 5, 
respectively, which is 2-2.5 times lower than that obtained by Visser et al. 
( 1984) . Another explanation for the observed differences between the two 
methods could be the use of different avidin conjugates to detect bound 
a-H-2Kk-biotin molecules. This possibility was tested in more detail (see 
below). 
THE INFLUENCE OF DIFFERENT AVIDIN- AND WGA-CONJUGATES ON THE 
RECOVERY OF CFU-S 
The main differences between the one sort procedure described above 
and the two sequential sort procedure described by Visser et al. (1984) is 
that in the former Av/PE was used instead of Av/FITC and that WGA/FITC 
was not removed from the sorted cells. 
Results of an experiment in which both avidin conjugates were compared 
in a two sorts experiment on the FACS are presented in Table 5. 2. Both 
samples were treated identically except for the avidin conjugate. Selection 
with Av/PE resulted in a four-fold lower enrichment of day-12 CFU-S and a 
1. 5-fold lower enrichment of day-8 CFU-5. The lower enrichment of CFU-S 
after isolation with Av/PE compared with selection by means of Av/FITC 
indicates that the reported protection of CFU-S by biotin and avidin against 
opsonisation by macrophages (Van den Engh et al., 1983; Bauman et al., 
1985) does not apply to biotin-Av/PE. A possible explanation for the 
observed phenomenon could be that after incubation with Av/PE not all biotin 
moieties on the a-H-2Kk molecule are occupied by Av/PE due to steric 
hindrance, because Av/PE conjugates are much bigger than Av/FITC 
conjugates. This could explain why the reduction of day-12 CFU-S was 
larger than that of day-8 CFU-5, since Mulder (1986) found that using the 
same batch of a-H-2Kk-biotin, day-12 CFU-S expressed more H-2Kk antigens 
than day-8 CFU-5. Incomplete shielding of the Fc-part of the a-H-2Kk 
molecule by avidin conjugates would result in opsonization by macrophages 
(Adler et al., 1978; Van den Engh et al., 1983; Bauman et al., 1985). 
According to Bauman et al. ( 1985) the degree of protection against 
opsonization is dependent on the amount of biotin per antibody molecule. 
High amounts give better protection. 
The effect of different avidin conjugates was further investigated on 
N BM and the low density bone marrow fraction obtained after a density cut 
(Table 5.3). Incubation of NBM cells with Av/PE or Av/FITC resulted in 24 
respectively 20 percent lower numbers of day-12 CFU-S in comparison with 
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unstained bone marrow. while no reduction in day-12 CFU-S was observed 
after incubation with Avidin/Texas Red (Av/TxR) (see later section). 
Addition of free avidin molecules (Av) resulted in an increased recovery of 
day-12 CFU-S for all the conjugates, above control values. This indicates 
that with Av/FITC and Av/PE in particular, not all biotin moieties on the 
a-H-2Kk molecules were occupied, resulting in opsonization of coated cells by 
macrophages and a loss of day-12 CFU-S. 
Table 5.2 
DIFFERENT AVIDIN CONJUGATES INFLUENCE THE ENRICHMENT OF CFU-S 
sorted fraction CFU-S/1 05 nucleated cells enrichment CFU-S 
day-.8 day-12 day-8 day-12 
NBM 26.7±3.5 31.0±3.8 
-WGA/a-H-2Kk-biotin 
+ Av/FITC 700 ±313 2500±646 26.2 80.6 
-WGA/a-H-2Kk-biotin 
+ Av/PE 467 ±226 600±226 17.5 19.4 
+WGA/a-H-2Kk-biotin 
+ Av/PE 267 ±189 533±267 10.0 17.2 
Low density bone marrow cells were stained and sorted with the two sorts 
procedure on a FACS-11 as described by Visser et al. (1984). WGA/FITC conju-
gates were either removed ( -WGA) by incubation with N-acetyi-D-~ucosa­
mine, or were not removed (+WGA). before incubation with a-H-2K -biotin 
and Av/FITC or Av/PE. 
For the spleen colony assay lethally irradiated mice (5-8 per group) were 
injected with 3 x 1 o4 N BM cells or 100 cells of the sorted fractions. Colonies 
were counted after 8 and 12 days. 
Labelling of low density cells with a-H-2Kk-biotin alone, resulted in a 
33% reduction of day-12 CFU-S numbers in comparison with the unlabeled 
control. After addition of Av/PE or Av/FITC to cells treated with 
a-H-2Kk-biotin only a slightly higher number of day-12 CFU-S was found. 
As was observed in NBM the least reduction was observed when Av/TxR was 
used. Addition of free avidin resulted in higher recoveries, in particular in 
case Av/PE was used. It is clear that Av/PE and Av/FITC did not completely 
protect coated day-12 CFU-S against opsonization. It may be that the cpn-
centration of Av/PE and Av/FITC, in contrast with the concentration of 
Av/TxR, was not high enough to shield all biotin moieties on the a-H-2Kk 
molecules. 
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Table 5.3 
THE EFFECT OF DIFFERENT AVIDIN CONJUGATES AND WGA CONJUGATES 
ON THE NUMBER OF CFU-S 
incubation day-12 CFU-S/1 o5 nucleated % 
cells recovery 
NBM 16.7 ± 5.2 100 
WGA/FITC 16.7 ± 3.3 100 
WGA/PYR 23.3 ± 5.0 140 
WGA/TxR 24.7 ± 3.2 148 
a-H-2Kk-biotin + Av/PE 12.7 ± 2.3 76 
a-H-2Kk-biotin + Av/PE + Av 19.3 ± 2.8 116 
a-H-2Kk-biotin + Av/FITC 13.3 ± 5.3 80 
a-H-2K k-biotin + Av/FITC + Av 19.3 ± 2.8 116 
a-H-2K k-biotin + Av/TxR 16.0 ± 2.5 96 
a-H-2Kk-biotin + Av/TxR + Av 22.0 ± 3.0 132 
low density bone marrow fraction 36.7 ± 3.9 100 
a-H-2 K k-biotin 24.5 ± 3.4 67 
a-H-2Kk-biotin + Av/PE 26.9 ± 3.8 73 
a-H-2 K k-biotin + Av/PE + Av 36.3 ± 3.9 99 
a-H-2Kk-biotin + Av/FITC 28.3 ± 3.7 77 
a-H-2Kk-biotin + Av/FITC + Av 32.2 ± 3.6 88 
a-H-2Kk-biotin + Av/TxR 33.0 ± 3.9 90 
a-H-2Kk-biotin + Av/TxR + Av 39.2 ± 4.0 107 
Bone marrow cells were labelled with WGA/ FITC, WGA/1-pyrenebutyryl 
(WGA/PYR) or WGA/TxR: 5 x 104 labelled cells were injected per irradiated 
mouse (8 per group). NBM cells and low density fraction bone marrow cells 
were incubated with a-H-2Kk-biotin alone (low density fraction), and 1 of 3 
different avidin conjugates, with or without extra avidin. The concentrations 
used were the same as used for CFC-S identification and sorting experiments 
(Chapter 2) 2.5 x 104 low density fraction cells were injected per mouse (8 
mice per group). Spleen colonies were counted 12 days post transplantation. 
Hardly any difference was observed between the recovery of day-12 
CFU-S from unseparated bone marrow cells or low density bone marrow cells 
when these suspensions were labelled with a-H-2Kk-biotin and Av/FITC or 
Av/PE (Table 5.3). In contrast, however, in experiments where low density 
cells were sorted employing either Av/FITC or Av/PE, a clear difference was 
observed between the recovery of CFU-S (Table 5.2). At present, no 
obvious explanation for this exists. The removal of accessory cells during 
the sort procedure has been proposed to cause a decrease in .the recovery of 
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CFU-S (Bauman et al., 1985; Bertoncello et al., 1985; McCarthy et al., 
1987; Visser and Eliason, 1983; Wickman et al., 1983). To achieve the 
highest recovery of CFU-S after sorting either the use of Av/TxR or the 
addition of free avidin after sorting of the cells seems advisable. 
In Table 5.1, it is shown that selection of CFU-S with WGA/TxR or 
WGA/ FITC resulted in about the same enrichment factor for day-12 CFU-S 
when the lectins were not removed from the cells. The enrichment with 
WGA/TxR was 1.2 times higher than with WGA/FITC. In Table 5.2 it is 
shown that removal of WGA/FITC from cells isolated by two sequential 
sorts did not result in a higher number of day-12 CFU-S, while the number 
of day-8 CFU-S was 1. 7 times higher when the fluorescent lectin was 
removed. 
No reduction of day-12 CFU-S was observed after incubation of NBM 
cells with WGA/FITC, WGA/TxR and WGA/PYR (see later section), although 
the recovery of CFU-S with the latter two conjugates was 1. 4 times higher 
than with WGA/FITC (Table 5.3). Lord and Spooncer (1986) obtained very 
high enrichments of CFU-S by two sequential sorts using WGA/FITC. They 
did not observe any influence on the recovery of CFU-S when the lectin was 
not removed from the sorted cells. Others, however, did report a significant 
reduction of CFU-S numbers when the WGA conjugates were not removed 
from the cells (Pioemacher and Brons, 1988a). 
Purification of CFU-S by the two-colour immunofluorescence one sort 
procedure- with a-H-2Kk-biotin, Av/PE and WGA/FITC did not result in the 
highest possible enrichment and recovery of CFU-S (Table 5.1, 5.2). In this 
respect, selection with Av/TxR and WGA/FITC using two lasers (see later 
section) would have been a better option. However, for double or triple 
labelling procedures Av/PE may be a useful conjugate if the homing and 
survival of the selected CFU-S is not of interest. The purity of the CFU-S 
selected with the method described above does not seem to be very high. 
However, in reality it is probably 4 times higher than shown, because the 
calculations did not take into account the loss of spleen seeding capacity of 
Av/PE labeled cells. The selection procedure described here can be used for 
the in vitro identification of CFC-S and would allow direct analysis of the 
cell surface characteristics of these cells, when probes conjugated to a third 
fluorochrome are used. 
THREE-COLOUR IMMUNOFLUORESCENCE MUL Tl PARAMETER 
CYTOMETRIC SCREENING OF MCAs FOR REACTIVITY WITH CFU-S 
FLOW 
In a previous section it was shown that at least part of the CFC-S 
could be identified on the basis of light scatter characteristics and the 
correlated expression of WGA binding sites and H-2Kk antigens. This 
procedure can be used for the screening of MCAs for reactivity with CFU-S 
without performing a CFU-S assay when MCAs are detected with a different 
fluorochrome. 
Although it is technically possible to excite three different fluoro-
chromes with one laser (Sasaki et al., 1987) the use of a dual laser system 
is recommended because it reduces the dependency on (only) optical filters 
to discriminate the different fluorescence signals. With the dual laser system 
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the different dyes are excited sequentially so that their emission occurs at 
different times and their spectra may overlap without causing any difficulty 
in analysis (Dean and Pinkel, 1978; Loken and Lanier, 1984). 
In this study the second (argon) laser of the RELACS, which allows for 
8 parameter measurements, was used to excite either the red fluorescent dye 
Texas Red (TxR) (Titus et al., 1982), or the blue fluorescent dye 
1-pyrenebutyryl ( PYR) (Molecular Probes). Because most MCAs have been 
inactivated by the conjugation process with TxR (Parks et al., 1983) and no 
procedure was known to conjugate PYR to MCAs, it was decided to use WGA 
conjugates of these dyes which are readily available. TxR was excited by the 
590 nm line emitted from a tunable dye laser circulating rhodamine 6G, which 
in turn was excited by the second laser operating in all lines mode 
(Arndt-Jovin et al., 1980; Lanier and Loken, 1984), TxR fluorescence was 
collected using two RG 630 nm LP filters (Fig. 5.1). PYR was excited by the 
second laser tuned to emit UV light with lines at 351 nm and 364 nm. 
The first laser, tuned at 488 nm, was used for the generation of TOF, 
FLS and PLS signals, for the excitation of PE fluorescence due to bound 
a-H-2Kk-biotin, and for the excitation of GARA-FITC fluorescence due to the 
binding of the MCA to be screened. By digital delaying of the signals from 
the first laser, all 6 parameters of a single cell were read and stored 
simultaneously in a list mode file. Fluorescence signals from both lasers were 
processed using logarithmic amplifiers, TOF and scatter signals were 
processed linearly. FITC fluorescence falling into the detector used to 
measure PE fluorescence was corrected before logarithmic conversion as 
described in a previous section. 
Screening of MCAs for r~activity with CFU-S was done basically in the 
same way as described in a previous section. Now, N BM was used, while 
WGA/TxR or WGA/ PYR was used to select the brightly WGA positive blast 
cells instead of WGA/FITC·. Results of this selection are shown in Fig. 5.3. 
First the blast cells were selected from all nucleated bone marrow cells by 
means of FLS and PLS, after exclusion of erythrocytes and cell clumps 
(TOF) (Fig. 5.3A). Subsequently, the strongly WGA positive blast cells were 
selected and finally the most strongly WGA/a-H-2Kk positive blast cells. In 
Figs. 5.3B and 5.3C the bivariate fluorescence distribution of the selected 
blast cells from Fig. 5. 3A are shown. The fluorescence windows set to select 
the WGA/a-H-2Kk positive cells from all blast cells are indicated. In this 
way, 0.8 to 1.2% of the total amount of nucleated cells were selected. 
In the contour plot of Fig. 5.3B a clear WGA negative, a-H-2Kk posi-
tive subpopulation of blast cells was present, while this population was 
absent in the. contour plot of Fig. 5. 3C. This difference can be caused 
either by a not completely identical blast cell selection (the plots were made 
in two different experiments), or by a less effective concentration and/or 
excitation of one dye or the other. In most experiments WGA/TxR was used 
(Table 5.1). 
Screening of MCAs was done by measuring the FITC fluorescence of the 
selected WGA/a-H-2Kk positive blast cells. In Fig. 5.4, the results of the 
screening for 5 MCAs are presented. Histograms from control samples 
(incubated with GARA/FITC only) were superimposed over histograms from 
MCA stained samples. The characteristics of the MCAs PV5. 6, 10-2.2 and 
10-7.3 were discussed in Chapter 4. In brief, MCA PV 5.6 was shown to be 
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directed ·against a leukocyte common antigen and to be reactive with day-8 
and day-12 CFU-5. MCA 10-2.2 did not react with day-8 or day-12 CFU-S, 
but was mainly reactive against normoblasts and erythroblasts. MCA 10-7.3 
(identical with MCA 10-9.6) was directed against day-8 CFU-S and day-12 
CFU-S and, against mature myelomonocytic cells. In Fig. 5.4 it is shown that 
PV 5.6 was reactive with all WGA/o:-H-2Kk positive blast cells (0.9% of all 
nucleated cells), while in the total bone marrow sample and in the blast cell 
population some unstained cells were present. MCA 10-2.2 did very weakly 
react with the WGA/o:-H-2Kk positive blast cells. in contrast with the total 
blast cells and total bone marrow sample where a clearly distinct subpopu-
lation of erythroid cells was stained. This could indicate that in the selected 
WGA/o:-H-2Kk positive blast cells some erythroid cells were present. How-
ever. since only weakly stained cells were found. the presence of other cell 
types .with a less specific binding of 10-2.2 (e.g .• monocytes) cannot be 
excluded. MCA 10-7.3 reacted with 98% of the selected WGA/o:-H-2Kk positive 
blast cells (1.2% of all nucleated cells). which was expected on ground of the 
data in Chapter 4. In the total bone marrow sample and in the blast cell 
population a larger proportion of the cells were unstained. 
In multicolour analysis each stain must give the same fluorescence 
profile as when the reagent is employed individually (Parks et al .• 
1984; Lanier and Loken, 1984). Comparison of the fluorescence profiles of 
the MCAs in Fig. 5.4 with those in Fig. 4.2, where instead of all nucleated 
cells, all cells are presented, shows that this was the case. The three 
examples show that the procedure described here to screen MCAs for 
reactivity with CFU-S leads to similar conclusions about the reactivity of the 
MCAs as obtained by cell sorting and a CFU-S assay (Chapter 4). Screening 
in the former way can substantially reduce the number· of CFU-S assays and 
is therefore much faster. About 20 MCAs can be screened in one day, which 
by means of the CFU-S assay would be hardly possible due to the time 
needed to sort and transplant the cells. In addition, the outcome of the tests 
is known the same day, whereas this takes 8-12 days when a CFU-S assay 
was performed. 
Figure 5.3: 
A. Bivariate distribution of the FLS versus the PLS intensities of nucleated 
mouse bone marrow cells. This plot was generated from listmode data of 
1 o5 cells. The rectangle indicates the selected blast cell population. 
Contour lines were drawn at 4.7, 9.3, 17.0, 37.0 and 70% of peak 
value. 
B. Bivariate logarithmic distribution of the PE(o:-H-2K k) versus the 
TxR(WGA) fluorescence distribution of the blast cells as indicated in A. 
The rectangle indicates the fluorescence windows to select CFC-5. 
Contour lines were drawn at 11, 22, 36,60 and 75% of peak value. 
C. Bivariate distribution of the PE(o:-H-2Kk) versus the PYR(WGA) 
fluorescence distribution of the blast cells as indicated in A. The 
rectangle indicates the fluorescence windows to select CFC-5. Contour 
lines were drawn at 4.7, 9.3, 17.0, 37.0 and 70% of peak value. Cells 
were stained and analyzed on the RELACS as described in Chapter 2. 
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Figure 5.4: 
PV 5.6 Thy-1 
.... 
10-2.2 GM-1.2 
log FITC fluorescence (a. u.) 
10-7.3 
log FITC fluorescence (a. u.) 
FITC fluorescence distribution due to binding of MCA PV5.6, 10-2.2, 10-7.3, 
a-Thy-1 and a-GM1 .2 to all nucleated cells (thick solid line), blast cells 
(thin solid line) and WGA/a-H-2Kk positive blast cells (dotted lines) from 
normal bone marrow. Cells were stained analysed and selected as described 
in the text and in Chapter 2. The control sample (broken line) was 
incubated without MCA. 
The validity of the in vitro screening assay was also demonstrated with 
two commercially available MCAs: a-Thy-1 and a-GM1 .2 (Fig. 5.4). It !"]as 
long been controversial if the mouse CFU-S do express the Thy-1 antigen 
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(Watt et al., in press). By means of the cell sorter it was shown that CFU-S 
express low levels of Thy-1 antigen (Muller-Sieburg et al., 1986; Williams et 
al., 1985). It has been reported that day-12 CFU-S are weakly Thy-1 
positive, while both Thy-1 positive and negative day-8 CFU-S exist (Berman 
and Bash, 1985; Mulder, 1986). Using three-colour analysis it was shown 
that most of the WGA/a-H-2Kk positive blast cells are weakly stained by the 
a-Thy-1 antibody. It can be seen that the selected putative CFU-S 
population was stained brighter than the unseparated blasts and total bone 
marrow. Since the histograms were generated by listmode the differences in 
peak channel number were true differences in fluorescence intensities and 
not due to staining variation from one sample to another (Pallavicini et al., 
1985b). Miller et a!. (1985b) showed that BFU-E and CFU-GM also express 
the Thy-1 antigen. Although not tested for progenitors, it is likely that the 
selected WGA/a-H-2Kk positive cells also contain CFU-C, because some types 
of CFU-C are copurified with CFU-S (Visser et a!., 1984; Lord and 
Spooncer, 1986). The presence of CFU-C in the selected WGA/a-H-2Kk posi-
tive blast cells could have been responsible for the staining by a-Thy-1. 
Bauman et al. (1986) described a two sorting run procedure to highly 
purify CFU-S, BFU-E and CFU-GM on basis of light scatter characteristics, 
WGA/FJTC staining and selection of the a-GM1.2/FITC negative cells in the 
second sort. MCA GM1.2 is not reactive with CFU-S or CFU-C, but it is 
only reactive with mature myelomonocytic cells (Hibbs et al., 1984) and thus 
could be used for negative selection of CFU-S. In Fig. 5.4 it is shown that 
most WGA/a-H-2Kk positive blast cells are weakly stained with this antibody, 
while a small portion of these ce,JJs are somewhat more intensly stained. This 
indicates that a part of the selected WGA/a-H-2Kk positive blast cells must 
be mature myelomonocytic cells, which is in agreement with data observed by 
others. The main contaminants in the highly purified CFU-S population 
obtained by Lord and Spooncer (1986) were granulocytic cells which have a 
wide density range and variable light scattering ability. Visser et al. (1984) 
also reported the presence of a small population (15% of all sorted cells) of 
more mature cells in their highly purified CFU-S suspensions. In the next 
section, it will be shown that the WGA/a-H-2Kk positive blast cells are 
contaminated with monocytes. 
The data of Bauman et al. (1986) are not necessarily in contradiction 
with the results presented here. Firstly, in FACS screening, the border set 
between negative and positive events is arbitrary chosen. Secondly, the 
simultaneous measurement of the a-GM1.2 fluorescence of the WGA/a-H-2Kk 
positive blast cells is probably more sensitive than the subsequent analysis. 
The latter proposition is supported by the data of Civin and Loken ( 1987), 
Parks et al. ( 1984), Lanier and Loken ( 1984), Herzenberg et al. ( 1987) and 
others. 
SELECTION OF CFU-S BY MEANS OF WGA AND MCA 15-1.1 FLUORESCENCE 
In Fig. 5. 5 the result of the screening of MCA 15-1.1 (Chapter 4) 
against the WGA/a-H-2Kk positive blast cells is shown. It can be seen that 
the intermediately positive population present in the total bone marrow 
sample and in the selected blast cells disappeared by selection of the 
WGA/a-H-2Kk positive blast cells. It was shown in Chapter 4 that this 
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intermediately 15-1.1 positive blast cell population consisted predominantly of 
monocytes and some mature granulocytes. It was also shown (see Chapter 6) 
that the monocytes are lost upon repeated manipulation of cell suspensions if 
no precautions are taken. This could explain why Lord and Spooncer (1986) 
obtained a higher enrichment of CFU-S after a second WGA sort. 
Labelling with MCA 15-1.1 separated the selected WGA/a-H-2Kk positive 
blast cell population into two subpopulations. Since it was shown (Chapter 4) 
that this MCA did not react with CFU-S it is clear that the selected cells 
in addition to CFU-S contain more mature cells, as was also suggested by 
the results of the three-colour screening with MCA GM1. 2. The strongly 
positive population in the WGA/a-H-2Kk positive blast cells predominantly 
consisted of monocytes, but also some erythroid, lymphoid and more mature 
granulocytic cells were present (results not shown). It was expected that 
sorting the 15-1.1 negative, WGA/a-H-2Kk positive blast cells would result in 
a higher enrichment of CFU-S than selection with WGA and a-H-2Kk only. 
The result of 3 experiments in which CFU-S were selected according to 
15-1.1/FITC fluorescence are listed in Table 5.4. In the first experiment it 
was shown that selection of the 15-1.1 negative, WGA/a-H-2Kk positive blast 
cells from unseparated bone marrow, resulted in a considerable enrichment of 
day-12 CFU-S. In this fraction, 8 times more CFU-S were present than in 
the 15-1.1 strongly positive, WGA/a-H-2Kk positive blast cells.- In the 
second experiment, it was demonstrated that selection of the low density 
fraction, 15-1.1 negative, WGA/a-H-2Kk positive blast cells resulted in a 
2-fold enrichment of day-12 CFU-S compared to selection of the 
WGA/a-H-2Kk positive blast cells only as shown in Table 5. 1. Since it was 
shown that the 15-1.1 negative blast cells were a-H-2Kk positive (Fig. 5.6) 
it was investigated if selection by means of 15-1.1 could replace selection by 
means of a-H-2Kk. This would have several advantages. First, since 15-1.1 
was directly conjugated with FITC (Chapter 2) the use of 15-1.1/FITC would 
speed up the labelling procedure. Second, 15-1.1 is not reactive with 
CFU-S, and therefore injection of 15-1.1 selected CFC-S would not lead to a 
reduction in the number of CFU-S, in contrast with a-H-2Kk labelled CFC-S 
(Tables 5.2 and 5.3). Thirdly, the a-H-2Kk MCA used in this study (clone 
11-4.1; Oi et al., 1978) is only reactive against cells of mice with a MHC k 
phenotype (H-2k) or with cells of mice with a partially H-2k phenotype like 
mice of the BC3 strain, used in this study, which have an H-2k/b pheno-
type. In contrast, it was determined that 15-1.1 was not H-2 phenotype 
restricted. MCA 15-1,1 reacted similar, i.e., same percentage of positive 
cells and same staining profile, with bone marrow cells from mice with H-2k, 
H_:2k/b, H-2b, H-2d, H-,2f and H-2q phenotype (data not shown). From this 
it is clear that selection of CFU-S with 15-1 .1 would be more widely 
applicable than with a-H-2Kk. 
It is shown in the second experiment of Table 5.4 that selection with 
15-1.1 and WGA only, resulted in the same enrichment, approximately 
1 00-fold, as selection with 15-1.1, WGA and a-H-2Kk, when low density bone 
marrow cells were used. It should be noted that in the former case the cells 
were also incubated with a-H-2Kk-biotin and Av/PE, but were not selected 
for PE fluorescence. In the third experiment shown in Table 5.4 normal 
unseparated bone marrow cells were incubated with WGA/TxR and 15-1.1/ 
FITC, but not with a-H-2Kk-biotin + Av/PE. Selection of the 15-1.1 
negative, WGA positive blast cells resulted in a 42-fold enrichment for day-8 
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Table 5,4 
SELECTION OF CFU-S WITH MCA 15-1.1 
sorted fraction 
NBM 
% 
nucleated 
cells 
--
100 
WGA+/a-H-2Kk+/15-1.1+ 
WGA+/a-H-2Kk+/15-1.1-
NBM 100 
WGA+/a-H-2Kk+/15-1.1-
WGA+/15-1.1- 0.17 
NBM 100 
WGA + /15-1 • 1- 0.38 
WGA+/15-1.1+ 13.8 
CFU-S/1 o5 nucleated cells 
day-8 day-12 
-- --
n.d. 24.8±2.9 
0,65 n.d. 
0,40 n.d. 
n.d. 24.2±3.0 
0,13 n.d. 
n.d. 2300 ±339 
18.3±2.3 18.2±2.1 
760 ±269 1583 ±363 
9.3±5.4 10.9±6.5 
enrichment (% recovery) 
CFU-S 
day-8 day-12 
-- -
1 ( 1 00) 
175 ± 66 7 (4.6) 
1450 ± 66 58 (23.4) 
1 (1 00) 
2450 ±350 101 (13.2) 
95 ( 16. 2) 
1 (1 00) 1 (1 00) 
42 (16) 87 (33. 1) 
0.5 (6,6) 0.6 (7.8) 
In experiment 1 and 2, NBM cells and the low density cell fraction respectively, were labelled with 
WGA/TxR, a-H-2Kk-biotin + Av/PE, and 15-1.1/FITC. In experiment 3, NBM cells were labelled with 
WGA/TxR and 15-1.1/FITC only. The cells were analyzed and sorted on the RELACS as described in the text. 
For the spleen colony forming assay, irradiated mice (6-10 per group) were injected with 3 x 104 NBM cells, 
and 150 sorted cells, respectively, except for mice receiving WGA + /15-1. 1 + cells (experiment 3). These were 
injected with 450 cells. Colonies were counted 8 and 12 days post transplantation. 
n.d.: not done • 
CFU-S and an 87-fold enrichment of day-1 2 CFU-S. Selection of the 15-1.1 
strongly positive, WGA positive blast cells shows that these cells contain 
fewer day-8 and day-1 2 CFU-S than unseparated bone marrow. 
DISCUSSION 
The regulation of haemopoiesis is dependent on complex interactions 
among haemopoietic cells, growth factors and stromal elements (Metcalf, 1984; 
McCulloch, 1983; Dexter, 1 982). Cell surface molecules on haemopoietic cells 
must form an integral part of this system, and must be involved in the 
mechanisms controlling self-renewal and commitment of stem cells (Watt et 
al., in press). Knowledge of the cell surface make-up of CFU-S could there-
fore attribute to a better understanding of the complex processes taking 
place during the· initial stages of haemopoiesis. 
The very low incidence of CFU-S in the extremely heterogeneous bone 
marrow population has prevented direct analysis of their cell surface 
characteristics (Van Bekkum, 1977; Van Bekkum et al., 1979; Visser and 
Sol, 1981; Lord and Spooncer, 1986; Watt et al., in press). Nevertheless, 
many antigens have been found to be present on CFU-S. The presence of 
these antigens could only be determined indirectly by sorting labelled cell 
fractions with different fluorescence intensities on a cell sorter. or by 
treatment of bone marrow samples with antibody, with or without complement, 
followed by a C FU-S assay (Chapter 4). 
It is known, from subsequent separation and analysis procedures, that 
CFU-S are characterized by a low density, a medium forward and a low 
perpendicular light scatter intensity and high densities of WGA binding sites 
and H-2Kk antigens on their surfaces (Visser et al., 1984). With the use of 
multicolour and multiparameter flow cytometry and listmode data processing it 
is possible to determine these characteristics (except density) simultaneously 
(Figs. 5.2 and 5.3). This procedure allowed for the rapid identification of 
CFC-S in vitro, without the necessity of performing a CFU-S assay. In this 
study, parallel CFU-S assays were necessary to show that the selected cells 
were indeed CFC-S. It is evident from the results in Tables 5.1, 5. 2 and 
5. 4 that the selected cell population indeed contained CFU-S. 
The lower enrichment and recovery of CFU-S obtained in the one sort 
procedure in comparison with the enrichment and recovery obtained by 
Visser et al. (1984) in the two sequential sort procedure, appeared to be 
mainly due to the used avidin conjugate to detect bound a-H-2Kk-biotin 
(Table 5.2). It was shown (Table 5.3) that Av/FITC and particularly Av/PE 
hardly protected CFU-S against opsonization, as was suggested by others 
(Van den Engh et al., 1983; Bauman et al., 1985). The use of higher 
concentrations of Av/PE and Av/FITC, or the addition of extra avidin to 
cover up the biotin moieties on the a-H-2Kk molecules, after the cells were 
sorted, or the use of Av/TxR would probably have resulted in higher 
enrichments and recoveries of CFU-S with the one sort procedure. 
The lower enrichment of CFU-S does not detract from the fact that by 
the addition of an extra fluorescence parameter, the CFC-S identification 
procedure allows for the direct analysis of the presence of certain antigens 
on, at least a part of, the CFC-S. From the results shown in Fig. 5. 4 it can 
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be concluded that the multicolour and multiparameter flow cytometric 
screening of the five MCAs for reactivity with CFU-S leads to similar results 
as obtained in Chapter 4 and those obtained by others who employed sorting 
of a-Thy-1 labelled (Berman and Basch. 1985; Mulder. 1986; Muller-Sieburg 
et al. • 1986) and a-GM 1 • 2 labelled cell fractions (Bauman et al. • 1986). 
Thus. this new screening procedure can substantially reduce the number of 
CFU-S assays and can be a powerful means for the rapid screening of MCAs. 
It is estimated that with the multicolour screening procedure the reactivity of 
about 20 MCAs with CFU-S can accurately be determined in one day. This 
way of screening can prevent the culture of many hybridomas of which only 
a few appear to be interesting by the time the results of the CFU-S assay 
are known. 
Screening of MCA 15-1.1 with the multicolour and multiparameter 
procedure learned that the selected CFC-S population did not entirely consist 
of CFU-S, as was already evident from the obtained enrichments (Table 5.1) 
and the screening of a:-GM1.2 (Fig. 5.4). MCA 15-1.1 separated the selected 
CFC-S population into two subpopulations (Fig. 5. 5). CFU-S are mainly 
present in the 15-1.1 negative subpopulation, while the 15-1.1 strongly 
positive subpopulation mainly consisted of monocytes and mature granulo-
cytes, which is in agreement with the result of the screening and the known 
reactivity of a-GM1.2 (Table 5.4; Fig. 5.4; Hibbs et al •• 1984). 
Figure 5.5: 
.... 
0 
... 
" .0 E 
" 
" 
r. 
I 
I 
I 
I 
I 
I 
I 
i 
I 
,_,/ 
log FITC (15-1.1) fluorescence (a.u.) 
FITC fluorescence distribution due to binding of MCA 15-1.1 to all nucleated 
bone marrow cells (thick solid line). blast cells (thin solid line) and 
WGA/a-H-2Kk positive blast cells (dotted line). Cells were stained, analysed 
and selected as de.scribed in the text and in Chapter 2. The control sample 
(broken line) was incubated without MCA. 
Based on listmode data analysis (Fig. 5. 6) a two-colour immunofluores-
cence procedure was developed to rapidly identify and purify CFC-S on the 
basis of 15-1.1 fluorescence and WGA fluorescence. This procedure has the 
advantage over selection by means of a-H-2Kk that it is faster due to fewer 
labelling steps. it excludes any influence of remaining labels on the sorted 
CFC-S. which might influence the homing and recovery of CFU-S, and that 
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it is widely applicable, because it is not restricted to cells of mice with 
specific H-2 haplotypes. 
Figure 5.6: 
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Bivariate presentation of the FITC ( 15-1.1) fluorescence versus the 
PE(a-H-2KKJ fluorescence distribution of normal bone marrow blast cells. 
Cells were selected as described in the text. Contour lines were drawn at 
6.5, 13.0, 19.0, 29.0 and 58% peak value. 
Selection of CFU-S using two lasers to excite 15-1.1/ FITC fluorescence 
and WGA/TxR fluorescence allows for the addition of other probes detected 
with other dyes, like for instance allophycocyanin coupled to another MCA 
and propidium iodide to exclude dead cells (Fig. 5.1; Chen et al.. 1987; 
Parks et al., 1983; Muller-Sieburg et al., 1986). It was shown by others 
that certain CFU-C types copurify with CFU-S (Bauman et al •• 1986; Bauman 
and Chen, 1987; Visser et al., 1984; Lord and Spooncer, 1986; Pallavicini et 
al., 1985a; 1987). This was also suggested by the reported reactivity of 
a-Thy-1 with CFU-GM and BFU-E (Miller et al., 1985) and the observed 
reactivity of a-Thy-1 with the selected WGA/a-H-2Kk positive blast cells 
(Fig. 5. 4). Although it was not tested in the present study. it should be 
possible, when the right probes are used, to very accurately discriminate 
between subsets of CFC-C and CFC-S and to isolate these cell types by 
means of multicolour immunofluorescence and multiparameter flow cytometry. 
Highly purified CFC-S and subsets of CFC-C could be used to study 
the effects of purified growth factors on these cells (Hoang et al.. 1983; 
Strife et al., 1987). On the other hand, multicolour immunofluorescence 
multiparameter flow cytometry could be used to examine the effect of growth 
factors on the cell surface antigen densities and types of CFC-S without 
doing a CFU-S assay. 
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CHAPTER 6 
HETEROGENEITY OF MURINE HAEMOPOIETIC STEM CELLS 
DETECTED BY RHODAMINE-123 LABELLING 
INTRODUCTION 
Since its description, the spleen colony forming assay (CFU-S assay; 
Till and McCulloch, 1961) has long been regarded as a means to identify and 
enumerate murine pluripotent haemopoietic stem cells (PHSC). However, data 
have accumulated indicating that the spleen colony forming cells (CFC-S) are 
a heterogeneous population of haemopoietic stem cells, the properties of 
which depend on the time the spleen colonies are counted (Magli et al., 
1982). Spleen colonies counted at 8 days after transplantation are formed by 
other cells ( day-8 CFU-S) than those observed at 12 days after transplanta-
tion (formed by day-12 CFU-S) (Magli et al., 1982; Wolf and Priestley, 
1986). 
Day-8 and day-12 CFU-S have been shown to differ in a number of 
properties, such as their capacity to generate secondary CFU-S upon 
transplantation (self-renewal) (Worton et al., 1969b; Siminovitch et al., 
1963; Hellman et al., 1978; Ross et al., 1982; Micklem and Odgen, 1976; 
Botnick et al., 1979; Micklem et al., 1975; Micklem, 1983; Hodgson and 
Bradley, 1979; Rosendaal et al., 1979), and their capacity to differentiate 
into the various haemopoietic lineages (Hodgson and Bradley, 1979; 
Schofield, 1978; Dexter et al., 1979; Jones et al., 1980; Mulder et al., 
1985). Differences between day-8 and day-12 CFU-S regarding their 
proliferative status (Micklem et al., 1975; Visser et al., 1981; 1984; Baines 
and Visser, 1983; Hodgson and Bradley, 1984), their cell surface character-
istics (Harris et al., 1984a; 1984b; 1985; Visser et al., 1984; Mulder, 1986; 
Ploemacher and Brons, 1988a) and their sensitivity to a variety of cytostatic 
drugs (Schofield and Lajtha, 1973; Rosendaal et al., 1979; Hodgson and 
Bradley, 1979; Hodgson et al.; 1982; VanZant, 1984) have also been 
reported. It is now generally held that day-12 CFU-S have a lower prolif-
erative index and, a higher self- replicative capacity than day-8 CFU-S and 
therefore are more primitive cells (Hodgson and Bradley, 1979; Rosendaal et 
al., 1979; Siminovitch et al., 1963; Micklem, 1983; Johnson and Nicola, 1984; 
Metcalf, 1984). 
Several different procedures have been described to purify murine 
haemopoietic stem cells, employing density gradient centrifugation, counter 
flow centrifugal elutriation, labelling with (fluorescent) lectins, antibodies or 
intracellular dyes and subsequent separation using light-activated cell 
sorters, complement lysis or immunoadherence ('panning) (Nicola et al., 1981; 
Visser and Bol, 1981; Hoang et al., 1983; Johnson and Nicola, 1984; Visser 
et al., 1984; Muller-Sieburg et al., 1986; Bauman et al., 1986; Lord and 
Spooncer, 1986; Pallavicini et al., 1985a; 1984b; Baines et al., 1984; 
Ploemacher et al., 1987; Ploemacher and Brons, 1988a). The various separa-
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tion procedures have also contributed to the notion that day-8 CFU-S and 
day-12 CFU-S are different cells. 
Recent observations have indicated that day-12 CFU-S are a hetero-
geneous population (Bertoncello et al., 1985; Mulder et al., 1985; Mulder, 
1986; Mulder and Visser, 1987; Visser and De Vries, in press; Ploemacher 
and Brons, 1988b). On the basis of the uptake of the supravital, fluorescent 
dye rhodamine 123 (Rh123) two subpopulations of day-12 CFU-S could be 
distinguished (Bertoncello et al., 1985; Mulder and Visser, 1987). Day-12 
CFU-S present in the dull Rh123 fluorescent fraction had a significantly 
higher marrow repopulating ability (MRA) than day-12 CFU-S in the Rh123 
bright fraction (Bertoncello et al., 1985) and were also significantly more 
effective for 30-day radioprotection (Mulder and Visser, 1987). Day-8 CFU-S 
were almost exclusively recovered from the Rh123 bright fraction. In addi-
tion, Mulder (1986) reported that day-12 CFU-S from a four day suspension 
culture in the presence of I L-3 had a reduced radioprotective ability and a 
reduced capacity to repopulate the thymus in comparison with day-12 CFU-S 
in uncultured bone marrow, which also indicated that day-12 CFU-S were 
heterogeneous. The newly discovered heterogeneity of day-12 CFU-S made it 
of interest to study what type(s) of day-12 CFU-S are isolated by several 
procedures to highly purify haemopoietic stem cells, since the endpoint of 
these procedures had been spleen colony formation at day-12. 
In this chapter the Rh123 fluorescence of highly purified CFU-S sus-
pensions has been investigated. The CFU-S were purified employing fluores-
cence activated cell sorting and WGA and a-H-2Kk fluorescence (Visser et 
al., 1984) (see also Chapter 5), two sequential sorts based on WGA fluores-
cence (Lord and Spooncer, 1986) and on basis of WGA and 15-1 . 1 fluores-
cence as described in Chapter 5. Fractions differing in Rh123 fluorescence, 
which were purified by the latter two procedures were assayed for their 
content of in vitro clonogenic progenitors and for their capacity to generate 
colonies when stimulated with a variety of haemopoietic growth factors. 
RHODAMINE-123 FLUORESCENCE DISTRIBUTION OF HIGHLY PURIFIED 
CFU-S SUSPENSIONS 
Rhodamine-123 ( Rh123) is a cationic lipophilic fluorescent dye that accu-
mulates specifically in the mitochondria of living cells (Johnson et al., 1980; 
James and Bohman, 1981). The Rh123 fluorescence intensity is not only 
determined by the mitochondrial content of a cell, but also by its metabolic 
state and the progression through the cell cycle (Chen et al., 1982; Darzyn-
kiewicz et al., 1981; 1982). It has been shown that the Rh123 uptake and 
the state of the cell cycle are correlated: actively cycling cells fluoresce 
more intensely than quiescent cells (Cohen et al., 1981; Darzynkiewicz et 
al., 1981). 
Recently,cBertoncello et al. (1985) using low density bone marrow cells, 
and Mulder and Visser ( 1987) using unseparated bone marrow, described 
that day-12 CFU-S are heterogeneous with respect to the uptake of Rh123 
and their marrow repopulating ability (MRA) and radioprotective ability 
(RPA). These observations lead us to investigate if highly purified day-12 
CFU-S are also heterogeneous. 
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Figure 6.1: 
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Schematic representation of the various separation steps in the three 
purification procedures for CFU-S used in the present study (for details, 
see Chapter 2 and text). 
15-1.1-f+; 15-1.1 negative and moderately positive cells. 
Rh12rl+; Rh123 dull (-) or bright (+) fraction. 
In the present study, CFU-S were purified in three different ways. 
The different steps in each procedure are schematically shown in Fig. 6.1. 
The initial separation steps in the three procedures were the same and were 
based on the purification procedure described by Visser and Bol ( 1981). 
They obtained an 80-fold enrichment of day-8 and day-1 0 CFU-S by sorting 
low density bone marrow cells on basis of WGA/FITC fluorescence, within a 
predefined light scatter blast cell window (Chapters 4 and 5). CFU-S were 
further purified by means of: 1) a second WGA/FITC sort using the same 
electronic windows as during the first sort (WGA+/WGA+; I, Fig. 6.1) (Lord 
and Spooncer, 1986); 2) a second sort on basis of MCA 15-1.1 fluorescence 
(Chapter 5) (WGA+/15-1.1-/+; II, Fig. 6.1); 3) a second sort on basis of 
o.-H-2Kk fluorescence as described by Visser et al. (1984) (see also previous 
chapters) (WGA+/o.-H-2Kk+; Ill, Fig. 6.1). In the latter two procedures 
bound WGA/FITC conjugates were removed from the cells before they were 
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labelled with MCA (chapter 2). As the last step in each of these three 
procedures, the different purified CFU-S suspensions were labelled with 
Rh123, and their Rh123 fluorescence distribution was analyzed on a FACS-11. 
Results of the Rh123 staining are shown in Figure 6. 2. The low density blast 
cell fraction showed a homogeneous Rh123 fluorescence distribution (Fig. 
6.2.A), except for a small negative population (5% of all cells in the blast 
cell window), which was not further investigated in the present study. A 
similar distribution was observed by Mulder and Visser (1987) using 
unseparated bone marrow, except that the small negative population was 
absent. In the WGA/FITC positive cell fraction three subpopulations could be 
distinguished (Fig. 6.2.8). No Rh123 negative cells were present, but a 
Rh123 dull, an intermediate and a bright subpopulation could be distin-
guished. In the WGA + /WGA + cell fraction (I, Fig. 6.1), the intermediate 
Rh123 subpopulation had disappeared and only a Rh123 dull and Rh123 
bright subpopulation were left (Figure 6.2. C). In this suspension most of 
the sorted cells belong to the Rh123 bright subpopulation. If after the first 
WGA/ FITC sort the suspension was further purified on the basis of MCA 
15-1.1 fluorescence (II, Fig. 6. 1) and subsequently analyzed for Rh123 
fluorescence, two subpopulations of equal size were observed (Fig. 6. 2. D). 
In the WGA+/a-H-2Kk+ suspension (Ill, Fig. 6.1) also two Rh123 subpopula-
tions were observed. In this suspension, the Rh123 dull fraction was larger 
than the Rh123 bright fraction (Fig. 6.2.E). From the Rh123 fluorescence 
histograms shown in Figure 6.2, it is clear that as a result of the sorting 
procedures a much better distinction could be made between Rh123 dull and 
bright cells than was possible without extra purification. 
It was shown by Mulder and Visser (1987) that, in contrast with day-12 
CFU-S, day-8 CFU-S were homogeneous with respect to Rh123 staining and 
were observed in the bright fraction only. To investigate if the hetero-
geneity in Rh123 fluorescence intensity of day-12 CFU-,S was also observed 
in purified day-12 CFU-S suspensions, the different Rh123 fractions were 
sorted and assayed for their CFU-S content (Table 6.1}. It can be seen that 
day-12 CFU-S purified with all three procedures were heterogeneous with 
respect to their Rh123 uptake. After two sequential WGA/FITC sorts almost 
equal numbers of day-12 CFU-S could be recovered from the Rh123 dull and 
bright fraction, whereas after selection by means of MCA 15-1.1 or a-H-2Kk 
Figure 6.2: 
Rh123 fluorescence distribution of bone marrow cell fractions. 
a. Low density bone marrow fraction. 
b. WGA positive low density blast cells, selected as described by Visser 
and Bol (1981). 
c. Double WGA sorted low density blast cells (WGA+/WGA+) (Lord .and 
Spooncer, 1986). 
d. Low density blast cells sorted on basis of WGA and 15-1.1 fluorescence 
(WGA+/15-1.1-) (Chapter 5). 
e. Low density blast cells sorted on basis of WGA and a-H-2Kk fluores-
cence (WGA+/a-H-2Kk+) (Visser et al., 1984). 
Cells were labelled, analyzed and sorted on a FACS-11 as described in 
Chapter 2. 
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fluorescence, the enrichment of Rh123 bright day-12 CFU-S was almost 
two-fold that of Rh123 dull day-12 CFU-S. 
Table 6.1 
ENRICHMENT OF CFU-5 AFTER Rh123 STAINING 
suspension sorted 
unfractionated bone marrow 
WGA+IWGA+IRh12r 
WGA+IWGA+ 1Rh123+ 
WGA+I15-1.1-1+1Rh12r 
WGA+I15-1.1-1+1Rh123+ 
WGA + la.-H-2Kk+ I Rh12r 
WGA +I a.-H-2K k+ I Rh123+ 
enrichment factor 
day-8 CFU-S day-12 CFU-S 
8 ( 0- 13) 130 39-208) 
158 (108-220) 123 86-179) 
9 ( 8- 10) 139 ( 96-231) 
159 ( 1 06-217) 245 (235-269) 
12 7- 18) 87 
88 64-117) 143 
Low density bone marrow cells were labelled, analyzed and . sorted as 
described in the text and Chapter 2 (see also Fig. 6.1). The figures 
represent the mean enrichment factor and range of enrichment factors 
(within parenthesis) of 6 (WGA+IWGA+), 3 (WGA+/15-1.1-I+) and 2 (day-8 
CFU-5) respectively 1 (day-12 CFU-5) (WGA+Ia.-H-2Kk+) experiments. The 
enrichment factors were calculated with regard to the number of CFU-S per 
105 unfractionated bone marrow cells, which were 28.3 ± 4.9 and 30.6 ± 5.3 
for day 8 and day 12 CFU-5, respectively in BCBA mice (WGA+IWGA+ and 
WGA+/15-1.1-I+) and 27.3 ± 4.1 and 29.8 ± 5.0 for day 8 and day 12 
CFU-5, respectively in C3H mice (WGA + la.-H-2K k+). For each determination 
groups of 7-10 lethally irradiated mice were used. 
In addition, and in agreement with the results obtained with 
unseparated bone marrow (Mulder and Visser, 1987) in all three purified 
CFU-S suspensions, day-8 CFU-5 were also highly purified but these are 
predominantly recovered from the Rh123 bright fractions. This is most 
clearly visible after two sequential WGAIFITC sorts (WGA+IWGA+) and after 
the selection of the WGA+/15-1.1- cells and is less pronounced after an 
a.-H-2Kk sort (WGA+ la.-H-2Kk+). The enrichment of day-8 CFU-S in the 
Rh123 bright fractions were respectively 20, 18 and 7 times higher than in 
the Rh123 dull fractions. 
Bertoncello et al. (1985) using low density bone marrow cells have 
studied the distribution of marrow repopulating ability (MRA) and day-13 
118 
CFU-S over the dull and bright Rh123 fractions. They showed that 92% of 
the total MRA content and 38% of the day-13 CFU-S were recovered from the 
Rh123 dull fraction, while the brightly stained fraction contained 62% of the 
day-13 CFU-S, but only 8% of the total MRA content. It can be calculated 
from the observed enrichment factors of day-12 CFU-S in the Rh123 dull 
fractions after selection by means of MCA 15-1.1 or a:-H-2Kk (Table 6.1) 
that the percentage of dull day-12 CFU-S in these suspensions are in 
agreement with those observed by Berton cello et al. ( 1985), while the 
percentage of Rh123 dull day-12 CFU-S after a double WGAIFITC sort was 
somewhat higher. 
In the present study the radioprotective ability ( RPA), measured as the 
number of cells needed to rescue 50% of lethally irradiated animals from death 
30 days after transplantation (30-day survival), of the Rh123 dull and bright 
cells present in the CFU-S suspension obtained after a double WGAIFITC 
sort was determined (Table 6. 2). Although the number of day-12 CFU-S 
needed for 50% survival in the two experiments was different, it is obvious 
that in agreement with data from unseparated bone marrow described by 
Mulder and Visser (1987), Rh123 dull day-12 CFU-S were more effective in 
radioprotection than Rh123 bright day-12 CFU-S. Thus, in combination with 
the previously described purification procedures, Rh123 staining allows for 
the purification of a subpopulafion of day-12 CFU-S which resembles the 
genuine pluripotent haemopoietic stem cell in MRA and RPA. It also indicates 
that the content of day-12 CFU-S is not the most reliable indicator of 
pluripotent haemopoietic stem cells. 
Table 6.2 
RADIOPROTECTION BY SORTED STEM CELLS 
number of cells number of day-12 
needed for 50% CFU-S needed for 
survival 50% survival 
experiment 1 
X 104 - 105 unfractionated bone marrow 5 10-21 
WGA + IWGA +I Rh123- 500-1000 7-14 
WGA + IWGA +I Rh123+ > 1200 > 32 
experiment 2 
2.5 X 104 unfractionated bone marrow 7.4 
WGA+IWGA+IRh12r 250 4 
WGA + IWGA + 1Rh123+ < 250-750 < 9-27 
Low density blast cells from BCBA mice were sorted on basis of two sub-
sequential WGA sorts followed by Rh123 staining and sorting as described in 
the text (see also Fig. 6.1). Sorted Rh12r (dull) and Rh123+ (bright) 
fractions were transplanted into groups of ten lethally irradiated recipient 
mice and the percentage of mice surviving after transplantation of serial 
dilutions of cells was determined after 30 days. Results of two independent 
experiments are shown. 
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SELECTION BY MEANS OF MCA 15-1.1 IS USEFUL FOR OBTAINING HIGHLY 
PURIFIED POPULATIONS OF Rh123 DULL FLUORESCENT DAY-12 CFU-S 
As was already suggested in Chapter 5. and is now further described 
in Table 6.3, selection of the WGA+/15-1.1- low density blast cells resulted 
in a high purification of CFU-S. Selection of the WGA+/15-1.1+ (moderately 
positive) low density blast cells resulted in a relatively small enrichment of 
day-12 CFU-S, while no day-8 CFU-S were gained from this fraction. No or 
very few (day-B) CFU-S were obtained from the WGA+/15-1.1++ (strongly 
positive) low density blast cell subpopulation (Table 6.3). In Table 6.3 it is 
shown that purification of CFU-S using MCA 15-1.1 results in an almost 
equal enrichment of day-8 and day-12 CFU-S. Employing a-H-2Kk fluores-
cence. Visser and colleagues (1984) obtained an 135-fold and a 53-fold 
enrichment for day-12 and day-8 CFU-S, respectively. Although, the enrich-
ment for day-12 CFU-S was similar with both procedures. the enrichment of 
day-8 CFU-S using MCA 15-1.1 was 2 to 3 times higher. Using two sequen-
tial WGA/FITC sorts to select CFU-S, Lord and Spooncer (1986) obtained a 
25% higher enrichment of day-12 CFU-S than of day-8 CFU-S. In this 
respect. selection of CFU-S on the basis of 15-1.1/FITC fluorescence 
resembles the double WGA selection procedure more than the selection 
procedure employing a-H-2Kk fluorescence. The similarity between the former 
two selection procedures was also demonstrated in Table 6.1 , except for the 
enrichment of day-12 CFU-S in the Rh123 bright fractions. 
Table 6.3 
SELECTION OF CFU-S BY MEANS OF MCA 15-1.1 
suspension sorted 
unseparated bone marrow 
WGA+/15-1.1-
WGA+/15-1.1+ 
WGA+/15-1.1++ 
enrichment factor 
day-8 CFU-S day-12 CFU-S 
1 
130 (91-172) 
0 
2 ( 0- 3) 
140 (88-225) 
16 ( 0- 29) 
0 
BCBA low density bone marrow cells were labelled with WGA/ FITC and 
sorted on a FACS-11 as described in Chapter 2. After removal of the 
WGA conjugates the sorted cells were labelled with 15-1.1/FITC and 
sorted again. Three subpopulations were sorted: 15-1.1- (negative), 
15-1.1+ (moderately positive) and 15-1.1++ (strongly J'ositive) (see Fig. 
6.3). Groups of 8 mice were injected with 2.5 x 10 unseparated bone 
marrow cells and 100-200 cells of the sorted fractions. The figures 
represent the mean enrichment factor of 2 experiments (day-8 CFU-S) 
and 3 experiments (day-12 CFU-S). respectively. The figures in 
parenthesis represent the range of enrichments. The enrichment was 
calculated with regard to the number of CFU-S/1 o5 unfractionated bone 
marrow cells which was 28.3 ± 4.9 and 30.6 ± 5.3 for day 8 and day 12 
CFU-S, respectively. 
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When the enrichment factors were compared before and after staining 
with Rh123 of the sorted WGA+/(15-1.1- + 15-1.1+) cells (Tables 6.3 and 
6.1), it is observed that selection of the Rh123 dull fraction did not lead to 
a further enrichment of day-12 CFU-S. In contrast it lead to a considerable 
(14-fold) depletion of day-8 CFU-S, resulting in a population almost com-
pletely devoid of day-8 CFU-S. On the other hand, selection of the Rh123 
bright WGA+/(15-1.1- + 15-1.1+) subpopulation resulted in an almost two-fold 
extra enrichment of day-12 CFU-S, while day-8 CFU-S were only slightly 
higher enriched in comparison with the results obtained without the Rh123 
staining. The separation of the day-12 CFU-S populations illustrates the 
usefulness of Rh123 based sorting for the purification of very primitive 
day-12 CFU-S. 
Selection by means of 15-1.1/ FITC fluorescence in a second sort will 
result ·in a better defined and more r:eproducible selection of CFU-S than 
selection by means of a second WGA/FITC sort. It is shown in Fig. 6.3A and 
B that as a result of the density gradient centrifugation and subsequent 
sorting of the WGA/FITC positive blast cells, the number of 15-1.1++ cells 
was markedly increased, while both the 15-1.1- and 15-1.1+ blast cell 
sub populations were decreased in size when compared to 15-1.1 stained 
unseparated blast cells. This phenomenon was only observed when the 
(glass) tubes used for collection of the WGA/FITC positive blast cells were 
pretreated. This pretreatment consisted of the addition of a sterile salt 
solution containing 10-15% fetal calf serum to the tubes one hour before use. 
The filled tubes were kept at room temperature. Immediately before use most 
of the serum containing salt solution was removed leaving about 0.5 ml 
behind. When the tubes were not pretreated, both the 15-1.1++ and 15-1.1+ 
subpopulations were significantly reduced in size, while in comparison with 
pretreated tubes, the 15-1.1- subpopulation was increased in size (Fig. 
6.3C). The loss of 15-1.1+ and 15-1.1++ cells must have been caused by 
adherence of a great part of the cells present in these subpopulations to the 
wall of the untreated tubes. Morphological analysis of the different 15-1.1 
sub populations that can be distinguished after a WGA/ FITC sort revealed 
that the 15-1.1 negative population consisted predominantly of immature 
myeloid cells. Forty percent of the cells were myeloblasts and 20% 
promyelocytes. In contrast, the 15-1.1+ and 15-1.1++ subpopulatlons 
consisted primarily of monocytes and mature granulocytic cells (data not 
shown, see also chapter 4). It is known that monocytes (and macrophages), 
but also banded and segmented granulocytes (Pioemacher and Brons, 1988a) 
are adherent cells, which bind WGA conjugates. Therefore it was not 
surprising that many of these cells were lost when no precautions were 
taken. The fact that the 15-1.1+ and 15-1.1++ subpopulations hardly 
contained any CFU-S in comparison with the 15-1.1- subpopulation (Table 
6.3) and that cells present in the former two subpopulations are selectively 
lost when the tubes used to collect the WGA/FITC positive blast cells were 
not pretreated, might be an explanation for the higher enrichment of CFU-S 
after a second WGA/FITC sort using the same sort criteria (Lord and 
Spooncer, 1986). Since it cannot be predicted what percentage of the 
adherent WGA positive low density blast cells will be lost during the 
washing, incubation and sorting steps it is obvious that selection on 
basis of 15-1.1/ FITC fluorescence will result in a more defined and repro-
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ducible selection of CFU-S, since this MCA is specifically directed against 
these adherent, mature cells. 
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Figure 6.3: 
Frequency distributions of the fluorescence intensities of fractionated mouse 
bone marrow cells labelled with 15-1.1/FITC. 
a. Blast cell population in unseparated bone marrow. 
b. Blast cell population after a density cut and selection of the brightly 
WGA fluorescent cells. The collection tubes were pretreated with a salt 
solution containing serum as described in the text. 
c. Same population as in B) except for the fact that in this case the 
collection tubes were not pretreated. 
Cells were labelled, analyzed and sorted as described in Chapter 2. 
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Figure 6.4: 
Frequency distributions of the Rh123 fluorescence intensities of fractionated 
mouse bone marrow cells. 
a. Low density WGA positive blast cells. 
b. WGA+/15-1.1- low density blast cells. 
c. WGA+/15-1.1+ low density blast cells. 
Cells were labelled, analyzed and sorted as described in Chapter 2. 
Selection of CFU-5 on basis of 15-1.1 fluorescence is needed to obtain 
pure populations of Rh123 dull day-12 CFU-5. In Figure 6.4A the Rh123 
distribution of the low density WGA/FITC positive blast cells is shown. The 
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three subpopulations observed are not always present. It was noticed in this 
study that sometimes no dull and intermediate peaks were discernable. This 
could be due to the quality of the separation in the density gradient, the 
staining intensity and the variation in the bone marrow constitution from one 
experiment to another (see also chapter 4). However, when the WGA/FITC 
low density blast cells are sorted on basis of 15-1. 1/ FITC fluorescence, 
selecting the 15-1.1- or 15-1.1- plus 15-1.1+ subpopulation(s), a Rh123 dull 
and bright fraction were always observed. In Fig. 6.4B this is shown for 
the 15-1.1- subpopulation. When the 15-1.1+ subpopulation was stained with 
Rh123 and subsequently analyzed, only one Rh123 dull fraction was observed 
(Fig. 6. 4C). Although it was shown in Table 6. 3 that this fraction contained 
about 10% of the day-12 CFU-S (which might have caused the Rh123 dull 
peak), it is more likely, that this Rh123 dull subpopulation consisted 
predominantly of monocytes. This means that when CFU-S are purified by 
means of two subsequent WGA/FITC sorts or a WGA/FITC sort followed by 
an a-H-2K k sort and the sorted cells are subsequently stained with Rh123 
and sorted again, it is most likely that an unpredictable amount of monocytes 
will be sorted in the Rh123 negative fraction, especially when pretreated 
tubes are used. Employing 15-1.1/FITC fluorescence, selecting WGA+/15-1.1-
blast cells only, will avoid the isolation of monocytes and therefore will 
result in purer populations of Rh123 dull day-12 CFU-S. 
IN VITRO COLONY FORMATION OF THE Rh123 DULL AND BRIGHT SUB-
POPULATIONS PRESENT IN THE WGA+/15-1.1- BONE MARROW SUSPENSION 
The development in the mid 1960's of a series of techniques for the 
clonal culture of haemopoietic cells in semisolid culture medium (Piuznik and 
Sachs, 1965; Bradley and Metcalf, 1966) has greatly attributed to the 
present understanding of haemopoietic development. Using these techniques, 
the formation of discrete colonies consisting of neutrophilic granulocytes or 
macrophages or both was observed. It was determined that each colony was 
derived from a single progenitor cell designated as CFU-C (colony forming 
unit-culture) (Wu et al., 1968). The presence of colonies consisting only of 
granulocytes or macrophages implied the existence of unipotent or lineage 
restricted progenitor cells (CFU-G and CFU-M, respectively), whereas the 
presence of both cell types within one colony implied the existence of 
bipotent progenitor cells (CFU-GM). Modifications of these original 
techniques now permit the clonal proliferation of progenitors of almost all 
haemopoietic differentiation lineages (Metcalf, 1985b) and have led to the 
identification of multipotent, oligopotent, tripotent and other bipotent 
progenitor cells, which differ in their capacities for self-renewal and lineage 
specific differentiation (Johnson and Metcalf, 1977; Nakahata and Ogawa, 
1982a; 1982b; Fausner and Messner, 1979; Keller and Phillips, 1982; Dexter 
et al., 1984a; .McCulloch, 1983; Metcalf, 1984; 1985b; 1986a; Spivak et al., 
1985; Whetton and Dexter, 1986; Suda et al., 1983; 1984; Ogawa et al., 
1985). 
It has become apparent from the in vitro clonal culture techniques that 
the survival, proliferation and differentiation of progenitor cells is strictly 
dependent on and under the absolute control of a family of glycoprotein 
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haemopoietic growth factors called colony stimulating factors (CSFs) (Nicola, 
1987a; 1987b; Stanley et al., 1986; Metcalf, 1985a; 1985b; 1986a; Nicolas and 
Vardas, 1984; Walker and Burgess, 1985; Whetton and Dexter, 1986). These 
CSFs are necessary at each level of commitment and need to be present to 
stimulate cell divisions •. They influence the duration of the cell cycle of 
responding cells and the ultimate number of progeny produced (Nicola, 
1987a; Metcalf, 1985a; 1985c). Analysis of the cell types contained within a 
colony grown in vitro provides a minimal estimate for the differentiation 
capacity of a progenitor cell. This has led to the characterization of several 
CSFs (Nicola, 1987a). In the murine system a number of CSFs that control 
the formation and function of granulocytes and macrophages have been 
purified to homogeneity and the genes have been cloned, sequenced and 
brought to expression (reviewed by Metcalf, 1985b; 1985c; 1986b; 
Broxmeyer, 1986). 
On the basis of in vitro clonal studies, haemopoietic growth factors may 
be classified into multi lineage growth factors, which stimulate the prolif-
eration and differentiation of primitive multipotent progenitor cells into more 
than one fully differentiated blood cell type, and lineage specific growth 
factors which act on cells capable of forming only one differentiated cell type 
(Stanley et al., 1986; Warren and Moore, 1988; Walker et al., 1985; Nicola, 
1987b; Spivak, 1986). An example of a multilineage growth factor is inter-
leukin-3 (I L-3; I hie et al., 1982), whereas CSF-1 or M-CSF (Stanley and 
Heard, 1977) is an example of a lineage specific growth factor. A third class 
of haemopoietic growth factors has been described that enhances the effect 
of other factors while they do not exert any growth promotion on their own. 
Such factors have been termed synergistic factors (SFs), although enhancing 
factors is probably a better term (for a recent review on SFs, see 
Quesenberry, 1986). Addition of SFs together with other growth factors 
results in increased colony numbers or sizes. In addition, SFs enable other 
growth factors like CSF-1 to act on more primitive cells than those stimulated 
to proliferate and differentiate by these growth factors alone (Quesenberry, 
1986; Chen and Clark, 1986; Koike et al., 1986; Warren and Moore, 1988; 
Bartelmez and Stanley, 1985; Williams et al., 1987a; Boland Williams, 1980; 
Stanley et al., 1986; lscove, 1978; lscove et al., 1982; Broxmeyer, 1986). 
An example of a SF is hemopoietin-1 (Bartelmez and Stanley, 1985; Jubinsky 
and Stanley, 1985). 
In this section results of experiments are reported that were designed 
to characterize both Rh123 subpopulations present in the CFU-S enriched 
WGA+/15-1.1- suspension (see previous sections). For this purpose both 
Rh123 fractions were cultured in semisolid agar medium to investigate if 
these two fractions did contain in vitro colony forming cells besides CFU-S 
and also if a difference between the two fractions with respect to the number 
of colony forming cells could be observed. The Rh123 subpopulations were 
cultured in the presence of recombinant murine I L-3 (prepared by Dorssers 
et al., unpublished results), recombinant human interleukin-1a (I L-1) which 
was recently shown to be biologically, biochemically and antigenically 
identical with hemopoietin-1 (H-1; Jubinsky and Stanley, 1985; Bartelmez and 
Stanley, 1985; Moore and Warren, in press; Mochizuki et al., 1987; 
Groopman, 1987), a crude preparation of PMUE which is known to be the 
main source of CSF-1 or M-CSF (Bradley et al., 1971; Stanley and Heard, 
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1977; Bradley and Hodgson, 1979). or with combinations of these factors. 
The results are shown in Table 6. 4. It can be seen that neither in the 
Rhl23 dull, nor in the Rhl23 bright fraction, any colony growth was 
observed in the presence of I L-1 alone. This lack of colony formation is ih 
agreement with data in the literature for H-1 or IL-l (Stanley et al., 1986; 
Mochizuki et al., 1987; Moore and Warren, 1987; Bartelmez and Stanley, 
1985; Jubinsky and Stanley, 1985; Neta et al., 1987; Quesenberry, 1986). 
Stimulation with (combinations of) other growth factors showed that both 
Rhl23 fractions were enriched in colony forming cells with regard to unsepa-
rated bone marrow. The number of colonies derived from responsive pro-
genitor cells in the Rhl23 bright fraction was considerably higher than in 
the Rhl23 dull fraction, particularly when colony formation was induced in 
the presence of I L-3 alone. 
Table 6.4 
IN VITRO CULTURE OF PURIFIED STEM CELL FRACTIONS 
colonies/1 o5 nucleated cells 
sorted fraction 
growth factor ( s) unseparated WGA+/15-1.1- WGA+/15-1.1-
added bone marrow Rhl23- Rhl23+ 
PMUE 140 ± 13 1010 ± 625 ( 7) 3349 ± 1807 ( 24) 
I L-1 2 ± 1 0 ( O) 0 ( 0) 
JL-3 107 ± 12 1095 ± 623 (1 0) 11953 ± 2619 ( 112) 
IL-l + JL-3 121 ± 12 2474 ± 913 (20) 15674 ± 3156 ( 130) 
IL-l + PMUE 160 ± 14 1991 ± 882 ( 12) 4890 ± 1478 ( 31) 
JL-3 + PMUE 174 ± 15 7100 ± 1840 ( 41) 20325 ± 3005 ( 117) 
IL-l + IL-3 + PMUE 183 ± 13 14166 ± 2790 (77) 21411 ± 5127 ( 117) 
BCBA low density bone marrow cells were stained and sorted as described in 
the text and Chapter 2. Unseparated bone marrow cells and cells in the 
sorted fractions were cultured in semi-solid agar medium as described in 
Chapter 2. The figures represent the mean number of colonies per 105 
nucleated cells of two experiments ± SE counted at day 7. Numbers of cells 
plated per culture dish: unseparated bone marrow 5 x 104; 
WGA+/15-l.l-/Rh12r (dull) 100 and 600 cells; WGA+/15-l.l-/Rhl23+ (bright) 
100 and 500 cells in two separate experiments. Numbers within parentheses 
represent the mean enrichment factor of colonies in sorted fractions with 
regard to unseparated bone marrow cells. 
After stimulation with IL-3 the number of colonies in the Rhl23 bright 
fraction was 11 times higher than that in the Rhl23 dull fraction. I L-3 is 
known to have a broad range of proliferative effects on murine haemopoietic 
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populations (Metcalf et al., 1987). IL-3 has been reported to stimulate, by 
direct action, the clonal proliferation in semisolid cultures of multipotent, 
granulocytic (neutrophilic), macrophage, eosinophilic, megakaryotic and 
erythroid progenitor cells to form colonies of differentiating progeny (Suda 
et al., 1985; Rennick et al., 1985; lhle et al., 1982; 1983; Bazill et al., 
1983; Cutler et al., 1985; Nicola and Metcalf, 1986; Clark-Lewis et al., 
1984). Our present data indicate that I L-3 by itself is not sufficient to 
stimulate colony formation by purified pluri- or multipotent haemopoietic stem 
cells. 
Rh123 dull cells seem equally sensitive to IL-3 and PMUE when it is 
assumed that this fraction is homogeneous. However, it could also indicate 
that two different types of progenitors are present in this fraction. The 
Rh123 bright cells were 3 to 4 times more sensitive to IL-3 than to PMUE. 
PMUE · is relatively specific in stimulating the proliferation of relatively 
mature macrophage progenitors with low proliferative potential (CFU-M or 
LPP-CFC; Bradley and Hodgson, 1979; Bradley et al., 1980), resulting in 
the formation of small colonies that almost exclusively consist of macro-
phages. Another more primitive progenitor cell which generates very large 
macrophage colonies in agar culture has been described. These progenitor 
cells have been named high proliferative potential colony forming cells 
(HPP-CFC; Bradley and Hodgson, 1979; Bradley et al., 1980). The formation 
of colonies by HPP-CFC is dependent on the presence of a combined stimulus 
consisting of a source of CSF-1 and a source of synergistic activity; either 
H-1 or IL-3 (Bradley and Hodgson, 1979; Bradley et al., 1980; Bertoncello 
et al., 1986, 1987). Subsets of H PP-CFC differing in their regeneration rate 
after FU treatment and in their recloning capacity can be identified by their 
differing SF requirements (McNiece et al., 1986; 1987; Bertoncello et al., 
1986; 1987; Bartelmez and Stanley, 1985; Bartelmez et al., 1985). HPP-CFC-1 
are responsive to the combined stimulus of CSF-1 plus a source of H-1, 
whereas HPP-CFC-2 are responsive to the combination of CSF-1 and IL-3. It 
has been determined by replating experiments that HPP-CFC-1 are more 
primitive cells than HPP-CFC-2, since the former can generate the latter, 
while both types of HPP-CFC can generate LPP-CFC (McNiece et al., 1986; 
1987). Recently, Bertoncello et al. (1987) described the existence of another 
type of HPP-CFC that strictly requires a combination of CSF-1, H-1 and IL-3 
and has the characteristics of a very primitive cell type. However, the 
status of this subpopulation of HPP-CFC in relation to HPP-CFC-1 is as yet 
unknown. 
In the Rh123 dull fraction the combined stimulus of PMUE and IL-1 
resulted in a two-fold higher number of colonies than was expected on basis 
of the colony counts observed with each factor alone. In the Rh123 bright 
fraction the combination of PMUE and I L-1 resulted in only a slightly higher 
number of colonies than expected. Addition of PMUE and I L-3 to the Rh123 
dull fraction showed that both factors acted synergistically; the number of 
colonies was 3-4 times higher than expected, whereas in the Rh123 bright 
fraction the number of colonies was about equal to that expected. The 
combination of all three factors used in this study, clearly resulted in the 
highest number of colonies produced by progenitor cells present in the 
Rh123 dull fraction. This was also true for cells present in the Rh123 bright 
fraction, but addition of I L-1 to cultures stimulated with I L-3 and PMUE did 
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not result in extra colonies in this fraction in comparison with the number of 
colonies observed with PMUE and IL-3. In the Rhl23 dull fraction the 
number of colonies observed with I L-3 and I L-1 was about 2-fold higher than 
expected, whereas in the Rhl23 bright fraction the combined stimulation with 
IL-3 and IL-l did not or only weakly increased the number of colonies. It 
was reported that H-1 acts on the most primitive cells yet shown to prolif-
erate and differentiate in culture and that H-1 permits CSF-1 or I L-3 to act 
on cells more primitive than those acted on by either factor alone (Stanley et 
al., 1986). The results indicate that the Rhl23 dull cells are more sensitive 
to IL-l in the presence of other growth factors than the Rhl23 bright cells, 
suggesting that the former are more primitive cells. 
In the present study, the diameter of the colonies was not determined 
routinely. However, there were clearly large HPP-CFC derived colonies 
present. In one experiment, the colonies could be easily counted with the 
naked eye. Colonies stimulated with IL-3 and PMUE or IL-l and PMUE were 
generally large and colonies cultured in the presence of all three growth 
factors were even larger. In contrast, the great majority of the colonies 
grown in the presence of IL-3 or PMUE alone or in the presence of IL-3 plus 
I L-1 could not be counted with the naked eye. The number of macroscopic 
colonies in the Rhl23 bright fraction was higher than the number of such 
colonies in the Rhl23 dull fraction. The highest amount of macroscopic 
colonies in the Rhl23 dull fraction was observed in the presence of the 
combined stimulus of PMUE, I L-3 and I L-1. With this combination, 24% of all 
colonies could be counted with the naked eye. In the Rhl23 bright fraction, 
stimulation with PMUE plus I L-3 and PMUE + I L-1 + I L-3 resulted in the 
highest number of macroscopic colonies, i.e., 17% of all colonies present 
(data not shown) . 
During the course of the cell separation procedures used in the present 
study most of the monocytes and lymphocytes were removed (previous 
section). When exposed to I L-1, bone marrow accessory cells like endothelial 
cells, fibroblasts and macrophages, but also T -lymphocytes are capable of 
CSF production. In the same way exposure to one kind of CSF can induce 
the release of other cytokines, such as IL-l and other kinds of CSFs by 
these cell types (Moore et al., 1980; Moore and Warren. 1987; Lee et al.. 
1987; Neta et al., 1987; Broudy et al., 1987; Broxmeyer, 1986; Oppenheim 
et al., 1987; Warren and Ralph. 1986). These secondary factors can 
influence the proliferation and differentiation of progenitor cells present in 
cultures where monocytes and lymphocytes are present (Williams et al., 
1987a; Broxmeyer, 1986). It could be that removal of these cells adversely 
affects the growth of progenitor cells present in the sorted fractions. This 
was investigated by adding monocytes (WGA+/(15-1.1+ and 15-1.1++). low 
density blast cells), or lymphocytes (low density WGA negative cells) to the 
cultures in quantities corresponding to their frequency in unseparated bone 
marrow. Addition of monocytes or lymphocytes resulted in basically the same 
numbers of colonies as observed without the addition of these cells (data not 
shown). This was observed for both Rhl23 fractions. This indicates that the 
colony formation observed by progenitors present in these fractions was a 
result of the direct action of the added growth factors on their target cells. 
128 
IN VITRO COLONY FORMATION OF THE Rhl23 DULL AND BRIGHT SUB-
POPULATIONS PRESENT IN THE WGA+/WGA+ BONE MARROW SUSPENSION 
In the previous section it was shown that the used growth factors acted 
directly on the sorted and cultured cells. However, it has also been reported 
that serum present in the culture medium might contain SFs, CSFs as well as 
other growth factors and hormones that can modulate CSF activities (Eliason, 
1986; Eliason and Odartchenko, 1985; Suda et al., 1986; Koike et al., 1986). 
It was shown by Eliason (1986) who compared serum-free and serum con-
taining cultures, that fetal calf serum modulated the effects of 3 different 
growth factors in different ways and to different extents. In addition, crude 
sources of CSFs might also contain serum proteins that may influence CSF 
activities (Baines et al., 1984). Thus, to improve the specificity of the 
culture system and to delineate the roles of CSFs and the characteristics of 
the cultured cells it is desirable to use purified growth factor suspensions 
and serum free chemically defined culture systems. 
In the present study the Rhl23 dull and bright cells present in the 
population of cells isolated by two subsequent WGA/FITC sorts (Lord and 
Spooncer, 1986) were examined for their colony forming ability in vitro in 
serum free methylcellulose culture medium (see Chapter 2). Results of an 
experiment are shown in Table 6.5. In general, the Rhl23 bright fraction 
contained mucli more progenitor cells than the Rh123 dull fraction, except 
for cultures stimulated with IL-l alone. IL-l on its own is unable to support 
any colony formation in both Rhl23 fractions. Stimulation with I L-3 resulted 
in a high number of colonies in the Rhl23 bright fraction; one out of 5 
plated cells was capable to develop a colony. The Rhl23 dull fraction was 
much less efficiently stimulated by I L-3 alone. 
In the experiment presented here (Table 6.5) a purified, serum free 
preparation of CSF-1 was used (Chapter 2). CSF-1 stimulated the formation 
of macrophage colonies only, over a wide range of concentrations 
(Wagemaker, personal communication). The Rhl23 bright fraction contained 
14 times more CSF-1 responsive progenitor cells than the Rhl23 dull 
fraction. The same ratio between the number of colonies from the Rhl23 
bright and dull fractions was observed after stimulation by IL-3. However, 
the number of colonies stimulated by CSF-1 was 2-3 times lower than that 
stimulated by IL-3. Although both CSFs stimulate macrophage progenitors the 
difference in colony numbers indicates that this might be different 
progenitors. 
The number of CSF-1 responsive cells in the Rhl23 bright fraction of 
the WGA + /WGA + suspension was 2. 5 times higher in the experiments 
described in Table 6. 5 than that in the Rh.l23 bright fraction of the 
WGA+/15-1.1- cells, stimulated with PMUE (Table 6.4). PMUE is the main 
source of CSF-1 and both primarily support the formation of macrophage 
colonies (Bradley et al •• 1971; McNiece et al., 1986; Stanley and Heard, 
1977). The number of colonies developed after stimulation with CSF-1 in the 
Rhl23 dull fraction of the WGA + /WGA + population was lower than that 
observed after stimulation with PMUE in the corresponding Rhl23 dull 
fraction from Table 6. 4 (compare Tables 6. 5 and 6. 4). This either indicates 
that the two sorted suspensions are different, or that the presence or 
absence of serum in the culture media or growth factor preparations or the 
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semisolid supportive medium caused the differences. This was not further 
investigated. 
Table 6.5 
IN VITRO CULTURE OF PURIFIED STEM CELL FRACTIONS 
colonies per 105 nucleated cells 
sorted fraction 
growth factor ( s) WGA+/WGA+ WGA+/WGA+ 
added Rhl23- Rhl23+ 
IL-l 0 0 
IL-3 1497 ± 669 21150 ± 2744 
CSF-1 599 ± 423 8383 ± 1506 
Epo + hemin 0 1198 ± 874 
IL-l + IL-3 299 ± 299 38623 ± 3401 
IL-l + CSF-1 898 ± 519 13174 ± 1986 
IL-l + Epo + hemin 299 ± 299 898 ± 519 
IL-3 + CSF-1 12874 ± 1963 39222 ± 3427 
IL-3 + Epo + hemin 5389 ± 1270 36826 ± 3321 
O* 5988 ± 1339* 
IL-l + IL-3 + CSF-1 9880 ± 1720 49401 ± 3846 
I L-1 + IL-3 + Epo + hemin 1198 ± 599 41317 ± 3053 
O* 6886 ± 1436* 
BCBA low density blast cells were sorted on basis of WGA/FITC fluorescence 
and Rhl23 fluorescence as described in the text and Chapter 2. Sorted cell 
fractions were cultured in serum-free methylcellulose medium (Chapter 2). 
Colonies were scored after 14 days. Cells were plated in duplicate at a 
density of 170 cells per dish. Figures indicated with an asterisk (*) 
represent the number of colonies contain in~ erythroid cells. The figures 
represent the mean number of colonies per 10 sorted cells ± SE. 
Erythropoietin (Epo) was the first humoral factor shown to regulate 
haemopoietic differentiation. Epo is obligatory for the proliferation and 
differentiation of committed erythroid progenitor cells (Suda et al., 1986; 
Spivak, 1986). Epo increases the number of developing erythroid progenitor 
cells which are usually defined in vitro by .their ability to form colonies of 
cells containing hemoglobulin. Epo does not interact with either pluripotent 
or multi potent stem cells and, on its own is hardly able to stimulate the 
formation of colonies (Goodman et al., 1985). For a recent review on the 
actions of Epo, see Spivak ( 1986). 
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The protoporphyrin hemin was shown to enhance colony formation by mouse 
erythroid progenitors and multilineage stem cells in the presence of Epo 
(Monette and Sigounas, 1984; 1987; Holden et a I. , 1983; Lu and B roxmeyer, 
1983) and therefore was used in the present study. It can be seen that only 
a few Epo plus hemin responsive cells were present in the Rh123 bright 
fraction, whereas in the Rh123 dull fraction no such cells were present. The 
observed colonies did not contain any hemoglobinized cells. 
Schooley et al. (1987) reported that IL-l antagonizes the capacity of 
Epo to stimulate the proliferation of erythroid progenitor cells in vitro. A 
'Similar observation was made in the present study when the Rh123 cell 
fractions were stimulated with IL-1 and Epo plus hemin. There were no 
hemoglobinized cells present in the formed colonies. 
Simultaneous addition of I L-1 and I L-3 to Rh123 bright cells resulted in 
an almost two-fold higher number of colonies than was expected on basis of 
the colony counts after stimulation with each factor individually. In the 
Rh123 dull fraction stimulation with I L-1 and I L-3 resulted in a lower colony 
number than was expected. The different effects on the colony formation 
after the combined stimulus with I L-1 and I L-3 on both Rh123 fractions 
illustrates that the progenitor cells present in each fraction must be 
different. 
Stimulation of the Rh123 bright fraction with I L-1 and CSF-1, the 
combination that stimulates colony formation by HPP-CFC-1 (McNiece et al., 
1986; 1987; Bartelmez and Stan ley, 1985), resulted in a slightly higher than 
expected number of colonies. The same result is observed for the Rh123 dull 
subpopulation. The observed lack of synergism between IL-1 + CSF-1 with 
respect to extra colony formation is in contrast with data by others using FU 
treated bone marrow or partly purified untreated bone marrow (Baines et 
al., 1984; Bartelmez and Stanley. 1985; Quesenbery. 1986; Stanley et al., 
1986; McNiece et al., 1986; 1987) and could have been due to the purifi-
cation procedures. 
Stimulation with I L-3 and CSF-1 resulted in a six-fold higher than 
expected colony number in the Rh123 dull fraction which clearly demonstrates 
that these factors can synergize in this fraction, which was also observed in 
Table 6. 4. Synergism between these two factors was also observed by 
Williams et al. (1987a), who used highly purified CFU-GM progenitors as 
targets. In the Rh123 bright fraction the combined stimulus with I L-3 and 
CSF-1 also resulted in more than the expected number of colonies with 
respect to the colony numbers observed with each factor separately. In the 
Rh123 dull fraction a 3- to 4-fold higher number of colonies was observed 
than expected after stimulation with I L-3 plus Epo and hemin, while in the 
Rh123 bright fraction the number of colonies was only slightly higher than 
expected. Synergism between IL-3 and Epo was observed by a number of 
investigators (I scove, 1978; I scove et at., 1982; Bartelmez et al., 1985; 
Koike et al., 1986). In contrast with the Rh123 dull fraction where no 
hemoglobinized cells were detected after stimulation with I L-3 and Epo plus 
hemin in the Rh123 bright fraction about 16% of all colonies contained 
hemoglobinized cells. Although not further determined in the present study, 
the latter colonies could have been derived from the most primitive erythroid 
progenitor cell (BFU-E) (Axelrad et al., 1974) or from CFU-GEMM which are 
known to require both I L-3 and Epo at some time point in their differentia-
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tion (lscove, 1978; Prystowsky eta!., 1984; Suda eta!., 1985; Whetton and 
Dexter, 1986). 
The combined stimulus of IL-3, IL-1 and CSF-1 in the Rh123 bright 
fraction resulted in a very high number of colonies. Almost half of the 
plated cells gave rise to a colony. In the Rh123 dull fraction, this combi-
nation of growth factors did not result in the best colony formation. The 
number of colonies with I L-3 plus I L-1 and CSF-1 was somewhat lower than 
the colony number observed after stimulation with I L-3 plus CSF-1. This may 
be due to antagonism between I L-3 and I L-1. An antagonism between I L-1 
and I L-3 could also be found when the Rh123 dull fraction was stimulated 
with I L-1 plus I L-3 and Epo plus hemin. The number of colonies observed 
with this combination of stimuli was 4 to 5 times lower than that observed 
with IL-3 plus Epo plus hemin. In that case, CSF-1 seems to be better 
capable to overcome the antagonistic behaviour of I L-3 and I L-1 than Epo 
plus hemin. Finally, in the Rh123 bright fraction, addition of IL-1 plus IL-3 
and Epo plus hemin resulted in a slightly higher total number of colonies and 
number of haemoglobinized colonies than addition of I L-3 plus Epo and 
hemin. In this fraction no antagonistic effect is observed. 
SUSPENSION CULTURE OF THE Rh123 SUBPOPULATIONS PRESENT IN THE 
DOUBLE WGA SORTED CELL FRACTION 
The Rh123 subpopulations that can be distinguished in the suspension 
isolated on the basis of two sequential WGA/FITC sorts (Fig. 6.2C) were 
cultured under serum-free conditions in suspension cultures in order to 
investigate the capacity of both subpopulations to generate day-8 and day-12 
CFU-S and different types of in vitro clonogenic progenitor cells. 
Comparison of the numbers and types of CFU-S and progenitor cells, before 
and after the culture in the presence of added growth factors, could give 
information about the properties of the cells present in the cultures with 
respect to their self-renewal and differentiation capacities. 
In this experiment the number of spleen colonies detectable after 
injection of cultured Rh123 dull cells was too low to draw any reliable 
conclusions about the effect of the different growth factors or combination of 
growth factors. In addition, the day-12 CFU-S content of the Rh123 dull 
fraction cultures could not be accurately determined because most of the 
transplanted recipient mice died before the twelfth day post-transplantation. 
For these reasons, the results of the culture of the Rh123 dull cell fraction 
are not shown in Table 6.6. In this table only the numbers of day-8 and 
day-12 CFU-S present in the Rh123 bright fraction before and after a four 
day culture period are shown. 
At the onset of the cultures, high numbers of day-8 and day-12 CFU-S 
were present. Both types of CFU-S were (almost) completely lost when 
cultured in the presence of IL-1 alone. In the presence of IL-3 the day-8 
CFU-S number was almost two-fold increased, whereas at the same time the 
number of day-12 CFU-S was almost two-fold decreased. Migliaccio and 
Visser (1986) observed an almost 3-fold increase in day-7 CFU-S and a 
5-fold decrease in day-12 CFU-S numbers when they cultured 
WGA +I a-H-2K k+ sorted cells for four days with I L-3 under exactly the same 
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culture conditions. These investigators concluded that the increase in day-7 
CFU-S was due to IL-3 induced proliferation of resting day-12 CFU-S. 
However, they did not use Rh123 to further separate the sorted cells before 
culturing them. Stimulation with a combination of I L-3 plus I L-1 resulted in a 
synergistic production of day-8 CFU-S, while the number of day-12 CFU-S 
was maintained at the same level as with IL-3 alone. The extra production of 
day-8 CFU-S in the presence of IL-3 plus IL-1 suggests that there are two 
cell types present in the Rh123 bright fraction that can form day-8 CFU-S. 
One type is sensitive to I L-3 alone, whereas the other is sensitive to a 
combination of I L-3 and I L-1. Alternatively, I L-3 could be more effective in 
the stimulation of cells that can form day-8 CFU-S when I L-1 is also 
present. 
starting 
material 
£l!!l;y!:.e.9 Y!'!!l.l 
IL-1 
IL-3 
I L-1 + IL-3 
Table 6.6 
SUSPENSION CULTURE OF PURIFIED STEM CELLS 
number of CFU-S per 1 o5 nucleated cells 
WGA + /WGA +I Rh123+ 
day-7 CFU-S day-12 CFU-S 
3800 :!: 330 2600 :!: 255 
107 ± 107 0 
6767 :!: 853 1504 :!: 614 
18582 :!: 1413 1654 :!: 499 
At day 0 lethally irradiated BCBA mice were injected with 500 sorted cells 
for determination of the CFU-S content (chapter 2). A part of the sorted 
cells were put into serum-free suspension cultures ( 170 cells/ culture). After 
4 days the cultures were terminated and their CFU-S content determined. 
Groups of 5 to 8 recipient mice were injected with the equivalent of 133 
initially seeded cells. The number of CFU-S after suspension culture is 
expressed per 105 initially seeded sorted bone marrow cells. 
In Table 6. 7 the progenitor cell content of both Rh123 subpopulations 
before and after a four day culture period in the presence of (combinations 
of) 3 different growth factors are shown. Both Rh123 fractions were tested 
for their content of progenitor cells responsive to CSF-1 alone, recombinant 
murine GM-CSF alone and a combination of purified Epo and Con-A stimulated 
mouse spleen cell conditioned medium ( MSCM). In the experiments described 
in Table 6. 7 CSF-1 responsive progenitor cells are designated as CFU-M. 
Recombinant GM-CSF responsive progenitors are designated as CFU-GM. It 
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Table 6. 7 
SUSPENSION CULTURE OF PURIFIED STEM CELL FRACTIONS 
number of progenitor cells/ 105 initially seeded nucleated cells 
WGA+/WGA+/Rh123 dull WGA + /WGA +I Rh1 23 bright 
CFU-M CFU-GM BFU-E CFU-M CFU-GM BFU-E 
---
starting 
material 599± 423 3593± 1037 0 8383± 1584 39820± 3453 8982±1640 
9Jlt!!r:!!Q Y:!.i.!IJ. 
I L-1 0 0 0 0 0 0 
IL-3 0 6000± 3464 0 344000±26230 416000±28844 22000±6633 
CSF-1 0 4000± 2828 0 72000±12000 42000± 9165 0 
IL-1+1L-3 2000± 2000 20000± 6325 0 402000±28355 418000±28914 106000±14560 
IL-1+CSF-1 12000± 4899 2000± 2000 0 96000±13856 40000± 8944 0 
I L-3+CSF-1 16000± 5637 50000±10000 2000±2000 566000±41840 640000±35777 62000±11136 
I L-1+1 L-3+CSF-1 128000±16000 144000±16971 6000±3464 644000±39786 760000±38987 52000±10198 
BCBA bone marrow cells were sorted as described in the text and Chapter 2. Sorted cells were cultured for 4 
days in serum-free suspension culture ( 167 cells/ culture) or immediately plated ( 167/ culture dish) in serum-free 
methylcellulose medium as described in chapter 2. After 4 days the suspension cultures were terminated and the 
equivalent of 25 originally seeded cells plated in methylcellulose. Progenitor numbers are expressed as numbers 
per equivalent of 105 originally seeded cells. Colonies were counted after 14 days. Figures represent mean 
numbers of colonies from duplicate plates ± SE. 
has been reported that the combination of Epo and MSCM (providing I L -3) 
(Gearing et al.. 1985; Metcalf. 1985a; Kelvin et al., 1986) not only 
stimulates the formation of pure erythroid bursts, but also the formation of 
colonies containing granulocytes, erythrocytes, megakaryocytes and macro-
phages. These latter colonies are ·derived from multi lineage stem cells 
indicated by the abbreviation CFU-GEMM ( lscove, 1978; Fauser and Messner, 
1979; Johnson and Metcalf, 1977; Prystowsky et al., 1984; Suda et al., 1985; 
Whetton and Dexter. 1986). In the present study no distinction was made 
between the two types of colonies. All colonies generated in the presence of 
Epo + MSCM are designated as BFU-E, although in unseparated bone marrow 
this combination results in about one half mixed colonies and one half pure 
erythroid colonies (Wagemaker, personal communication). 
At the onset of the cultures a marked difference between the progenitor 
cell content of both fractions was observed. The Rh123 bright fraction 
contained much more progenitor cells of each type than the Rh123 dull 
fraction. In both fractions CFU-GM were predominant. In both fractions 5-6 
times fewer CFU-M we're present. The Rh123 dull fraction did not contain 
any BFU-E, while these cells were abundantly present in the Rh123 bright 
fraction. It has been described that in general most of the progenitor cells, 
including CFU-GEMM are rapidly proliferating and possess little or no 
self-renewal capacity and act as an amplification compartment for the 
production of mature cells (Metcalf, 1985a; 1985b; Moore and Williams, 1974; 
Dexter et al., 1984a; Metcalf et al., 1979; Nakahata and Ogawa, 1982a; 
Ogawa et al., 1983). This implies that any increase or maintenance of the 
progenitor cells after liquid culture must have been caused by the generation 
of these progenitor cells by more primitive cells. 
After 4 days in liquid culture in the presence of I L-1 alone, no CFU-M. 
CFU-GM and BFU-E could be recovered from both Rh123 fractions. Obvious-
ly, I L-1 alone was not capable to maintain or stimulate precursor cells for 
the tested progenitors. Stimulation of the Rh123 dull cell fraction with I L-3 
or CSF-1 alone did not result in the generation of CFU-M and BFU-E, 
whereas CFU-GM were generated in the presence of I L-3 or CSF-1. This 
indicates that in the Rh123 dull fraction I L-3 and CSF-1 responsive cells 
must be present that were able to form CFU-GM but not CFU-M and BFU-E 
during a four day culture period. 
The combined stimulus of IL-1 and IL-3 of Rh123 dull cells resulted in 
the generation of CFU-:-GM in a synergistic fashion. Again no BFU-E were 
generated and it is doubtful if CFU-M were generated. According to Stanley 
et al. (1986) H-1, permits IL-3 to act on more primitive progenitors than 
those acted upon by I L-3 alone. If this was true for the Rh123 dull cells it 
means that this more primitive precursor was not' oligopotent since it did not 
generate CFU-M and BFU-E or that the culture period was too short to allow 
the differentiation of this precursor into CFU-M and BFU-E. Culturing with 
IL-l plus CSF-1 resulted in a high production of CFU-M, but CFU-GM and 
BFU-E were not generated. These CFU-M are most likely formed by HPP-
CFC-1 (Bradley and Hodgson, 1979; Bradley et al., 1980; McNiece et al., 
1986; 1987; Bartelmez and Stanley, 1985). This is supported by data of 
McNiece et al. ( 1987) who reported that HPP-CFC-1 could generate CFU-M 
but not BFU-E. IL-3 + CSF-1, the combination which is known to stimulate 
HPP-CFC-2 to form colonies (McNiece et al., 1986; 1987) induces the 
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generation of CFU-M and CFU-GM and perhaps BFU-E in a synergistic 
fashion. The most effective stimulation of colony formation by Rh1 23 dull 
cells is the combined addition of IL-3, IL-1 and CSF-1. Bertoncello et al. 
( 1 987) described the existence of a subpopulation of HPP-CFC that strictly 
requires these three growth factors for colony development. It is clear from 
the presented data that the I L-3 + I L-1 + CSF-1 responsive progenitors must 
be at least oligopotent since they very efficiently generated CFU-M, CFU-GM 
and BFU-E. However, it is not known to what extent the assayed progenitor 
cells overlap. 
From the numbers of progenitor cells it is clear that during the culture 
a production of total nucleated cells must have occurred. It is not known 
how many cells are produced during the culture period, because the cell 
content of the culture tubes was not determined in this study. 
Stimulation of the Rh1 23 bright cells with I L-3 resulted in a significant 
generation of CFU-M ( 41 times the input number), CFU-GM (1 0 times the 
input number) and BFU-E (2-3 times the input number). The generation of 
BFU-E in the presence of IL-3 was not observed in the Rh123 dull fraction. 
This indicates that in the Rh123 bright fraction a tripotent or even a 
multi potent I L-3 responsive precursor cell was present, which was not 
detected in the Rh123 dull fraction. Stimulation of the Rh123 bright cells 
with CSF-1 alone resulted in the generation of CFU-M and CFU-GM but not 
BFU-E. This indicates that a CSF-1 responsive precursor for CFU-M and 
CFU-GM must have been present. This was unexpected since thusfar the 
generation of CFU-M was demonstrated by HPP-CFC only, which require two 
or more growth factors (Bradley et al., 1980; Bradley and Hodgson, 1979). 
Simultaneous addition of I L-1 plus I L-3 to the cultures did not lead to an 
increased generation of CFU-M and CFU-GM in comparison with IL-3 alone, 
whereas both factors synergistically induced the generation of BFU-E. A 
similar effect was observed for day-8 CFU-S (Table 6. 6) and it has been 
reported that BFU-E and day-8 CFU-S might be developmentally closely 
related (Chertkov and Drize, 1984; Gregory, 1976; Magli et al., 1982). No 
synergistic effect of I L-1 and CSF-1 was observed concerning the generation 
of CFU-M, CFU-GM and BFU-E. This could indicate that no HPP-CFC-1 were 
present in the Rh1 23 bright fraction. 
Only a slightly more than additive generation of CFU-M and CFU-GM 
was observed when IL-3 plus CSF-1 were added to the cultures. In contrast, 
the number of BFU-E was almost three times higher than expected and is 
hard to explain. Stimulation of the Rh123 bright cells with all three growth 
factors did not result in an extra increase in progenitor numbers in 
comparison with cultures stimulated with I L-3 + CSF-1 which was clearly the 
case in the Rh1 23 dull fraction. 
Thus, the suspension cultures followed by methylcellulose culture 
revealed a heterogeneity of both Rh1 23 fractions in response to growth 
factors. Enhancement by IL-1 is more clearly observed in cultures of Rh123 
dull sorted cells than in that of the Rh123 bright cells. 
DISCUSSION 
For a better understanding of the mechanisms control I ing the process of 
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proliferation (self-renewal) and commitment to differentiation of pluripotent 
haemopoietic stem cells (PHSC), pure populations of these cells are 
desirable. Several procedures have been developed for the purification of 
haemopoietic stem cell subpopulations (Bauman et al., 1986; Hoang et al., 
1983; Lord and Spooncer, 1986; Muller-Sieburg et al., 1986; Nicola et al., 
1981; Ploemacher et a I.,' 1987; Visser and Bol, 1981; Visser et al., 1984). In 
many of these procedures the CFU-S assay was used to identify and 
enumerate PHSC during the purification steps. However, the validity of the 
CFU-S assay as a means to quantitate PHSC came up for debate since it was 
shown that stem cells that give rise to spleen colonies eight days post-
transplantation (day-8 CFU-S) are not pluripotent but committed stem cells 
and are different from cells that generate colonies twelve days post-
transplantation (day-12 CFU-S) (Magli et al., 1982; Wolf and Priestley, 1986; 
Mulder et al., 1985; Harris et al., 1984a). In addition, it has been 
demonstrated that part of the spleen colonies visible at day-8, remain 
throughout day-12 post-transplantation (persistent colonies) (Magli et al., 
1982; Wolf and Priestley, 1986; Priestley and Wolf, 1985). 
It is generally held that day-12 CFU-S are more primitive cells than 
day-8 CFU-S (Micklem, 1983; Hodgson and Bradley, 1979; Rosendaal et al., 
1979; Mulder et al., 1985; Metcalf, 1984). However, at least a part of day-12 
CFU-S are not pluripotent. A discrepancy has been reported between the 
content of day-12 CFU-S and that of cells that could reconstitute the bone 
marrow of lethally irradiated recipients and protect these animals against 
radiation induced death (Mulder et al., 1985; Boggs et al., 1982; Ploemacher 
a'nd Brons, 1988b; Hodgson and Bradley, 1979; 1984; Hodgson et al., 1982; 
Van Zant, 1984). Marrow repopulating ability ( MRA) and radioprotective 
ability (for 30 days) are considered to be properties of real PHSC and might 
be better ways to determine the presence of PHSC in a bone marrow suspen-
sion than the CFU-S assay (Rosendaal et al., 1979; Hodgson and Bradley, 
1979; 1984; Watt et al., in press; Van Bekkum et al., 1981; Bertoncello et 
al., 1988; Metcalf, 1984). 
In the present study it was demonstrated that day-12 CFU-S purified 
from untreated bone marrow using three different procedures were hetero-
geneous with respect to the amount of uptake of the fluorescent dye Rh123, 
whereas day-8 CFU-S were uniformly stained with Rh123 (Table 6.1; Fig. 
6. 2). Furthermore, it was shown that subpopulations of highly purified 
day-12 CFU-S that could be distinguished on the basis of Rh123 staining 
were qualitatively different cells. Day-12 CFU-S in the Rh123 dull fraction 
were much more effective in the 30-day radioprotection of lethally irradiated 
mice than day-12 CFU-S from the Rh123 bright fraction (Table 6.2). In spite 
of this the majority of the day-12 CFU-S were recovered from the Rh123 
bright fraction as were almost all day-8 CFU-S (Table 6.1). Similar 
observations were made by Mulder and Visser (1987) using unseparated bone 
marrow. In addition, it was shown by Bertoncello et al. (1985) that Rh123 
dull cells had a much better MRA than Rh123 bright cells. In the present 
study the M RA of the sorted fraction was not determined. However, 
according to Van Bekkum et al. ( 1981) and Berton cello et al. ( 1988) deter-
mination of the radioprotective ability is probably the most accurate way to 
determine the presence of PHSC. Thus, day-12 CFU-S from the Rh123 dull 
fractions may be closely similar to true PHSC, while day-12 CFU-S from the 
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Rh123 bright fraction seem to have lost pluripotency. The presence of almost 
all day-8 CFU-5 and the majority of day-12 CFU-5 in the Rh123 bright 
fraction of the sorted suspensions, and the relatively poor radioprotective 
capacity of cells in this fraction compared with the Rh123 dull cells, indicate 
that day-8 CFU-5 and most of the day-12 CFU-5 are incapable to protect 
lethally irradiated recipients against radiation induced death. Although it 
seems that Rh123 dull and bright day-12 CFU-5 are qualitatively different 
cells it cannot be excluded that an even more primitive cell, the pre-CFU-5 
is copurified in the Rh123 dull fraction and that this cell is also responsible 
for the better RPA of the Rh123 dull cells (Hodgson and Bradley, 1979; 
1984; Hodgson et al., 1982; Van Zant, 1984; Mulder and Visser, 1987). 
The heterogeneity of day-12 CFU-5 revealed by Rh123 staining might be 
an explanation for the observed discrepancy between the day-12 CFU-5 
content and the marrow repopulating or radioprotective ability of a graft 
(Mulder et al., 1985; Bertoncello et al., 1985; Boggs et al., 1982; Hodgson 
et al., 1982; Hodgson and Bradley, 1979; 1984; Van Zant, 1984). It might 
also explain the defective ability of day-12 CFU-5 isolated by two sequential 
WGA/ FITC sorts to reconstitute haemopoiesis in vitro (Spooncer et al., 1985) 
because it can be calculated from the enrichment factors for CFU-5 (Table 
6.1) that only 33% of the isolated CFU-5 are Rh123 dull, using the procedure 
described by Lord and Spooncer ( 1986) . 
Actively cycling cells are more intensely stained by Rh123 than 
quiescent cells (Cohen et al., 1981; Darzynkiewicz et al., 1981). This should 
then indicate that almost all day-8 CFU-S and the majority of day-12 CFU-5 
are in active stages of the cell cycle (Fig. 6.1). This is in contrast with 
data reported by others showing that less than 1 0% of both day-8 and day-12 
CFU-5 are killed by 5-phase specific agents, like tritium thymidine, cytosine 
arabinoside and hydroxyurea ( Cherkov and Drize, 1984; Van Zant, 1984; 
Johnson and Nicola, 1984). In addition, it was reported that CFU-5 isolated 
on basis of WGA and a-H-2Kk fluorescence were all quiescent (G0/G1) cells (Visser et al., 1984; Migliaccio and Visser, 1986). Since there does not seem 
to be much difference between the three sort procedures used in the present 
study (Table 6.1; Fig. 6.2), it is assumed that the isolated cells using all 
three procedures are quiescent cells. Thus, the heterogeneity in Rh123 
staining intensities cannot be caused by the presence of actively cycling and 
quiescent cells. It seems more likely that the Rh123 staining reveals the 
existence of two stages of quiescence. The Rh123 dull cells may then be 
deep dormant (G0) cells, whereas the Rh123 bright cells may be (early) G1 
cells (Baines and Visser, 1983). In addition, it has been suggested that 
Rh123 uptake depends· on differentiation processes which might cause the 
presence of many or very active mitochondria (Mulder and Visser, 1987). In 
this respect, it was not surprising that almost all day-8 CFU-5 were brightly 
stained because it was demonstrated that day-8 CFU-5 are differentiating 
cells (Mulder et al., 1985). The few day-8 CFU-5 recovered from the Rh123 
dull fractions are probably quiescent cells or persistant day-8 colonies that 
remain in the spleen throughout day-12 post-transplantation (Wolf and 
Priestley, 1986). 
Rh123 selectively stains mitochondria (Johnson et al., 1980; James and 
Bohman, 1981) and the intensity of the staining is a measure for their 
activity. The observed heterogeneity of day-12 CFU-5 with respect to the 
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staining intensity could indicate that mitochondria of day-12 CFU-S can 
switch rapidly from an inactive (Rh123 dull) to an active (Rh123 bright) 
state. Since it has been reported that stem cells depend on glycolysis which 
takes place in the cytoplasm, and not on respiration which process is located 
in the mitochondria (Delio Sharba et al .• 1987; Whetton and Dexter. 1986; 
Whet ton et al., 1984; Dexter et al., 1984b). the Rh123 staining seems to be 
able to distinguish between stem cells that depend on glycolysis only and 
stem cells that depend on both glycolysis and respiration. Alternatively, it 
could be that the Rh123 dull cells have much less mitochondria than the 
Rh123 bright cells which meets the proposition that putative haemopoietic 
stem cells have very few mitochondria (Visser et al., 1984). 
It can be seen in Table 6.1 that employing any of the three procedures 
to purify CFU-S in combination with Rh123 staining, resulted in a high 
enrichment of Rh123 dull day-12 CFU-S. No big differences are observed 
between the three procedures, although it seems that selection by means of 
WGA and a-H-2Kk fluorescence resulted in the lowest enrichment of Rh123 
dull day-12 CFU-S. In the present study the spleen seeding efficiency 
(f-factor; Lahiri and Van Putten, 1970) of the different Rh123 fractions was 
not determined, so that it is not known what the purity of the fractions with 
respect to the different CFU-S types was. In this respect, it should be 
noted that Lord and Spooncer ( 1986) did not observe a change in the 
f-factor of CFU-S present in the suspension obtained by two sequential 
WGA/FITC sorts and CFU-S present in unseparated bone marrow. However, 
it has been proposed that cells which exhibit MRA preferentially home to the 
bone marrow rather than the spleen (Hodgson. and Bradley, 1979; Van Zant, 
1984). thus it could be that Rh123 dull cells which contain cells with MRA 
( Bertoncello et al., 1985) have a different (lower) spleen seeding efficiency 
as Rh123 bright cells. It should be noticed than, however, that each stem 
cell in the bone marrow may give rise to several spleen co'1ony forming cells 
and, therefore, to more than one late appearing spleen colony (Micklem et 
a I. , 1975). 
It can be deduced from Figs. 6. 3 and 6. 4 that selection by means of 
15-1.1 and WGA fluorescence is likely to result in the highest purity of 
Rh123 dull cells which exhibit repopulating ability. Selection with MCA 15-1 .1 
selectively removes granulocytes and monocytes, which appear to be Rh123 
dull (Fig. 6.3) and bind WGA/FITC conjugates (Pioemacher and Brons, 
1988a). This removal of mature monocytes and granulocytes will be less 
reproducible and specific when a second WGA/FITC sort or an a-H-2Kk sort 
are used. Thus, purification of cells exhibiting RPA employing WGA and 
15-1.1 fluorescence and Rh123 fluorescence as a last step, at present, seems 
the most effective and reproducible way. When 15-1.1 and WGA are conju-
gated with different fluorochromes this could be done more rapidly (Chapter 
5). 
Haemopoietic growth factor requirements can be used to define subsets 
of early haemopoietic progenitor cells ( Bertoncello et al., 1987; Metcalf, 
1984; Watt et al., in press). When the Rh123 fractions present in the 
WGA + /15-1.1- and WGA + /WGA + sorted suspensions were cultured in semisolid 
media, a striking difference between the Rh123 dull and bright fractions was 
observed. The Rh123 bright fractions contained (much) more colony forming 
cells than the Rh123 dull fractions, whereas both the Rh123 dull and bright 
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fractions contained more in vitro clonogenic progenitors than unseparated 
bone marrow (Tables 6.4 a~6.5). The Rh123 bright cells are very 
responsive to I L-3, resulting in high cloning efficiencies. Addition of other 
growth factors in combination with IL-3, roughly resulted in the expected 
(additive) numbers of colonies. It has been reported that IL-3 does not act 
on cells in G0 , but that other factors, e.g. IL-1 are required to make the 
cells leave G0 and start cycling (Quesenberry, 1986; Kelvin et al., 1986; 
Koike et al., 1987; Suda et al., 1985) for which IL-3 is needed. In addition, 
according to Moore and Warren (1987), IL-3 is not capable to act directly on 
the most primitive stem cells. These findings support the notion that Rh123 
bright cells are in G1 (active mitochondria) and are not the most primitive 
stem cells. 
Addition of two or three growth factors to cultures of WGA+/15-1.1-
Rh123 dull cells, resulted in a higher than additive number of colonies 
(Table 6. 4). This synergism between growth factors indicated that Rh123 
dull cells are more primitive than Rh123 bright cells (where no synergism 
was observed) because it has been reported that synergistic factors enable 
growth factors to act on more primitive cells (Quesenberry, 1986). The 
observation that Rh123 dull cells are sensitive to IL-1 in the presence of 
IL-3 and PMUE, while Rh123 bright cells are not, also suggested that Rh123 
dull cells are more primitive than Rh123 bright cells. It has been reported 
that IL-1 target cells are more primitive than IL-3 sensitive cells (Stanley et 
al., 1986; Bartelmez and Stanley, 1985; Jubinsky and Stanley, 1985). 
According to Pike and Nossal (1985) the action of IL-1 is related primarily, 
if not exclusively, to early events in the activation of G0 cells, which is in 
favour of the notion that Rh123 dull cells are G0 cells. 
When the Rh123 dull fraction of the double WGA sorted suspension was 
cultured, it was observed that I L-1 antagonized the action of I L-3 (Table 
6.5). This is hard to explain in view of the reported data showing that 
haemopoietic growth factors do not cross react with other growth factor 
binding sites (Nicola, 1987b). although Walker et al. (1985b) reported that 
some growth factors can down modulate receptors for other growth factors. 
The pattern of down modulation parallels the pattern of potency of its 
biologica I activity. 
The observed difference between the Rh123 dull cell fractions of the 
WGA+/15-1.1- and WGA+/WGA+ suspensions with respect to their sensitivity 
to I L-1 in combination with other growth factors is hard to explain, because 
no differences were observed for the Rh123 bright fractions and the staining 
profiles after Rh123 labelling (Fig. 6. 2) and the enrichments of CFU-S types 
also seemed very similar (Table 6.1). However, the different culture condi-
tions, i.e., agar and methyl cellulose respectively in the presence or absence 
of serum might have caused the observed differences. In addition, it might 
be that PMUE besides CSF-1 contains other factors that might have 
influenced the results. 
It was observed that the Rh123 dull cells in the double WGA sorted 
suspension could not be stimulated to produce erythroid cells, whereas the 
Rh123 bright cells could generate erythroid cells in the presence of IL-3 
plus Epo and hemin. This lack of erythroid colony formation by the Rh123 
dull cells is in agreement with the observation by Berton cello et al. ( 1988) 
that in unseparated bone marrow, the Rh123 bright fraction was predomi-
140 
nantly responsible for the erythroid repopulation. 
A four-day period in suspension culture of the Rh123 bright fraction 
from the WGA+/WGA+ sorted cell population in the presence of IL-3 or IL-3 + 
IL-1 resulted in a production of day-8 CFU-S whereas day-12 CFU-S were 
maintained at about 60% of the input level (Table 6. 6). The production of 
day-8 CFU-S is most likely caused by day-12 CFU-S present in the Rh123 
bright fraction. These Rh123 bright day-12 CFU-S strongly resemble day-12 
CFU-S that were present in cultures of purified CFU-S suspensions selected 
on basis of WGA and a.-H-2Kk fluorescence (Migliaccio and Visser, 1986; 
Mulder et al., 1985). It was shown that these day-12 CFU-S did not 
repopulate the thymus and did not exhibit RPA (Mulder et al., 1985; Mulder, 
1986). Thus, Rhl23 bright day-12 CFU-S obviously lost pluripotency which 
coincides with the production of day-8 C.FU-S and with the dependency on 
respiration. 
In vitro clonogenic progenitors, were generated by the Rhl23 dull cells 
during a four day suspension culture period (Table 6. 7). This is in 
agreement with the observation by Ploemacher et al. (1987) who reported 
that highly purified day-12 CFU-S suspensions which exhibited MRA and 
RPA had a high ability to proliferate and differentiate into more mature 
progeny. Rhl23 dull cells were effectively stimulated by the combination of 
IL-l plus IL-3 plus CSF-1 to generate clonogenic progenitor cells and seemed 
to be very sensitive to IL-l in combination with CSF-1 and IL-3 (Table 6.7). 
In contrast, Rhl23 bright cells did not seem to be sensitive to IL-l in 
combination with CSF-1 or IL-3, but responded to IL-3 only. The Rhl23 
bright fraction generated much more progenitors than the Rh123 dull 
fraction. Although some 8 FU-E were generated by the Rhl23 dull cells, much 
larger numbers of BFU-E were generated by Rhl23 bright cells. This might 
be explained by the close relationship between day-8 CFU-S which were 
almost exclusively recovered from the Rhl23 bright fraction (Table 6.1) and 
BFU-E (Magli et al., 1982; Gregory, 1976). It has been reported that the 
most primitive stem cells are absolutely dependent on I L-1 for survival, 
proliferation and up regulation of growth factor receptors (Moore and 
Warren, 1987). Since it has been proposed that JL-1 acts primarily if not 
exclusively on G0 cells (Pike and Nos sal, 1985) it may be that I L-1 acts as a 
competent factor inducing the Rh123 dull cells to leave G0 and enter the 
active stages of the cell cycle (Quesenberry, 1986; Kelvin et al., 1986). 
In conclusion, the Rh123 staining in combination with (previous) 
described purification procedures for day-12 CFU-S, allows for the purifi-
cation of a subpopulation of day-12 CFU-S which resemble the ultimate PHSC 
in MRA and RPA. Rhl23 staining also reveals heterogeneity of in vitro 
clonogenic progenitor cells with respect to their sensitivity for haemopoietic 
growth factors. 
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CHAPTER 7 
GENERAL DISCUSSION 
The haemopoietic system is a very complex system consisting of a large 
variety of cell types belonging to a number of differentiation lineages at 
different stages of maturation and with different functional capacities. The 
haemopoietic system can be subdivided into three compartments of increasing 
size and maturity: 1) the pluripotential (PHSC) and multipotential (MHSC) 
haemopoietic stem cells; 2) the lineage restricted committed progenitor cells; 
and 3) the mature blood cell types (chapter 1, Fig. 1.1). It is generally 
believed that all haemopoietic cells are derived from a small pool of PHSC 
which have the ability to self-renew and to generate the lineage restricted 
stem cells (CFU-C). CFU-C have lost the ability to self-renew but proliferate 
and differentiate into the mature blood cell types which exhibit highly 
specialized functions but have only a limited lifespan. Thus, haemopoiesis 
provides a unique opportunity to study the mechanisms controlling the 
generation of a great diversity of cell types from a common ancestor cell. 
Relatively much is known about the mature cell types with regard to 
their function, cell surface characteristics and morphology. In contrast, 
relatively little is known about the antigenic and functional properties of the 
various stem cell subpopulations and the changes they undergo during commit-
ment to a particular differentiation lineage and subsequent terminal differ-
entiation. This has generally been due to the very low frequency of stem 
cells in haemopoietic tissues and the fact that the various stem cell subsets 
cannot be distinguished from each other on the basis on morphological 
criteria (Ferrero et al., 1985; Van den Engh et al., 1981). Indeed, most 
stem cell types are identified solely by their ability to reconstitute the 
haemopoietic system of lethally irradiated recipients or to form colonies in 
vivo or in vitro. One of the problems in the study of haemopoiesis is that it 
is difficult to obtain various stem cell subpopulations in quantities sufficient 
and homogeneous enough for analysis at the molecular level. Another still 
unresolved problem is the lack of knowledge of the events leading to 
self-renewal or differentiation commitment of haemopoietic stem cells. 
Resolution of these problems would be aided by the availability of 
probes to distinguish and isolate multi-lineage and single-lineage restricted 
stem cells at the time of commitment. Since commitment takes place before 
typical morphological characteristics are developed (Van den Engh et al., 
1980) and since the cell membrane is intimately involved in receiving and 
transmitting molecular information (Berridge, 1982), the cell surface 
properties of a cell at a specific stage of commitment might be directly 
related to its maturational state and functional capacity. Therefore, methods 
depending upon the recognition of cell surface determinants specifically 
expressed by stem cells of different potentiality could be valuable for studies 
concerning the self-renewal and differentiation commitment of stem cells. 
Monoclonal· antibodies ( MCAs), especially in combination with flow cytometry, 
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have been shown to be powerful tools for the detection of cell surface deter-
minants. 
MCAs which recognize cell surface determinants unique to different 
types of haemopoietic stem cells would be ideal reagents to analyse the 
earliest differentiation steps in the stem cell compartment including the order 
of restriction of potentialities, to elucidate the relationships between the 
various stem cell subsets and to identify, purify and characterize subpopu-
lations of stem cells. Such MCAs might identify receptors involved in inter-
actions between stem cells and humoral or cellular regulatory elements. 
Comparison of the antigenic profile of stem cells and their progeny provides 
a method of analyzing cell surface changes that occur as cells differentiate 
and mature. This knowledge may help to elucidate the molecular mechanisms 
controlling differentiation and the function of certain specific surface 
antigens in this process. 
On basis of the above described considerations, in this study attempts 
were undertaken to produce MCAs that would specifically react with antigenic 
determinants uniquely expressed on subpopulations of haemopoietic stem cells 
(chapter 3 J. Despite an efficient ( intrasplenic) immunization protocol (Fig. 
3.4) which allowed the use of bone marrow suspensions significantly enriched 
for day-12 CFU-S, no MCAs were obtained which were exclusively directed 
against determinants uniquely expressed on these stem cells. In addition, no 
MCAs specific for any in vitro clonogenic progenitor cell type or for cells of 
a single differentiation pathway were produced (chapter 4). 
These results are in agreement with data from the literature and may 
most simply be explained by the assumption that stem cell specific antigens 
do not exist, which is in contrast with the hypothesis proposed by Till 
( 1976; Fig. 1.1). On the other hand, stem cell specific antigenic deter-
minants may exist but were not detected in the present studies due to a 
number of reasons. For instance, it is well known that polyethylene glycol 
(PEG) induced fusions have a low efficiency (fusion frequency under the 
most optimal conditions 1 o-5) and lack of specificity (Reason et al., 1987; Lo 
et al., 1984). Several considerable improvements of the fusion efficiency 
including "bridging" of specific immune 8-cells to the antigen and simulta-
neously to the myeloma cells by means of the avidin-biotin system prior to 
fusion, whether or not in combination with electrofusion, have been 
described (Reason et al.. 1987; Wojchowski and Sytkowski, 1986; Lo et al., 
1984). However, these improvements are described for soluble antigens only 
and do not seem feasible for cellular immunogens. Circumvention of this 
problem would be to use solubilized cell membranes obtained from purified 
stem cell suspensions. However, to solubilize membranes detergents are 
needed which may destroy the antigenic sites. 
A number of techniques that would improve the immunogenic response 
against weakly immunogenic antigens in a mixture of antigens or on a 
complex antigen (like cells are) have been described. They include neonatal 
tolerization with common unwanted antigens, cascade immunization and treat-
ment with cytostatic drugs (French et al., 1986; Golumbeski and Dimond, 
1986; Thalhamer and Freund, 1985). A disadvantage of most of these 
procedures is that they are complicated and long-lasting and therefore they 
were not used in the present study. 
Apart from the possibly insufficient purity of the immunization sus-
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pensions used, another reason why no stem cell specific antigens were 
detected might be a low sensitivity of the screening assays used. It is 
assumed that stem cell specific markers are related to the functional capacity 
of a cell, this could for instance be a growth factor receptor. It is known 
that growth factor receptors on haemopoietic cells are expressed in very low 
densities (Whetton and Dexter, 1986; Nicola, 1987a; 1987b; Metcalf, 1985c). 
The limit for cellular fluorescence detection in a flow cytometer is 
approximately 1000 molecules (Civin and Loken, 1987). This indicates that a 
distinction between a cell expressing for instance 100 growth factor receptors 
and a cell expressing no growth factor receptors at all can barely be made 
or not at all. Thus, stem cell specific MCAs may have been missed. This 
would have been circumvented by sorting the MCA labelled cells on a FACS 
followed by an assay of colony formation. Such an assay, however, would be 
impractical as a screening procedure for large numbers of newly formed 
hybridomas. 
On basis of the data described in chapter 4 of this thesis and the 
above mentioned considerations, the hypothesis of Till (1976) which does not 
exclude the existence of stem cell specific antigenic determinants can neither 
be accepted nor rejected. The hypothesis of Davis (1975) that PHSC are 
"null" cells can be rejected on the basis of the reactivity of some of the 
produced MCAs with CFU-5. 
Haemopoietic differentiation is a process of continuous changes rather 
than a series of discrete steps and involves the control of many different 
genes some of which are coding for cell surface determinants (Till, 1976; 
Fitchen et al., 1981; Civin and Loken, 1987). As a consequence it can be 
expected that cell surface antigens expressed on closely related cell types do 
not abruptly appear and disappear during the differentiation process and 
that changes in cell surface marker expression are observed rather as 
smooth quantitative increases or decreases. Indeed, most procedures for 
enriching haemopoietic stem cell subsets have relied on quantitative dif-
ferences in the level of expression of cell surface determinants. Early use of 
the FACS dealt primarily with sorting for cells expressing a single antigenic 
determinant. These studies did not result in very high enrichments and 
purifications of stem cell subsets. Better enrichments and purities were 
obtained by sequential multiparameter procedures employing more than one 
fluorescently labeled MCA or a combination of a fluorescently labelled MCA 
and lectins. In Fig. 7.1 the distribution and quantitative expression of 
certain cell surface determinants that appeared useful for purification and 
isolation of stem cell subsets is shown. From this figure it is clear that a 
particular differentiation state is characterized by the presence of a 
particular array of surface determinants and their quantitative expression, 
rather than the absence or presence of a single determinant. 
It can therefore be envisaged that multi parameter analysis in which the 
expression of a number of different determinants is measured at the same 
time might improve the speed and sensitivity for the identification and puri-
fication of a particular stem cell subpopulation. In this thesis (chapter 5) 
the use of such an approach has resulted in a new widely applicable 
procedure for the enrichment of murine CFU-5. In addition, it was shown 
that using simultaneous multiparameter analysis the expression of deter-
minants on CFC-5 could be determined without the need for CFU-5 assays. 
145 
... 
~ 
"' 
Qa-m2++ 
I 
I 
I 
' 
I 
I 
I 
I 
I 
I 
__ ,. 
Thy-1+ 
'":::~;~It,.,--
H-2K/D+ 
··-•'' Qa-m7+ 
VI Qa-m2++ ++ + Qa-m7 "''~'' -tilii[~~::! /~ece-,• j:::~,•l 
Thy-1+ 
• 
WGA+ 
0,,_,. 
Qa-m7++ 
It may be expected that investigation of more MCAs, either available ones, 
e.g., Thy-1, Qa-m7, or MCAs to be generated, might result in an improve-
ment in the isolation and purification of particular haemopoietic stem cell 
populations. 
Besides the use of MCAs which appeared to be very powerful tools for 
the resolution and enrichment of subsets of haemopoietic stem cells it has 
been demonstrated that haemopoietic stem cell subpopulations could also be 
separated on basis of differences in their DNA content and metabolic state 
by using a cell sorter (Pallavicni et al., 1985a; 1985b; 1987; Baines and 
Visser, 1983; Bertoncello et al., 1985; Mulder and Visser, 1987; Visser et 
al., 1981). With this approach (chapter 6), it was demonstrated that day-12 
CFU-S suspensions highly enriched and purified on basis of light scatter 
characteristics and cell surface properties, were heterogeneous with respect 
to the amount of uptake of the supravital mitochondrial stain rhodamine 123 
( Rh123). This not only suggested a difference between stem cells in these 
purified populations with respect to the state of activation of the mito-
chondria but also revealed a difference in reconstituting capacities of these 
cells. The Rh123 dull cell fraction appeared to have a higher capacity to 
protect lethally irradiated recipients against death, at least for 30 days, 
than the cells in the Rh123 bright fraction. Thus, a combination of multiple 
cell surface determinant expression measurements and Rh123 staining might 
result in the enrichment and purification of true PHSC. To confirm that the 
Rh123 dull day-12 CFU-S suspension contains PHSC, the long-term ( > 3 
months) reconstitution capacity of this cell fraction should be tested. The 
observed heterogeneity in highly purified day-12 CFU-S suspension indicates 
that the interpretation of results obtained with highly purified day-12 CFU-S 
suspensions should be reevaluated. The heterogeneity might also explain the 
observed discrepancy between the radioprotective capacity of a graft and the 
day-12 CFU-S content and the lack of self-renewal capacity in vitro of 
purified day-12 CFU-S suspensions (Boggs et al., 1982; Van Zant;""l984; 
Hodgson and Bradley, 1979; Spooncer et al., 1985). 
The results presented in this thesis clearly demonstrate that a 
combination of measurements of physical, cell surface and metabolic 
properties are indispensable for the purification of murine haemopoietic stem 
cell populations to high degrees. The availability of such highly purified 
stem cell suspensions is very important for a better understanding of the 
contribution of specific cell surface molecules (e.g., growth factor receptors) 
Figure 7.1: 
Schematic representation of the distribution of a number of cell surface 
determinants expressed on cells of the primitive stem cell compartment. 
++ high density or all cells positive for this determinant. 
+ intermediate density. 
+/- low(er) density or subpopulation of cells positive for this 
determinant. 
expression of determinant not demonstrable. 
Data obtained from the literature cited in this thesis and from the 
present studies (MCA 15-1.1). 
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to cellular function during sequential stages of development. In addition, 
these highly purified stem cell suspensions are of importance in the search 
for growth factors which induce self-renewal which is necessary for the 
introduction of cloned genes to correct genetic defects by bone marrow 
transplantation. Culture of stem cells in unseparated bone marrow for this 
purpose leads to unwanted differentiation due to the production of growth 
factors by mature cells. Finally, purified pluripotent haemopoietic stem cells 
are not only an interesting alternative for T -cell depletion to obviate the 
often life-threatening acute Graft-versus-Host disease of allogeneic trans-
plants, the use of purified stem cells also has considerable advantages to 
study the role of committed precursor cells or specific subpopulations of 
lymphocytes in graft-rejection. 
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SUMMARY 
Haemopoiesis is a complex ongoing process in which many interactions 
between a large number of different cell types of various maturation stages 
and humoral factors are involved. All the different cell types that can be 
found in the peripheral blood are derived from a small pool of common 
ancestor cells: the pluripotential haemopoietic stem cells (PHSC). PHSC are 
capable to reconstitute cell compartments of the haemopoietic system of 
lethally irradiated recipients. The fraction of cells that gives rise to discrete 
macroscopic colonies on the spleen of lethally irradiated recipients (CFU-S) 
are generally equated with PHSC. Besides the PHSC a number of haemo-
poietic stem cells with more restricted potentialities have been described by 
the use of in vitro clonal assays. Some of these stem cells can give rise to 
descendants-in--a-number of lineages: the multipotential haemopoietic stem 
cells (MHSC), whereas others can give rise to mature cells belonging to only 
one (or two) differentiation pathway ( s) : the lineage restricted stem cells, or 
committed progenitor cells (CFU-C). The various stem cell subsets are 
present in only very low frequencies in the complex heterogeneous bone 
marrow and cannot be distinguished from each other on the basis of morpho-
logical criteria. Indeed, most stem cell subpopulations are still solely 
identified on the basis of the type of colonies they produce in in vivo or in 
vitro clonal assays. - -- -
--It is generally assumed that cell surface molecules on haemopoietic stem 
cell subsets must be intimately involved in the mechanisms controlling the 
selfrenewa I, pro I iferation and commitment of these cells. Therefore, a 
detailed knowledge of the cell surface make-up of haemopoietic stem cell 
subsets might contribute to a better understanding of the function of these 
cells and the complex processes taking place during the earliest steps in 
haemopoietic stem cell differentiation. Monoclonal antibodies (MCAs) that 
would exclusively react with cell surface determinants uniquely expressed on 
(subsets of) haemopoietic stem cells, together with flow cytometry and cell 
sorting, would be ideal reagents for the identification. purification and 
characterization of these cells. Highly purified stem cell suspensions would 
make it possible to directly analyse these cells and to further elucidate the 
relationships between the various haemopoietic stem cell subpopulations and 
the processes that control self renewal, proliferation and differentiation 
commitment of these cells. 
The experiments described in this thesis were aimed at the production 
of haemopoietic stem cell (subset) specific mo'noclonal antibodies and the 
application of these for the purification and characterization of the 
haemopoietic stem cell subpopulations. 
In chapter 1 some of the basic principles of haemopoiesis and the 
various haemopoietic stem cell subpopulations and the assays for their 
detection are introduced. In addition. different techniques for the 
segregation and purification of stem cells are introduced. Special attention is 
payed to the role cell surface structures may play in the control of 
haemopoiesis and the usefulness of the knowledge of these structures for the 
purification of stem cell subsets. 
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In chapter 2, the animals, equipment and technical procedures used in 
this thesis are described in detail. 
Chapter 3 deals with the production of MCAs that would specifically be 
directed against cell surface determinants uniquely expressed on CFU-S 
and/or various types of CFU-C. It was demonstrated, by comparison of three 
different rat strains and myeloma cell lines of rat and mouse origin, that 
fusions between immune BN-rat spleen cells and mouse myeloma cells (SP2) 
resulted in the highest number of stable MCA producing hybridomas. In 
addition, it was found that the frequency of MCA producing hybridomas 
obtained was higher when rats were immunized by intrasr,lenic (i. s.) 
injection of relatively small numbers of cells (approximately 1 0 ) than after 
i.p. and/or i.v. immunization with approximately 100-fold higher numbers of 
cells. This injection made it possible to use significantly for day-12 CFU-S 
enriched cell suspensions for immunization. 
In chapter l!, ten of the in this way produced MCAs are characterized. 
It appeared that none of the MCAs was specifically directed against CFU-S 
or any of the tested committed progenitor cell types ( CFU-GM, CFU-M, 
CFU-C2, BFU-E). The reactivity of the MCAs could be roughly divided into 
two groups. One group of MCAs reacted with only small percentages of bone 
marrow cells. None of the MCAs from this group, except one (15-2.4) was 
reactive with CFU-S or any of the tested committed progenitor cells. MCA 
15-2 .l! reacted with 50% of the BFU-E. The MCAs of the other group all 
reacted with larger percentages of bone marrow cells and some of them 
reacted with CFU-S or ( subpopulations of) committed progenitor cells. Two 
MCAs from this second group were most likely directed against antigenic 
determinants on previously described cell surface structures: the leukocyte 
common antigen (MCA PVS.G) and the transferrin receptor (MCA 10-2.2), 
and could be of use for the negative selection of CFU-E and BFU-E, respec-
tively. Two other MCAs of this group were directed against a determinant 
expressed on a subpopulation of CFU-M (MCA 15-1.1) and/or CFU-GM (MCAs 
15-1.1 and 7-15.1) and could therefore be potentially of use in studies 
concerning the heterogeneity of granulocyte-macrophage progenitors. In 
addition, MCA 7-15.1 and MCA 15-1.1 in particular, could be of use for the 
negative selection and purification of CFU-S, CFU-C2 and BFU-E. 
In chapter 5, a two-colour immunofluorescence, multiparameter single 
sort procedure is described for the purification of CFU-S. Based on this 
procedure, making use of list mode data analysis and processing, a three-
colour immunofluorescence, multiparameter flow cytometric screening assay 
was developed to determine the reactivity of MCAs with CFU-S. The use of 
this procedure resulted in similar conclusions about the reactivity of the 
MCAs with CFU-S as cell sorting experiments followed by a CFU-S assay 
(Chapter 4) and thus can drastically reduce the number of CFU-S assays 
needed. With this in vitro screening procedure approximately 20 MCAs could 
be accurately screened for reactivity with CFU-S in one day. In addition, it 
has the advantage that the results are known the same day. 
Screening of MCA 15-1.1 in this way resulted in the development of a 
new procedure for the negative selection and purification of CFU-S. It was 
demonstrated that selection with MCA 15-1.1 could replace selection with 
a.-H-2K k-biotin and a fluorescent avidin conjugate as was used previously. 
This is not only faster but also more widely applicable since the expression 
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of the determinant recognized by MCA 15-1.1 is not mouse strain (H-2 
haplotype) restricted. In addition, it was shown (chapters 5 and 6) that 
selection by means of MCA 15-1.1 results in purer CFU-S suspensions than 
can be obtained with previously applied purification procedures, because in 
the latter also an unpredictable amount of monocytes and granulocytes are 
selected, which is avoided by selection with MCA 15-1.1. 
In chapter 6, CFU-S were purified in three different ways. It was 
demonstrated by staining of the purified suspensions with the supravital 
mitochondrial dye Rh123 that the day-12 CFU-S in these suspensions were 
heterogeneous with respect to the amount of Rh123 uptake. The Rh123 dull 
fractions contained almost exclusively day-12 CFU-S whereas the Rh123 
bright fractions contained the majority of day-12 CFU-S and almost all day-8 
CFU-S. The day-12 CFU-S in both Rh123 fractions appeared to be qualita-
tively different cells. The Rh123 dull day-12 CFU-S were significantly better 
in 30..:day radioprotection experiments than the Rh123 bright day-12 CFU-S. 
The former day-12 CFU-S might therefore resemble PHSC, whereas the latter 
seem to have lost pluripotency. This observed heterogeneity of purified 
day-12 CFU-S after Rh123 staining necessitates a reevaluation of the results 
obtained with highly purified day-12 CFU-S suspensions and challenges the 
validity of the day-12 CFU-S assay as a measure for PHSC. 
Differences between both Rh123 fractions were also demonstrated after 
in vitro culture. Rh123 bright cells produced more colonies in agar and 
methylcellulose cultures than Rh123 dull cells. Rh123 bright cells could be 
very well stimulated by I L-3 alone, whereas the Rh123 dull cells were best 
stimulated in the presence of more than one growth factor and seemed more 
susceptible to the enhancing effect of I L-1 than the Rh123 bright cells. It 
was also demonstrated that in a four day suspension culture Rh123 dull cells 
could not or hardly be stimulated to generate BFU-E, whereas the Rh123 
bright cells could produce much larger numbers of these progenitors. 
Finally, in chapter ·7 (General Discussion) the most important results 
and their possible implications for future research are discussed and placed 
in broader perspective. 
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SAMENVATTING 
Hemopoese is een ingewikkeld continu proces waarin vele interakties 
tussen een groot aantal verschillende celtypen van verschillende rijpings-
stadia en humorale factoren zijn betrokken. AI de verschillende celtypen die 
in het bloed voorkomen zijn afkomstig van een klein aantal gemeenschappe-
lijke voorlopercellen: de pluripotente hemopoetische stamcellen (PHSC). PHSC 
zijn in staat om al de compartimenten van het hemopoetische systeem van 
letaal bestraalde ontvangers te reconstitueren. De cellen die in staat zijn 
discrete macroscopische knobbels (kolonies) op de milt van letaal bestraalde 
ontvangers te vormen (CFU-S) worden veelal gelijk gesteld met PHSC. 
Behalve de PHSC is er, door gebruik te maken van in vitro klonogene 
testen, een aantal hemopoetische stamcellen met beperktere potenties 
beschreven. Sommige van deze stamcellen kunnen nakomelingen geven in een 
aantal differentiatielijnen: de multipotente hemopoetische stamcellen (MHSC), 
terwijl anderen volwassen cellen kunnen vormen die slechts tot een (of twee) 
differentiatielijn (en) behoren: de differentiatielijn-gebonden stamcellen of 
gecommiteerde voorlopercellen (CFU-C). De verschillende typen stamcellen 
komen slechts in zeer lage frequentie voor in het bijzonder heterogene 
beenmerg en · kunnen niet van elkaar onderscheiden worden op grond van 
morfologische criteria. De meeste stamcelsubpopulaties zijn tot op heden 
uitsluitend te identificeren op grond van het type kolonie dat ze kunnen 
vormen in in vitro of in vivo klonogene testen. 
Het wordt algemeen verondersteld dat molekulen op het oppervlak van 
hemopoetische stamcelsubpopulaties nauw betrokken moeten zijn bij de 
mechanismen die de produktie van nieuwe stamcellen (11 self-renewal 11 ), de 
proliferatie en de differentiatielijn 11 vastle.gging 11 ( 11 commitment 11 ) van deze 
cellen reguleren. Daarom zou een gedetailleerde kennis van de samenstelling 
van het celoppervlak van hemopoetische stamcelsubpopulaties kunnen bij-
dragen tot een beter begrip van de functie van deze cellen en de complexe 
processen die plaats vinden tijdens de vroegste gebeurtenissen in de diffe-
rentiatie van hemopoetische stamcellen. Monoklonale antilichamen (in het 
Engels 11 monoclonal antibodies11 , MCAs) die uitsluitend zouden reageren met 
celoppervlaktedeterminanten die specifiek aanwezig zijn op ( subpopulaties 
van) hemopoetische stamcellen zouden, samen met 11 flow 11 cytometrie en cel-
sortering, ideale reagentia zijn voor de identificatie, zuivering en het 
karakteriseren van deze cell en. In hoge mate gezuiverde stamcelsuspensies 
zouden de direkte analyse van deze cell en mogelijk maken, alsmede het 
ophelderen van de relaties tussen de verschillende hemopoetische stamcel-
subpopulaties en de processen die de 11 self-renewal 11 , proliferatie en 
differentiatie 11 commitment11 van deze cellen reguleren. 
De in dit proefschrift beschreven experimenten waren gericht op de 
produktie van hemopetische stamcel ( subpopulatie) specifieke monoklonale 
antilichamen en de toepassing van deze voor het zuiveren en karakteriseren 
van hemopoetische stamcelsubpopulaties. 
In hoofdstuk 1 worden enkele basisprincipes van hemopoese en de ver-
schillende hemopoetische stamcelsubpopulaties en de technieken voor de 
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detektie van deze cellen geintroduceerd. Verder worden verschillende 
technieken voor de scheiding en zuivering van stamcellen besproken. 
Speciale aandacht wordt besteed aan de rol die celoppervlaktestructuren 
kunnen • spelen in de regulatie van hemopoese en het nut van kennis van 
deze structuren voor het zuiveren van stamcelsubpopulaties. 
In hoofdstuk 2 worden de in dit proefschrift gebruikte dieren, 
apparaten en technische procedures in detail beschreven. 
Hoofdstuk 3 handelt over de produktie van MCAs die specifiek gericht 
zouden zijn tegen celoppervlaktedeterminanten die uitsluitend op CFU-5 en/of 
verschillende CFU-C-typen zouden voorkomen. Het werd aangetoond door 
vergelijking van drie verschillende rattestammen en myelomacellijnen van rat-
en muis-origine, dat fusies tussen miltcellen van BN ratten en muizemyeloma-
cellen (SP2) in de hoogste frequentie van MCA- producerende hybridomas 
resulteerde. Bovendien bleek dat de frequentie van MCA-producerende 
hybridomas hoger was wanneer ratten werden geimmuniseerd door het direkt 
in de milt ( "intrasplenic") injecteren van relatief kleine aantallen cellen 
(circa 105) dan na i.p. en/of i.v. immunizatie met ongeveer 100x grotere 
celaantallen. De "intrasplenic" injectie maakte het mogelijk om met significant 
voor dag-12 CFU-S verrijkte celsuspensies te immuniseren. 
In hoofdstuk 4 worden 10 van de op deze manier geproduceerde MCAs 
gekarakterizeerd. Het bleek dat geen enkel MCA specifiek gericht was tegen 
CFU-S of een van de geteste gecommiteerde voorloperceltypen ( CFU-GM, 
CFU-M, CFU-C2, BFU-E). De reaktiviteit van de MCAs kon in twee groepen 
verdeeld' worden. Een groep MCAs reageerde met slechts kleine percentages 
beenmergcellen. Geen enkel MCA van deze groep, op een na (MCA 15-2.4) 
reageerde met CFU-5 of een van de geteste gecommiteerde voorlopercellen. 
MCA 15-2.4 reageerde met 50% van de BFU-E. De MCAs van de andere groep 
reageerden allemaal met grote(re) percentages beenmergcellen en sommige 
reageerden met CFU-S en/of (subpopulaties van) gecommiteerde voorloper-
cellen. Twee MCAs uit deze groep waren hoogst waarschijnlijk gericht tegen 
antigene determinanten van eerder beschreven celoppervlaktestructuren: de 
"leukocyte common antigen" (MCA PV5.6) en de transferrine receptor (MCA 
10-2.2). Deze MCAs zouden nuttig kunnen zijn voor de negatieve selektie 
van respectievelijk CFU-E en BFU-E. Twee andere MCAs uit deze groep 
waren gericht tegen een determinant aanwezig op een subpopulatie van de 
CFU-M (MCA 15-1.1) en CFU-GM (MCA 15-1.1 en MCA 7-15.1) en zouden 
daarom mogelijk van nut kunnen zijn voor studies naar de heterogeniteit van 
granulocyt-macrophaag voorlopers. MCA 7-15.1 en MCA 15-1.1 in het bij-
zonder, zouden bovendien van nut kunnen zijn voor de negatieve selektie en 
zuivering van CFU-5, CFU-C2 en BFU-E. 
In hoofdstuk 5 wordt een twee-kleuren immunofluorescentie, multipara-
meter, eenstaps "sort" procedure voor de zuivering van CFU-S beschreven. 
Gebaseerd op deze methode en gebruik makend van "list mode" data analyse 
en verwerking, werd een drie-kleuren immunofluorescentie, multi parameter 
"flow" cytometrische "screening" methode ontwikkeld om de reactiviteit van 
MCAs met CFU-5 te bepalen. Het gebruik van deze methode resulteerde in 
dezelfde conclusies wat betreft de reaktiviteit van MCAs met CFU-5 als 
celsorteringsexperimenten gevolgd door een CFU-S test (hoofdstuk 4) en kan 
daarom het aantal benodigde CFU-S testen drastisch verminderen. Met deze 
in vitro "screening" methode konden in een dag ongeveer 20 MCAs nauw-
keurig getest worden op reaktiviteit met CFU-S met als voordeel dat de 
resultaten van de testen dezelfde dag bekend waren. 
Het op deze manier "screenen" van MCA 15-1.1 resulteerde in de ont-
wikkeling van een nieuwe methode voor de negatieve selektie en zuivering 
van CFU-5. Het werd aangetoond dat selektie met MCA 15-1.1 selektie met 
a.-H-2Kk- biotine en een fluorescerend avidine conjugaat, zoals eerder werd 
gebruikt, kon vervangen. Dit is niet aileen sneller, maar ook algemener 
toepasbaar omdat de expressie van de determinant die door MCA 15-1.1 
herkend wordt niet beperkt is tot bepaalde muizestammen (H-2 haplotype). 
Het werd bovendien aangetoond (hoofdstukken 5 en 6) dat selektie van 
CFU-S door middel van MCA 15-1.1 in in hogere mate gezuiverde CFU-S 
suspensies resulteerde dan mogelijk was met de eerdere gebruikte zui-
veringsprocedures. Het bleek dat met de laatsten ook een onvoorspelbaar 
aantal monocyten en granulocyten wordt geselekteerd, hetgeen vermeden 
wordt door selektie met MCA 15-1.1. 
In hoofdstuk 6 werden CFU-S op drie verschillende manieren gezuiverd. 
Het werd aangetoond, door de gezuiverde suspensies te "kleuren" met de 
supravitale mitochondriale kleurstof Rh123, dat de dag-12 CFU-S in deze 
suspensies heterogeen waren wat betreft de hoeveelheid opgenomen Rh1 23. 
De fracties die weinig Rh1 23 had den opgenomen ( Rh1 23 "dull" fracties) 
bevatten bijna uitsluitend dag-1 2 CFU-S, terwijl de fracties die vee! Rh1 23 
hadden opgenomen (Rh123 "bright" fracties) de meerderheid van de dag-12 
CFU-S en bijna aile dag-8 CFU-S bevatten. De dag-12 CFU-S in beide Rh123 
fracties bleken kwalitatief te verschillen. De Rh1 23 "dull" dag-1 2 CFU-S 
bleken significant beter te zijn dan de Rh1 23 "bright" dag-1 2 CFU-S in 
30-dagen radioprotectie experimenten. De Rh1 23 "dull" dag-1 2 CFU-S zouden 
daarom PHSC kunnen zijn, terwijl de Rh123 "bright" day-12 CFU-S het 
pluripotente karakter lijken te hebben verloren. De waargenomen hetero-
geniteit van gezuiverde dag-1 2 CFU-S maakt het noodzakelijk de verkregen 
resultaten met gezuiverde dag-12 CFU-S suspensies opnieuw te beschouwen 
en stelt bovendien vraagtekens bij de waarde van de dag-1 2 CFU-S test als 
maat voor PHSC. 
Verschillen tussen be ide Rh1 23 fracties werden ook aangetoond na in 
vitro kweken. Rh1 23 "bright" cell en produceerden meer kolonies in agar en 
methylcellulosekweken dan Rh1 23 "dull" cellen. De Rh1 23 "bright" cellen 
bleken zeer goed gestimuleerd te kunnen worden door IL-3 aileen, terwijl de 
Rh123 "dull" cellen het best gestimuleerd werden in de aanwezigheid van 
meer dan een groeifactor en bovendien gevoeliger bleken voor het kolonie-
aantal-verhogende ("enhancing") effect van I L-1 dan de Rh1 23 "bright" 
cell en. Het werd ook aangetoond dat in een Ll dagen suspensiekweek Rh1 23 
"dull" cellen niet of nauwelijks gestimuleerd konden worden om BFU-E te 
genereren, terwij I de Rh1 23 "bright" cell en vee! grotere aantallen van deze 
voorlopercellen konden produceren. 
Tenslotte worden in hoofdstuk 7 (Aigemene Discussie) de belangrijkste 
resultaten en hun mogelijke toepasbaarheid voor verder onderzoek bediscus-
sieerd en in een breder perspectief geplaatst. 
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